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ABSTRACT 
 
The heterotrimeric AMP-dependent protein kinase (AMPK) family is activated 
upon low energy states, conferring a switch towards energy-conserving metabolic 
pathways through immediate kinase actions on enzyme targets, and delayed alterations in 
gene expression through its nuclear re-localization. This family has known roles in stress 
resistance, lifespan, and nutrient adaptation, making it a relevant target for improving 
human health. The budding yeast Saccharomyces cerevisiae (S. cerevisiae) AMPK, the 
SNF1 kinase, is readily activated by low glucose growth conditions making it a simple 
model to study the activation and activity of this enzyme class. These 3-subunit enzymes 
contain a highly conserved ubiquitin-associated (UBA) motif in most catalytic subunits 
whose function we have confirmed to be inhibitory. We demonstrated that UBA motif 
mutations significantly enhanced SNF1 kinase activation and biological activity including 
oxidative stress resistance and lifespan. Significantly, the enhanced UBA-dependent 
longevity and oxidative stress response is dependent on the Forkhead 1 (Fkh1) and Fkh2 
stress response transcription factors, which in turn influence Snf1 catalytic subunit 
expression. The catalytic subunits are poly-ubiquitinated in yeast and humans with 
negative regulatory impacts on enzyme activity, yet the ubiquitin cascade enzymes 
involved are unknown. S. cerevisiae has 13 ubiquitin conjugating enzymes (E2) and a 
simplified repertoire of ubiquitin ligases (E3) that were screened for their impact on 
SNF1 kinase activity. We discovered that a discrete cluster of stress-responsive E2s 
(Ubc1, Ubc4, and Ubc5) and their associated E3 enzyme, Rsp5, affected discrete aspects 
of SNF1 kinase regulation, none through proteolytic degradation. The deletion of Ubc1 
lowered catalytic subunit abundance, due to a synchronized decrease in Fkh1/2 proteins 
resulting in impaired SNF1 gene transcription. Furthermore, the Fkh1/2 cognate 
transcription factor, Hcm1, failed to enter the nucleus in the absence of Ubc1. This 
implies that Ubc1 acts indirectly through transcriptional effects to modulate SNF1 kinase 
activity. We also determined that yeast strains disrupted for Ubc4/5 and Rsp5 functions 
were markedly impaired for nuclear import of the SNF1 kinase despite its full 
phosphorylation and activity, all without effecting protein stability. Together, this study 
supports a positive role for ubiquitin enzyme cascade in SNF1 kinase activation at 
multiple steps and is not limited to proteolytic degradation.  
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CHAPTER 1 Literature Review 
1.1 Yeast is a fundamental tool to study biology 
Yeast is one of the simplest eukaryotes, yet many essential cellular processes are 
the same in yeast and higher eukaryotic cells. Many important proteins in humans and 
other mammals were first discovered through their yeast orthologs, including enzymes, 
cell cycle proteins, and cell signaling proteins (Ohsumi et al. 1993). The yeast genome 
has been fully sequenced and can be easily manipulated. Yeast cells divide approximately 
every 1.5-2 hours (Jorgensen et al. 2002), and therefore can be easily maintained in the 
lab. All these advantages make yeast a very powerful and inexpensive tool to study 
conserved cellular mechanisms. Yeast has been widely used to study cellular and 
molecular biology, and used as a fundamental tool to study cell cycle (Dutcher and 
Hartwell 1982; Kuhne and Linder 1993; Landry et al. 2014), DNA (Deoxyribonucleic 
Acid) repair (Niu and Klein 2016), aging (Lin et al. 2003; Lu et al. 2011), gene functions 
(Celenza et al. 1989; Dubacq et al. 2004), and protein interactions (Schmidt et al. 1999). 
The high similarity between yeast and other eukaryotes allows us to investigate basic 
processes in yeast and then extend that knowledge to humans and other species. Studying 
lifespan in yeast, for instance, has extended our understanding of aging in humans. For 
example, publications indicate that yeast lacking SCH9 show significant increase in 
lifespan under caloric restriction growth conditions (Liu et al. 2015). Similarly, Akt, the 
mammalian ortholog of Sch9, has been shown to negatively regulate lifespan of human 
cells (Choi et al. 2016; Miyauchi et al. 2004). In addition, many other research areas 
including cancer biology, are highly related to the findings of cell cycle studies in yeast 
(Guaragnella et al. 2014). Various mutations involved in cell division and DNA 
replication had been found in yeast before their human orthologs in cancer were realized. 
For example, genes that regulate cell division (CDC genes) were first found in yeast 
(Martegani et al. 1984; Hwang et al. 1998). Strains lacking these genes lose the ability to 
regulate normal cell division, indicating their responsibility in maintaining proper cell 
growth (Kuhne and Linder 1993; Zachariae and Nasmyth 1999). Findings in yeast have 
contributed to the universal understanding of how the cell cycle is organized and 
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regulated in eukaryotic cells, and have applications within a number of different fields to 
prevent, diagnosis, and treat cancer (Guaragnella et al. 2014).  
1.2 AMP-activated protein kinase (AMPK) enzyme family 
 All cells require a constant energy supply to survive despite variations in nutrients 
or necessary energy expenditures. From single yeast cells to higher eukaryotes such as 
plants, fish, and mammals, there are nutrient and energy sensors, which constantly 
monitor and adjust metabolic pathways to ensure cellular homeostasis. One of the most 
important sensors to regulate homeostasis is the 5’ adenosine monophosphate-activated 
protein kinase (AMPK) family of enzymes (Backhed et al. 2007; Hedbacker and Carlson 
2008; Coughlan et al. 2013). AMPK acts as a metabolic switch between anabolic and 
catabolic metabolism through its activity as a protein kinase to switch to catabolic states 
(Gowans and Hardie 2014). In mammalian systems, under conditions of abundant caloric 
intake/sedate lifestyle, insulin control of metabolism is dominant and AMPK is inactive. 
In the ‘feasting’ conditions, higher eukaryotes store fat, glycogen, and protein due to the 
influence of insulin. In contrast, under low energy states, insulin levels drop and AMPK 
is maximally activated to trigger catabolism, burn stored fuel for ATP (adenosine 
triphosphate), and subsequently correct the energy deficit under conditions of ‘fasting’. 
The AMPK complex in all eukaryotes consists of three subunits that together make a 
functional heterotrimeric enzyme, including one each of α (catalytic), β (regulatory), and 
γ (regulatory) subunits. Each of these three subunits takes on a specific role in the 
specificity and activity of AMPK. In mammalian cells, there are two types of α subunits, 
two types of β subunits, and three types of γ subunits (Gowans and Hardie 2014; Hardie 
2014). Yeast provides a much simpler system to study AMPK regulation as it contains 
only a single α and γ subunit each, and three β subunits (Hedbacker and Carlson 2008). 
In yeast, the simple manipulation of glucose abundance in the growth media allows 
regulated activation of the yeast AMPK without the confounding influences of insulin or 
other hormones, or the subtle effects that tissue differences appear to have in animal 
models (liver versus muscle versus adipose tissue for example) (Ross et al. 2016). The 
SNF1 (Sucrose Non-Fermenting) kinase is the yeast version of AMPK, and is also found 
as a heterotrimeric complex containing the Snf1 catalytic subunit (α subunit), Snf4 
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activating subunit (γ subunit), and one of three (Sip1/Sip2/Gal83) regulatory subunits (β 
subunits) (Hedbacker and Carlson 2008) (note the capital “SNF1” refers to the kinase 
complex and “Snf1” refers to the α subunit of the kinase). The Snf1 α subunit can be 
phosphorylated, which is necessary for the activation of the SNF1 kinase itself. Snf4, the 
single γ subunit, has been shown to non-catalytically contribute to the activation of the 
SNF1 kinase (McCartney and Schmidt 2001). It physically associates with Snf1 through 
the bridge of one of the β subunits. Each of the three β subunits can independently exist 
within the heterotrimeric complex, depending on the cellular compartment and biological 
cues (Vincent et al. 2001). Research indicates that the enzyme complex preferentially 
binds different β subunits under different circumstances. Details of the SNF1 kinase 
subunits will be described in section 1.5. 
1.3 General mechanisms of AMPK activation and regulation 
 The mechanisms that trigger the activation of AMPK are similar in almost all ways 
between yeast and mammalian systems, including the canonical and essential step of the 
single phosphorylation of the α subunit within the catalytic domain by upstream discrete 
kinases (Woods, Johnstone, et al. 2003; Mairet-Coello et al. 2013). Additionally, the γ 
subunit of AMPK undergoes a conformational change that enhances the physical 
association with the catalytic α subunit and is triggered by an increased AMP (adenosine 
monophosphate)/ATP ratio, a signal of depleted cellular energy stores. The excess AMP 
or ADP (adenosine diphosphate) binds the two “Bateman domains” (domain that 
composed of a beta-alpha-beta-beta-alpha secondary structure pattern) located on the γ 
subunit, consequently changing its protein conformation in both yeast and mammalian 
AMPK family members (Momcilovic et al. 2008; Mayer et al. 2011; Davis et al. 2013; 
Gowans and Hardie 2014). This allosteric change of the γ subunit further enhances the 
exposure of the active site threonine (Thr) on the α subunit to its upstream kinases. As a 
result, the upstream kinases phosphorylate the α subunit of AMPK on its activating loop 
at Thr172 residue (Thr210 in yeast), promoting maximum enzyme activation. In yeast, 
there are three well-identified upstream kinases targeting the SNF1 kinase, comprising 
Pak1, Elm1, and Tos3. Each alone has the ability to phosphorylate Thr210 and fully 
activate the SNF1 kinase (Sutherland et al. 2003; Kim et al. 2005; Liu et al. 2011). In 
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addition to the activating signal triggered by the ratio of AMP/ADP abundance, there are 
additional signals that influence AMPK activity. It is also activated by other cellular 
signals such as calcium (Mairet-Coello et al. 2013), heat shock (Kodiha et al. 2007), 
leptin (Minokoshi et al. 2002; Suzuki et al. 2007), and muscle contraction after exercise 
(McGee et al. 2003). Although AMPK must be phosphorylated for activation, 
phosphorylation has now been revealed to not be the only mechanism regulating the final 
activity of AMPK. New reports have determined that post-translational alterations 
including ubiquitination (Al-Hakim et al. 2008), SUMOylation (Simpson-Lavy and 
Johnston 2013), and acetylation (Lu et al. 2011), can influence the activity of AMPK 
enzymes, adding a subtle layer, rather than an ON/OFF switch, of regulatory complexity 
to this central energy sensing enzyme. 
1.4 Nuclear localization of AMPK in response to its activation state 
 Both mammalian and yeast AMPK have been shown to undergo a rapid 
cytoplasmic-nuclear relocation upon stimulating conditions (Vincent et al. 2001; Ju et al. 
2011). Phosphorylation and the presence of a nuclear localization signal (NLS) on the 
catalytic subunit are essential for mammalian AMPK (Ju et al. 2011). The entry and exit 
of AMPK from the nucleus likely utilizes the general cargo-protein nuclear import 
machinery at the nuclear pore (Kazgan et al. 2010). However, import regulation and the 
specific process that converts the low energy trigger to result in import are still unknown.  
 The nuclear heterotrimeric complex has a discrete β subunit incorporated into the 
complex. In yeast, the β subunit, Gal83 (galactose metabolism 83), has the unique ability 
to translocate between the cytoplasm and nucleus, and was long thought to direct the 
whole kinase complex for nuclear shuttling. In contrast, the other β subunits, Sip1 and 
Sip2 (Snf1-interacting protein), do not localize to the nucleus, but rather to the ER/Golgi 
(endoplasmic reticulum/Golgi apparatus) (Yu et al. 2012) or plasma membrane (Lin et al. 
2003), respectively. Surprisingly, previous research indicated that the Snf1 catalytic 
subunit has the ability to move into the nucleus even without the presence of Gal83, as 
shown by GAL83 deletion studies in yeast (Vincent et al. 2001). Also interesting was the 
observation that a non-phosphorylatable, yet kinase active, version of the Snf1 catalytic 
subunit was sufficient to tether the Snf1-Gal3-Snf4 trimeric complex in the cytosol 
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(Vincent et al. 2001). Many questions remain regarding the glucose-responsive 
translocation of the activated SNF1 kinase into the nucleus. Is there a cytosolic tether? 
Does the Snf1 α subunit contain a functional nuclear localization signal? These remain 
important questions to determine in order to elucidate the mechanisms that direct the 
nuclear import and export of the yeast SNF1 kinase/AMPK in response to environmental 
signals.  
1.5 Cellular and biological functions of the SNF1 kinase in yeast 
 The SNF1/AMPK family of protein kinases is highly conserved in fungi, yeast, 
plants, invertebrates, and animals. In the budding yeast Saccharomyces cerevisiae (S. 
cerevisiae), the SNF1 kinase is primarily known for its role in adaptation to growth in the 
presence of limited glucose, its preferred energy source, and adapt instead to growth on 
sucrose or other non-fermentable sugars (Carlson et al. 1981; Celenza and Carlson 1986; 
Hardie et al. 1998). Yeast strains with deletions of SNF1 or SNF4 unable to grow on 
sucrose (Celenza et al. 1989; Jiang and Carlson 1997; Momcilovic and Carlson 2011), 
explaining the naming of these genes. 
 In yeast, the Snf1 catalytic subunit is comprised of 632 amino acid residues, and 
contains a kinase domain near the N terminus, and independent C termini regulatory 
regions including domains that associate with other subunits (Fig. 1.1). Activation of the 
Snf1 catalytic subunit requires phosphorylation on Thr210 on the activation loop (Nath et 
al. 2003). Mutation of Thr210 results in complete inactivity of the SNF1 kinase 
(McCartney and Schmidt 2001). However, neither Snf4 nor the β subunits are mandatory 
for phosphorylation to occur on Thr210 (McCartney and Schmidt 2001; Zhang et al. 
2011).  
 The Snf4 subunit is a constitutively expressed protein independent of glucose 
availability or the activation state of the enzyme (Jiang and Carlson 1997; Vincent et al. 
2001). It has a relatively larger number of protein abundance (20 times more than Snf1) 
and simultaneously binds both Snf1 and β subunits (Celenza et al. 1989; Ghaemmaghami 
et al. 2003; Adams et al. 2004). Snf4 is required for the activity of the SNF1 kinase 
complex, both in vivo and in vitro, through binding to the auto-inhibitory domain within 
the Snf1 subunit, and preventing the allosteric exposure of the catalytic domain to allow 
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for full activation (Momcilovic and Carlson 2011). A classic yeast 2-hybrid method 
assessing Snf1-Snf4 associations offered a powerful tool to investigate the activation of 
the SNF1 kinase, utilizing Snf1-Snf4 association (Jiang and Carlson 1997).  
 The three well-characterized β subunits of the SNF1 kinase are Sip1, Sip2, and 
Gal83. They exhibit a large structural overlap among each other and are individually 
sufficient for SNF1 kinase activation even when they are present alone (Hedbacker and 
Carlson 2008). Overall, the abundance (molecule/cell) of Sip1 and Sip2 is about 2:1 in 
yeast cells, and with a greater number of Gal83 (~10 times of Sip2) (Ghaemmaghami et 
al. 2003). Therefore, yeast cells can survive under different growth conditions when 
SNF1 kinase activity is required. However, each β subunit has its own discrete function 
that is required under different circumstances. For example, Gal83 is the major 
component contributing to SNF1 kinase activity when grown under glucose limitations, 
due to its ability to shuttle with the complex to the nucleus and alter the transcription of 
the adaptive pathways to use non-fermentable sugar sources (Vincent et al. 2001). Sip2 is 
also required when cells grow in non-fermentable carbon sources but additionally, the 
acetylation on Sip2 subunit has been shown to affect aging (Lin et al. 2003; Lu et al. 
2011). Sip2 appears to remain in the cytosol regardless of the activation state of the 
enzyme. Sip1 is unique as it contains an N-myristorylation sequence and will localize to 
the vacuole in response to carbon stress (Hedbacker et al. 2004). All three β subunit 
isoforms are able to independently complement for the loss of the other two, and can 
maintain a strong degree of the normal function of the SNF1 kinase (Vincent et al. 2001). 
The abundance of the Snf1 subunit is decreased in the absence of all three β subunits 
(Schmidt and McCartney 2000). However, it is not known if deletion of a single β 
subunit affects the Snf1 protein abundance, and whether this observation is through 
transcription or protein stability.  
 As a sensor of glucose abundance, the SNF1 kinase remains fully inactive under 
normal (abundant) glucose conditions and is rapidly and reversibly activated under 
limiting glucose conditions. Yet, this is not the only important biological pathway the 
SNF1 kinase is involved in. Importantly, the SNF1 kinase also functions as a central 
component of the kinase signaling pathways that responds to environmental stress, such 
as salinity (Kulik et al. 2012), oxygen free radicals (Li et al. 2005), temperature extremes 
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(Morano et al. 2012), and pH changes (Hsu et al. 2015). Under optimal growth 
conditions, when glucose and ATP are abundant, cells are anabolic and producing more 
ATP than is consumed. There is active regulation of gene expression to maintain this 
metabolic state, and although we focus on those in yeast, there is analogous regulation of 
gene expression in higher eukaryotes and humans. In animals, this anabolic state is also 
finely regulated through the anabolic actions of insulin and its signaling pathway 
(Reynolds et al. 2012; Arkun 2016). In yeast, under anabolic conditions, there is up-
regulation of several genes including those encoding glycolytic enzyme hexokinase 2 
(HXK2) (Palomino et al. 2006), ribosomal protein S22B (RPS22B) (Celton et al. 2012), 
and hexose transporter 1 (HXT1) (Solis-Escalante et al. 2015). Simultaneously, this 
optimal growth condition state represses the expression of many genes, including those 
involved in the utilization of alternative carbon sources (sucrose-proton symporter 2, 
SUC2) (Yang et al. 2015), gluconeogenesis (RDS2) (Soontorngun et al. 2007), and 
respiration (POR1 and POR2 that encode mitochondrial porin) (Strogolova et al. 2012) 
by a process known as glucose repression.  
 Under low glucose and/or high stress conditions, the yeast SNF1 kinase is activated 
and its kinase activity targets key cytosolic and nuclear targets to change the activity of 
metabolic pathways toward catabolism. Stored fuels are burned for energy, synthetic 
pathways are repressed, and energy homeostasis is restored (Carlson et al. 1981; Amodeo 
et al. 2010; Momcilovic and Carlson 2011; Hsu et al. 2015). Active SNF1 kinase 
phosphorylates metabolic pathway components, altering their ON/OFF status to switch to 
a catabolic environment. For instance, the SNF1 kinase phosphorylates acetyl-coenzyme 
A carboxylase during glucose-limiting growth conditions (Zhang et al. 2013), and 
inhibits fatty acid biosynthesis (Shirra et al. 2001; Nicastro et al. 2015). In addition, 
activated SNF1 kinase translocates to the nucleus and further activates downstream 
targets including transcription factors. For example, the SNF1 kinase phosphorylates 
Mig1 (multicopy inhibitor of GAL gene expression 1), the repressor of SUC2 expression, 
subsequently releasing the glucose repression and allowing adaptation to sucrose 
utilization (Carlson et al. 1981).   
 The budding yeast S. cerevisiae contains seven unlinked genes (SUC genes) that 
encode invertase (Carlson et al. 1981; Carlson and Botstein 1982). Invertase is an 
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important enzyme that catalyzes the hydrolysis of both sucrose and raffinose, thereby 
supplying glucose for yeast to survive in low- or non- glucose environments (Carlson and 
Botstein 1982, 1983). Yeast may produce one or several invertases, however, the 
reference strain S288C, which is used in our and others research, only encodes and 
expresses SUC2 (Carlson and Botstein 1983). Therefore, most of the studies that 
investigate invertase activity mainly focus on SUC2. SUC2 encodes two forms of 
invertase in S. cerevisiae, external and internal. Internal invertase is localized in the 
cytoplasm, and has very low expression levels and has no known function in any cellular 
process (Gascon et al. 1968). External invertase is localized in the periplasmic space 
hydrolyzes non-fermentable carbon sources and produces monosaccharides including 
glucose and fructose, which are utilized by the cell (Gascon et al. 1968; Carlson and 
Botstein 1983; Schmidt and McCartney 2000). For our research purposes, we evaluate 
both invertase activity and SUC2 expression to determine the SNF1 kinase activation and 
its nuclear activity.  
1.6 Phosphorylation is an activating signal for the SNF1 kinase 
 Activation of the SNF1 kinase requires a single phosphorylation on the Thr210 
residue of the Snf1 catalytic subunit (Hardie 1999; Nath et al. 2003). Snf1 consists of a 
catalytic domain, a ubiquitin-associated domain (UBA) domain adjacent to the auto-
inhibitory domain, and the domains that can interact with β or γ subunits (Fig. 1.1) 
(Rudolph et al. 2005; Amodeo et al. 2007; Cho et al. 2014). The catalytic domain is in 
the N-terminal of this subunit. Phosphorylation causes an unfolding of the Snf1 catalytic 
subunit, releasing its autoinhibitory domain from the catalytic domain and thereby 
enhancing function. The UBA domain is found in many catalytic subunits of the AMPK 
enzyme family, and early studies in both yeast (Momcilovic and Carlson 2011) and 
mammalian systems (Jaleel et al. 2006; Cho et al. 2014) suggest that it plays a modest 
role in regulating the activity of the enzyme complex. The UBA domain was believed to 
affect the kinase activity and have the ability to bind to independent substrates that are 
mono- or poly-ubiquitinated. However, there is no proof of this sort of interaction in 
either mammalian or yeast AMPK to date.  
 When yeast cells grow in glucose-rich environments, the SNF1 kinase is 
maintained in an inactive dephosphorylated state and resides mainly in the cytoplasm 
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(Hardie 1999; Zhang et al. 2011). When the levels of glucose become depleted, the SNF1 
kinase is phosphorylated by upstream kinases including Sak1 (also known as Pak1) (Nath 
et al. 2003), Tos3 (Kim et al. 2005), and Elm1 (Sutherland et al. 2003). Once activated, 
the SNF1 kinase can regulate the expression of different genes after its import into the 
nucleus by inhibiting transcriptional repressors (e.g. Mig1) and targeted phosphorylation 
of nuclear proteins (Treitel et al. 1998; McCartney and Schmidt 2001), either by 
stimulating transcriptional activators (e.g. Sip4) (Schmidt and McCartney 2000), or by 
activating the transcription machinery directly (Shirra et al. 2005; Ruiz et al. 2011). 
When glucose is added back to cells, the SNF1 kinase is rapidly inactivated by 
dephosphorylation, via the Reg1-Glc7 protein phosphatase 1 (PP1) complex and further 
exported from the nucleus (Fig. 1.2) (Sanz, Ludin, et al. 2000; Ruiz et al. 2011; Zhang et 
al. 2011). 
 
Figure 1.1 The functional domains of the Snf1 catalytic subunit. The 
Snf1 subunit consists of the N-terminal catalytic domain, a UBA domain, 
an auto-inhibitory domain, as well as documented binding sites for the 
associated β subunit, and γ subunit. The allosteric changes within the 
Snf1 subunit triggered by phosphorylation or associations with the β or γ 
subunits effect the conformation of catalytic domain and its enzymatic 
activity. 
1.7 The ubiquitin system and AMPK  
 Ubiquitination is an important post-translational modification that has a pivotal role 
in numerous biological functions including cell growth, apoptosis, and innate immune 
responses (Chen et al. 1993; Muratani and Tansey 2003; Harkness et al. 2004; Finley et 
al. 2012; Postnikoff and Harkness 2012; Becuwe and Leon 2014). Ubiquitin is a small, 
abundant, and highly conserved regulatory protein that has been found in every eukaryote 
examined (Hoeller and Dikic 2009; Finley et al. 2012). It attaches to the target proteins 
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via a covalent bond. There are three sequential steps in this process of ubiquitin 
attachment. First, the E1 ubiquitin-activating enzyme activates ubiquitin. This ATP-
requiring step initiates the cascade. Second, ubiquitin is transferred to an E2, the 
ubiquitin-conjugating enzyme (UBC). The final step of ubiquitination creates a covalent 
isopeptide bond between a lysine of the target protein and the C-terminal glycine of 
ubiquitin. Non-lysine, or non-conventional ubiquitin attachments have been found 
including at the N-terminal end of proteins (Varshavsky 1996), and at serines and 
cysteines (Kravtsova-Ivantsiv and Ciechanover 2012). In general, this step requires the 
activity of one of hundreds of E3 ubiquitin ligases in higher eukaryotes (Chang et al. 
2000; Rodrigo-Brenni and Morgan 2007; Baskin and Taegtmeyer 2011; Stoll et al. 2011). 
The most well-known consequence of ubiquitination is protein degradation of the 
substrate protein via the proteasomal pathway. Substrates that have been poly-
ubiquitinated can be recognized by the receptor of the proteasome and then undergo 
protein degradation (Fig. 1.3) (Finley et al. 2012). 
 
 
Figure 1.2 Schematic illustration of the SNF1 complex. The SNF1 
kinase consists of three subunits. Growth in low glucose activates the 
SNF1 kinase and the catalytic α-subunit, Snf1, is phosphorylated on 
Thr210. The phosphorylated SNF1 kinase complex then translocates into 
the nucleus, and targets Mig1 for phosphorylation. Conversely, growth in 
high glucose is repressive, and the Thr210 residue on Snf1 is actively 
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1.7.1 The ubiquitin system in yeast 
 In yeast, the ubiquitination system has been widely investigated and has been shown 
to share the same enzyme cascade as in mammals, albeit with fewer E2 and E3s. There is 
one E1, thirteen E2s, and it is difficult to state an exact number of E3s (60-100) as they 
are still being discovered (Finley et al. 2012). Nonetheless, yeast provides a simpler 
system in which to study ubiquitination (Finley et al. 2012). Studies have shown that 
conversion of lysine to arginine can effectively abolish ubiquitination on that site, 
preventing degradation, if that was the substrates fate, and affect the normal functions of 
the target proteins (Al-Hakim et al. 2008; Hiraishi et al. 2009).  
 The cellular consequences of ubiquitin attachment are diverse and extend far 
beyond degradation. For example, proteins targeted with a poly-ubiquitin chain built 
through lysine-48 (of the ubiquitin moieties themselves) can be recognized by the 
proteasome and undergo degradation (Jacobson et al. 2009), whereas mono-ubiquitin may 
function as a localization signal (Hicke 2001). In addition, poly-ubiquitin chains formed 
through lysine-63 have been shown to participate in cell signaling events (Li and Ye 
2008). Researchers indicate that ubiquitination also functions as protein trafficking or 
kinase/phosphatase activation signals. These processes are involved in cell survival and 
cancer development (Hoeller and Dikic 2009). Clarifying the purpose of Snf1 
ubiquitination from among the many potential outcomes will be important to further our 
understanding of the role of ubiquitination in SNF1 kinase/AMPK family regulation 
(Jaleel et al. 2006; Al-Hakim et al. 2008; Cho et al. 2014). 
1.7.2 The current knowledge of the role of ubiquitination in regulating SNF1 
kinase and AMPK 
 The biological or environmental signal that triggers ubiquitination of the α subunits 
of AMPK is not yet known. Research in mammalian cells and tissues have shown that 
discrete subunits of AMPK can be ubiquitinated under experimental conditions (Baskin 
and Taegtmeyer 2011; Lee et al. 2013; Pineda et al. 2015). This generated much interest, 
as there are several potential roles that ubiquitin may play in the regulation of the AMPK. 
This includes potential roles for ubiquitin in targeting the enzyme for degradation (a 
negative influence), signaling for subcellular localization (relevant when considering the 
nucleo-cytoplasmic shuttling of the enzyme), and in promoting protein associations (a 
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potential positive role).   
 There are valid concerns and limitations to the previous studies of catalytic subunit 
ubiquitination. The experimental conditions used to detect poly-ubiquitination of the α 
subunit for yeast and mammalian AMPK were far from physiological, and involved 
manipulation of the targets, including plasmid overexpression, mutations, and strong 
inhibition of deubiquitination (Al-Hakim et al. 2008; Wilson et al. 2011; Lee et al. 2013). 
In both yeast and mammalian systems, the result of ubiquitination was a decrease in the 
catalytic subunit abundance, and a decrease in direct or indirect kinase activity on 
downstream targets. This led to the conclusion that ubiquitination of the AMPK family 
has an inhibitory function. Importantly, the nuclear import and allosteric associations 
were not investigated. The specific ubiquitination sites on the α subunits have not been 
formally identified, nor have the identity of the responsible ubiquitin cascade enzymes 
been determined. In yeast, large-throughput proteomic analysis has consistently identified 
two lysines within the catalytic subunit that are ubiquitin-attachment sites (Starita et al. 
2012). The biological importance of these residues has not been tested. Also, 
ubiquitination and degradation have not been correlated to the activation state of the 
AMPK enzymes, and have not been tested under physiological conditions. 
 Different research groups have reported that AMPK function can be regulated by 
ubiquitination on the α subunit, the β subunits, and the upstream kinases. However, the 
findings vary immensely with the system being studied and the analytical methods used. 
For example, AMPK β subunit in mouse brown adipose tissue can be targeted for 
degradation by the E3 ubiquitin ligase CIDEA (cell death-inducing DNA fragmentation 
factor A-like effector A) (Qi et al. 2008). Another group tested whether Lkb1 (liver 
kinase B1), upstream kinase of AMPK, was poly-ubiquitinated and subsequently behaved 
as a functional enzyme (Lee et al. 2015). Research also showed that AMPK α1 subunit 
when targeted for poly-ubiquitination is followed by a decreased enzymatic activity of 
AMPK (Pineda et al. 2015). In yeast, the Snf1 α subunit has been shown to be poly-
ubiquitinated, affecting its Thr210 phosphorylation (Wilson et al. 2011). Proteomic 
analysis using mass spectroscopy identified 2 lysine (Lys) residues (Lys80 and Lys461) 
within the α subunit as sites for ubiquitination (Starita et al. 2012). No report of 
ubiquitination on the Snf4 subunit has been published. 
	  	  




Figure 1.3 Illustration of protein ubiquitination and proteasomal 
degradation. Ubiquitin (Ub) can be activated by E1 ubiquitin-activating 
enzyme, then transferred on E2 ubiquitin conjugating enzyme, eventually 
attached to the target substrate by E3 ubiquitin ligase. Ubiquitin can also 
attached to the exciting ubiquitin on the substrate, forming a poly-ubiquitin 
chain. The poly-ubiquitin chain can be recognized by the proteasome, 
further undergo protein degradation.  Adapted from (Finley et al. 2012). 
 
  
1.7.3 The current knowledge of the role of ubiquitin-associated domains in SNF1 
kinase and AMPK regulation  
 Ubiquitin cascade enzymes are able to bind free ubiquitin protein, and subsequently 
transfer the ubiquitin to selected substrates. Besides these E2/E3 enzymes, there are 
proteins that also non-covalently bind ubiquitin including those that contain the motif 
called the ubiquitin-binding domain (Hicke et al. 2005). Generally, ubiquitin-binding 
domains can interact directly with mono-ubiquitin and/or poly-ubiquitin with, or without, 
ubiquitin-ubiquitin linkage specificity. To date, there are 9 known such motifs that can 
bind either mono- or poly-ubiquitin (Hicke et al. 2005). One well-investigated motif is the 
UBA domain. The UBA is a protein motif that has been found throughout eukaryotes and 
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relatively short ~45 amino acid residues that is thought to fold to form a hydrophobic 
protein face that interacts non-covalently with the globular head of ubiquitin that is 
independently attached covalently to another protein substrate. The covalent ubiquitin 
second site can be within the same protein as the UBA domain in larger proteins. The 
UBA motif has been identified to bind ubiquitin, multi-ubiquitin chains, and ubiquitinated 
proteins, and thus functions as a motif to enhance protein-protein interaction and 
subcellular relocation (Raasi et al. 2005). Most components of the ubiquitin-proteolysis 
pathway, including ubiquitin enzymes, and/or receptors, contain the UBA domain, 
suggesting that a major role of the UBA domain is in protein degradation. However, some 
UBA motifs are incapable of binding ubiquitin regardless of mono- or poly-ubiquitin 
chains or the linkage involved. For instance, the proteasome subunit, Rpn10 (proteasome 
regulatory particle), has an UBA domain but does not bind either mono-ubiquitin or poly-
ubiquitin chains under any circumstances (Lin et al. 2011; Lipinszki et al. 2012). The 
UBA domain has been separated into 4 defined classes based on linkage-selective poly-
ubiquitin chains. Specifically, class 1 UBA selectively binds lysine-48 ubiquitin chains 
whereas class 2 UBA motifs prefer to bind lysine-63 ubiquitin chains. Class 3 UBA 
motifs do not bind any ubiquitin, and class 4 UBA binds all kinds of ubiquitin (Raasi et 
al. 2005).   
 Despite the fundamental role of the UBA domain in recognition and attachment of 
ubiquitin-interacting substrates, it also contributes to the stability, function, and 
subcellular localization of the proteins that bind to ubiquitin or ubiquitin chains (Aguilar 
et al. 2003; Jang et al. 2012). These functions have both proteolytic and non-proteolytic 
outcomes. For example, many E2s and E3s contain the UBA domain. These ubiquitin 
cascade enzymes have the ability to process the substrates, and following proteolysis. 
However, non-proteolytic outcomes also regulate the normal function of the cells. For 
instance, ubiquitin chains can be protected when attached to a UBA domain, and therefore 
cannot be disassembled by deubiquitination or ubiquitin-specific protease (Ubp) enzymes, 
results in protein stability. Also, research shows that the UBA motif on Ent1, a key 
endocytic protein in yeast, can bind the ubiquitinated cell-surface transmembrane protein, 
Ste2, which facilitates Ent1 subcellular localization (Aguilar et al. 2003). Another 
potential role of the UBA motif is to provide a chaperone-like function to protect specific 
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ribosomal proteins that have N-terminal ubiquitinations (Murata et al. 2009). It is unclear 
how they escape the detection of the ubiquitination degradation pathway, but possibly the 
UBA domain on ribosomal subunits bind the ubiquitin moiety on these nascent ribosomal 
proteins to escape the proteasome detection and eventually assemble into the mature 
ribosome (Finley et al. 1989; Madura 2002). These roles are of particular interest to us, 
given that the Snf1 catalytic subunit has a Class 3 UBA motif. 
 The UBA domain is found within the yeast Snf1 α catalytic subunit as well as on 
nearly all mammalian AMPK-like α subunits (Jaleel et al. 2006; Cho et al. 2014). Of 
significance, the yeast SNF1 kinase UBA domain is a Class 3, non-ubiquitin binding 
motif (Momcilovic and Carlson 2011). Thus, the function of the UBA domain remains 
unclear, yet early insights through systematic mutations throughout the catalytic, UBA, 
and regulatory domains of the yeast Snf1 α subunit suggest it may play an inhibitory role 
in SNF1 kinase activity. Mutations throughout these regions resulted in enhanced 
phosphorylation of the α subunits and enhanced targeting against in vitro SNF1 kinase 
substrates (Momcilovic and Carlson 2011).   
1.7.4 Functions of the E2 ubiquitin conjugating enzyme Ubc1 in yeast 
 Knowing that the α subunit of the yeast AMPK is ubiquitinated, it will be of interest 
to use yeast to identify the E2 and/or E3 involved in targeting the Snf1 protein, and 
investigate details of ubiquitin-mediated AMPK regulation. The ubiquitin conjugating 
enzymes responsible for targeting the AMPK catalytic subunits have not yet been 
revealed in yeast, mammals, or other eukaryotes, to the best of our knowledge. In yeast, 
there is only one E1 enzyme and 13 known E2s that have been identified (Finley et al. 
2012). There are discrete phenotypes in yeast associated with the loss of these E2 
functions that have highlighted their normal biological functions in the cell. In particular, 
there are a cluster of E2s (Ubc1, Ubc4, and Ubc5) that are associated with the yeast stress 
response and their mutation slowed growth and division (Seufert and Jentsch 1990; 
Seufert et al. 1990; Stoll et al. 2011). Given that the SNF1 kinase functions within the 
stress response pathway, it will be of particular interest to determine if there is a link 
between these E2s and the ubiquitination of the Snf1 catalytic subunit. 
 Ubc1 has functions that overlap with other E2s such as Ubc4 and Ubc5. They have 
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been recognized as the same subfamily of E2s, due to the similarity of their stress-related 
functions. Ubc4 and Ubc5 are such close homologs of each other; they are frequently 
simultaneously disrupted in yeast, as they can independently complement for each other 
(Seufert and Jentsch 1990). Literature indicates that simultaneous disruption of UBC1 in 
the ubc4Δ or ubc5Δ mutant strains enhances the severity of stress sensitive phenotypes to 
a greater degree than that of single mutation. Additionally they exhibit phenotypes such as 
slow growth, prolonged doubling time, and failure to survive after meiotic segregation 
(Seufert and Jentsch 1991; Chen et al. 1993). However, despite this functional overlap, 
Ubc1 does have discrete functions and target preferences, and it plays an important role in 
regulating yeast cell growth.  
 Of interest, Ubc1 and Ubc4 both individually interact with a multi-subunit ubiquitin 
E3 ligase, the Anaphase Promoting Complex (APC), which can target selected proteins 
for degradation in synchrony with the cell cycle, yet the E2s exhibit their own target 
preferences. Specifically, Ubc1 was found to catalyze rapid poly-ubiquitination of pre-
ubiquitinated substrates, whereas Ubc4 prefers to initiate the first ubiquitin covalent bond 
onto targets (Stoll et al. 2011). Also, Ubc1 is essential for the lysine-48 linked poly-
ubiquitin chain (Rodrigo-Brenni and Morgan 2007), whereas Ubc4 is dispensable for 
poly-ubiquitin chain formation and may be important in mono-ubiquitination (Stoll et al. 
2011). In addition, UBC1 mRNA (messenger ribonucleic acid) and protein level have 
been found to be elevated when yeast cells proceed into stationary phase, compared to 
exponentially growing cells (Rodrigo-Brenni and Morgan 2007), whereas UBC4 is 
expressed in growing cells but hardly detectable in stationary phase (Seufert and Jentsch 
1990).  
 Ubc1 appears to be involved in many discrete biological functions through its effect 
on modifying protein turnover, protein degradation, and vesicle production (Seufert et al. 
1990; Horak and Wolf 2001; Rodrigo-Brenni and Morgan 2007; Xu et al. 2009). UBC1 
gene disruption results in yeast strains that grow slowly with enlarged cells, and tend to 
form aggregates. Even though an abnormal cell morphology was observed (Rodrigo-
Brenni and Morgan 2007) (Seufert et al. 1990), the molecular explanation for the 
formation of the enlarged cell body and cellular aggregation is not clear. Interestingly, 
there is a strain dependency on the requirement of Ubc1 for cell viability. Even through 
	  	  
	   17	  
some publications suggest that cells cannot survive in the absence of Ubc1 (implying it is 
an essential gene) (Seufert and Jentsch 1991), others indicate that the UBC1 deleted strain 
is viable, including the strain we use for our investigations. For example, our ubc1Δ 
mutant, derived from the sporulated UBC1/ubc1Δ diploid, survives. In fact, the haploid 
ubc1Δ has an increased growth rate and cell size after growth on yeast peptone dextrose 
media (YPD) plates after several generations (Seufert et al. 1990).   
 The most striking phenotype of ubc1Δ strains is observed in the regulation of the 
cell cycle. Ubc1 is specifically required for viability during early stages of cell growth 
after germination (Seufert et al. 1990). Also, a recently published paper indicated that 
Ubc1 can be regulated by phosphorylation. This post-translational modification on Ubc1 
affects its activity, and further enhances the tolerance to high temperatures in yeast 
(Meena et al. 2011).  
 Orthologs of Ubc1 in other species such as human, plants, and insects have been 
widely investigated. For example, UbcH1, the human ortholog of Ubc1, is involved in UV 
damaged DNA repair (Kaiser et al. 1994); Ubc1 is related to the stress response in higher 
plants, and also affects flowering time in Arabidopsis (Xu et al. 2009); knockdown of 
Ubc20, the ortholog of Ubc1 in Caenorhabditis elegans (C. elegans), results in arrested 
larval development (Jones et al. 2002). Together, this indicates that Ubc1 is highly related 
to the stress response and to cell cycle regulation. Nowadays, more details of yeast Ubc1 
and its orthologs in other species have been discovered. In this thesis, we identified Ubc1 
as required for Snf1 function.  
1.7.5 The role of the ubiquitin conjugating enzymes Ubc4 and Ubc5 in yeast 
 Two highly homologous E2s, Ubc4 and Ubc5, are essential to the yeast ubiquitin 
cascade, like Ubc1, and are particularly involved in selective degradation of short-lived 
and abnormal proteins (Seufert and Jentsch 1990, 1991; Chen et al. 1993). They 
complement each other, therefore either Ubc4 or Ubc5 could be dispensable if the other 
one is absent (Seufert and Jentsch 1990; Stoll et al. 2011).  They are strongly linked to the 
yeast stress response. Therefore, they are also potential candidates of interest that may 
target SNF1 kinase and affect its function. Ubc4 and Ubc5 are usually studied together, 
and yeast strains harboring the double ubc4/5Δ are viable, but have extremely slow 
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growth rates and exquisite sensitivity to elevated temperatures. As mentioned above, 
Ubc1, Ubc4, and Ubc5 constitute a subfamily of E2s. Overexpression of Ubc1 in the 
ubc4/5Δ mutant yeast strain can partially compensate for these phenotypes (Seufert et al. 
1990). There are, however, subtle differences between Ubc4 and Ubc5, with Ubc4 
showing the dominant role in some cases, including sporulation (Seufert and Jentsch 
1990). In addition, UBC4 mRNA transpation is found in exponential growing phase, 
whereas UBC5 mainly expresses in stationary phase (Seufert and Jentsch 1990). 
Furthermore, only the deletion of UBC4 in combination with UBC1 is lethal, whereas 
ubc1Δ ubc5Δ double null mutant can survive (Seufert et al. 1990).  
 In mammalian cells, the main function of the Ubc4 and Ubc5 orthologs is via 
protein targeting and degradation. For example, epidermal growth factor receptor (EGFR) 
can be ubiquitinated by Ubc4/5 after internalization, and subsequently degraded (Eden et 
al. 2012). Also, Ubc5 contributes to the regulation of the transcription factor and tumor 
suppressor, p53. Suppression of Ubc5 activity inhibits p53 ubiquitination and degradation 
(Davis et al. 2013). Interestingly, an E3 ubiquitin ligase NEDD4.2 (neuronal precursor 
cell-expressed developmentally downregulated 4.2), an ortholog of Rsp5 (Reverses Spt- 
Phenotype 5) in mammalian cells, works closely with Ubc4/5 through its HECT 
(homologous to the E6-AP carboxyl terminus) domain (Stoll et al. 2011). Both genetic 
and cellular studies in yeast indicate that Rsp5 is the main E3 ubiquitin ligase that 
associates with Ubc4 and Ubc5 (Stoll et al. 2011), and there have been reports of 
interactions with Ubc1 also (Hiraishi et al. 2006; Stoll et al. 2011). 
1.7.6 The role of E3 ubiquitin ligases in yeast 
 During ubiquitination, the last step involves a large variety of ubiquitin ligases 
(E3s). Humans have an estimated 1000 ubiquitin ligases, which provide protein target 
specificity. These E3s are classified into four major families, including HECT, RING-
finger (really interesting new gene), U-Box, and PHD-finger (plant homeodomain). 
Particularly, HECT and RING-finger families constitute the majority of E3s (Finley et al. 
2012). The RING-finger E3 family contains subfamilies such as APC and Skp1-Cullin-F-
box (SCF) subfamilies, which are highly relevant to cell cycle regulation (Harkness et al. 
2002; Harkness et al. 2004; Rodrigo-Brenni and Morgan 2007). In addition, the binding 
domains of these E3s provide the specificity to bind the substrates (Finley et al. 2012). 
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1.7.6.1 The yeast APC ubiquitin E3 ligase 
 The APC is an E3 ubiquitin ligase that selects target proteins involved in cell cycle 
regulation for degradation. In yeast, it is a multi-subunit protein complex containing 11 
core subunits, with two co-activators, Cdc20 (cell-division cycle protein 20) and Cdh1 
(Cdc20 holomogy), which bind the APC in a cell-cycle dependent manner (Zachariae and 
Nasmyth 1999). It is highly conserved in eukaryotic cells and is represented in a similar 
form and function in humans and other animals. The APC localizes to the nucleus, and its 
major function is to trigger the transition from metaphase to anaphase, by degrading 
specific proteins that inhibit sister chromatin separation (Jia et al. 2013; de Boer et al. 
2016). As an example, Pds1 (precocious dissociation of sisters 1) and Clb2 (Cyclin B2) 
are APC targets that have to be degraded in order for cells to exit metaphase and reenter 
the cell cycle (Hilioti et al. 2001; Wang et al. 2001; Simpson-Lavy and Brandeis 2010; 
Machu et al. 2014). In yeast, four subunits of the APC complex (including Cdc16, Cdc27, 
Cdc23, and Apc5) consist almost entirely of repeating protein motifs, providing 
scaffolding and support to mediate protein-protein interactions within this multi-subunit 
enzyme complex (Thornton et al. 2006). Mutations in these key components of the APC 
complex led to decreased infinity for the substrates targeted for degradation and decreased 
activation of APC by upstream activators. In addition, there is evidence that Apc5 and 
Apc10 are required for yeast lifespan and stress response, which has the potential to 
connect to the SNF1 kinase functions in stress and aging (Harkness et al. 2004).  
1.7.6.2 The yeast Rsp5 ubiquitin E3 ligase 
 Rsp5, and its mammalian counterpart, Nedd4.2, are essential ubiquitin ligases 
required for ubiquitination of a wide variety of proteins and biological functions. It is a 
member of the HECT superfamily of E3 ubiquitin ligases (Stoll et al. 2011). The 
literature has shown multiple roles for Rsp5 including contributing to intracellular 
trafficking of proteins (Becuwe et al. 2012), regulation of lipid biogenesis (Kaliszewski et 
al. 2006), and response to a variety of stresses (Stoll et al. 2011). Rsp5 contains a 
catalytic HECT domain (Krsmanovic and Kolling 2004), a C2 domain that recognizes and 
binds lipids and proteins, and three WW domains that are involved in various protein-
protein interactions through a PY motif (Chang et al. 2000). In addition, Rsp5 has been 
shown to contain both a NLS and a nuclear export signal (NES), which allows it to shuttle 
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between the nucleus and cytoplasm and select targets in both subcellular locations 
(Cholbinski et al. 2011). The variety of domains and flexibility of the Rsp5 protein 
structure extends the ability of Rsp5 to bind substrates and consequently makes Rsp5 a 
key protein implicated in various critical pathways. 
 Protein quality control systems in eukaryotic cells protect them from the 
accumulation of abnormal proteins. Rsp5/Nedd4.2 has been identified as a major 
constituent of this quality control system. A well-known mechanism whereby Rsp5 
functions in the protein degradation pathway is to remove heat-damaged, misfolded 
proteins (Fang et al. 2014; Sommer et al. 2014). Rsp5 targets cytosolic misfolded proteins 
for proteasomal degradation in respond to heat shock, allowing for cell survival after this 
damage. Loss of Rsp5 function results in a massive accumulation of misfolded proteins in 
the cell and a loss of cell viability. Rsp5 also targets misfolded proteins, which 
accumulate in the plasma membrane, through the ART (adaptor protein)-Rsp5 pathway. 
In this pathway, ART-Rsp5 clears the misfolded proteins and protects cell surface 
integrity (Zhao et al. 2013; Becuwe and Leon 2014).  
 In addition to protein quality control through proteasomal pathways, Rsp5 is also 
involved in autophagy (Shcherbik and Pestov 2011; Belgareh-Touze et al. 2017), 
endocytosis (Becuwe et al. 2012; Becuwe and Leon 2014), and the lysosomal degradation 
pathway (Hettema et al. 2004). Rsp5 has also been determined to play a role in regulating 
biogenesis of RNA at several steps. In detail, Rsp5 binds Rpb1 (RNA polymerase 1), the 
largest subunit of RNA polymerase II, through its WW domain, subsequently 
ubiquitinating and degrading it, thereby altering the activity of the polymerase 
(Huibregtse et al. 1997; Chang et al. 2000). Secondly, Rsp5 is involved in pre-RNA 
maturation and nuclear export. Research indicates that nuclear export of the pre-RNA S60 
is affected in the rsp5 mutant, and failed to transport from the nucleus to the cytoplasm 
(Neumann et al. 2003). Also, S35 pre-mature RNA is accumulated in the Rsp5 mutant, 
consistent with the RNA-processing defect (Neumann et al. 2003). In addition, Rsp5 can 
also modulate transfer RNA (tRNA) processing and transport (Neumann et al. 2003). All 
of these aspects indicate the essential role of Rsp5 in RNA biogenesis and processing.  
 Another well-established mechanism of Rsp5 in yeast is to modulate plasma 
membrane endocytosis through the arrestin-like protein Rod1 (Becuwe et al. 2012; 
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Becuwe and Leon 2014). Rod1 (resistance to o-dinitrobenzene 1) is known to be a 
cytosolic target for SNF1 kinase phosphorylation under low glucose conditions. It 
corresponds with endocytosis and vacuolar trafficking of Hxt1 and Hxt3, which function 
as high-capacity glucose transporters (O'Donnell et al. 2015). However, upon the return of 
abundant glucose, Rod1 is rapidly dephosphorylated and becomes a substrate for 
ubiquitination by Rsp5, which is a prerequisite for glucose transporter endocytosis and 
membrane insertion, allowing glucose to enter the cells. This mechanism reveals a 
coordinated action between Rsp5 and the SNF1 kinase in response to glucose signaling 
within the cells (Becuwe et al. 2012; Becuwe and Leon 2014).  
1.8 Lifespan and stress response  
1.8.1 Role of AMPK and SNF1 kinase in cellular stress response and aging 
 The cellular stress response pathways are highly conserved throughout eukaryotic 
cells, and many insights into these molecular mechanisms have been elucidated in yeast 
(Martegani et al. 1984; Hwang et al. 1998) and proven to be conserved in human cells 
and tissues (Woods, Johnstone, et al. 2003). The stress pathways are responsive and 
monitor environmental conditions through multiple sensor proteins including heat shock 
proteins or stress proteins (Hong and Carlson 2007; Morano et al. 2012). They quickly 
react to a variety of stresses including lack of nutrients, heat shock, hypoxia, or exposure 
to hyperosmolarity, and initiate a variety of responses to allow for cell survival. In 
mammalian cells, AMPK can be activated by a high AMP:ATP ratio such as during 
exercise, fasting, or muscle contraction (Andersson 2003; McGee et al. 2003; Backhed et 
al. 2007; Chiacchiera and Simone 2010); in eukaryotes such as yeast or plants, SNF1 
kinase functions as an environmental sensor, responding to reduced glucose levels, 
dehydration and low light availability (Ludin et al. 1998; Kulik et al. 2012; Hsu et al. 
2015). The role of the SNF1 kinase in cellular adaptation and survival in response to 
limited glucose/nonfermentable carbohydrates is particularly well elucidated (Hedbacker 
and Carlson 2008). SNF1 kinase quickly responds to nutrient limitation, and 
phosphorylation of the Snf1 subunit is essential for further activation of the kinase 
complex. Lack of the catalytic subunit Snf1 dramatically reduces the ability to respond to 
glucose limitation.  
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1.8.2 The SNF1 kinase is required for normal lifespan 
 The SNF1 kinase is also required for cell survival upon exposure to several other 
environmental stressors and to facilitate a normal lifespan. Quantitative measure of 
lifespan is possible in yeast using either the chronological lifespan (CLS) or replicative 
lifespan (RLS) assays, which measure distinctly different aspects of aging. CLS measures 
the survival of stationary phase (non dividing) cells, whereas RLS measures the number 
of daughters that can bud off from a single mother cell (Fabrizio et al. 2001; Fabrizio et 
al. 2004; Sinclair 2013; Postnikoff and Harkness 2014; Sutphin et al. 2014). CLS 
measures how long a cell population remains metabolically active without 
doubling/budding, and RLS defines the mitotic activity of individual yeast cells. Deletion 
of any single subunit of the yeast SNF1 kinase decreased maximal lifespan. For instance, 
the Sip2 β subunit of the SNF1 kinase has been proven to be a key regulator to effect 
yeast lifespan (Ashrafi et al. 2000; Lin et al. 2003; Lu et al. 2011). Deletion of the Sip2 β 
subunit results in a rapid aging phenotype with the average RLS reduced by 60% 
compared to a wild type (WT) isogenic yeast strain. However, the sip2Δ mutant exhibits 
normal growth on nonfermentable carbohydrates (Jiang and Carlson 1997). Deletion of 
the Sip1 β subunit, which localizes the complex to the vacuole, causes even greater 
lifespan reduction, to 80% of WT. The third β subunit, Gal83, is the subunit that co-
localizes with the SNF1 kinase to the nucleus. Deletion of GAL83, or the single γ subunit, 
SNF4, does not exert significant effects on yeast lifespan. Surprisingly, research indicates 
that removal of the Snf4 subunit is able to rescue the shorted lifespan of sip2Δ mutant 
(Ashrafi et al. 2000).  
1.8.3 The yeast FOXO orthologs, Fkh1 and Fkh2, contribute to the stress response 
 The forkhead box O (FOXO) transcription factors are a family of well-known stress 
sensors. The FOXO family of proteins are strongly conserved between yeast and higher 
eukaryotes and carry out similar roles (Greer, Dowlatshahi, et al. 2007; Greer, Oskoui, et 
al. 2007; Reynolds et al. 2012; Tullet et al. 2014). The FOXO protein orthologs regulate 
diverse biological processes including cell cycle control, metabolic regulation to 
environmental cues, apoptosis, and DNA damage repair. A large number of FOXO family 
members have been identified in higher eukaryotes, making it difficult to precisely 
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determine their respective contributions to cellular stress responses. In contrast, yeast has 
only four FOXO members, (Fkh1, Fkh2, Hcm1, and Fhl1) (Hollenhorst et al. 2000; 
Rodriguez-Colman et al. 2013), which present a chance to investigate their regulation in a 
greater depth. Fhl1 (forkhead-like 1) regulates ribosome biogenesis. Research indicates 
that Fhl1 binds to Ifh1 (interact with forkhead 1), a co-activator that binds promoter 
regions of ribosome mRNA, and further enhances their transcription (Martin et al. 2004; 
Mallick and Whiteway 2013). Hcm1 (high-copy suppressor of calmodulin 1) has a role in 
regulating cell cycle progression through G2 (Gap2 phase of cell cycle). It has also been 
determined to be an upstream transcription nal activator of the two remaining FOXO 
family member in yeast, Fkh1 and Fkh2 (Pramila et al. 2006; Rodriguez-Colman et al. 
2010; Landry et al. 2014; Negishi et al. 2016). Fkh1 and Fkh2 (forkhead 1 and 2) are 
conserved with those in higher eukaryotes, and exhibit a strong degree of homology to 
each other (Hollenhorst et al. 2000). Genetic redundancy of these two genes in yeast 
means that many studies have to use yeast strains harboring a combined deletion. Indeed, 
double deletion of FKH1 and FKH2 affects cell morphology, cell cycle progression, 
longevity, and stress response (Hollenhorst et al. 2000; Postnikoff et al. 2012; Ostrow et 
al. 2014).    
1.8.4 The yeast FOXO orthologs, Fkh1 and Fkh2, have a role in aging 
 Many models, including yeast, flies, and worms have found that FOXO family 
members extend lifespan when FOXO expression is increased. For example, the FOXO 
protein ortholog, DAF16, in C. elegans enhanced worm lifespan through changes to the 
insulin-signaling pathway (Greer, Dowlatshahi, et al. 2007; Tullet et al. 2014). Also, 
dFoxO, the ortholog in Drosophila melanogaster (D. melanogaster), has been shown to 
be a key regulator that modulates growth and proliferation of fruit flies (Puig and Tjian 
2006; Alic et al. 2014). Conversely, mutations or deletions of FOXO proteins in multiple 
model systems resulted in reduced lifespan and diminished stress responses. In addition, 
AMPK directly phosphorylates and activates DAF16 in C. elegans, subsequently 
increases stress resistance and extends its longevity (Greer, Dowlatshahi, et al. 2007; 
Tullet et al. 2014). In yeast, a double deletion of both FKH1 and FKH2 dramatically 
impaired CLS and response to caloric restriction (Postnikoff et al. 2012). Besides, the 
double deletion cells were shown to be more sensitive to oxidative stress in stationary 
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phase, compared to the isogenic WT or single deletions (Postnikoff and Harkness 2012; 
Postnikoff et al. 2012). 
1.8.5 The yeast FOXO orthologs, Fkh1 and Fkh2, are required for stress survival 
 The longevity of the cell depends on its own health status. It also depends on the 
response to the environment in which it lives. Fast and proper responses to environmental 
changes including, but not limited to, heat, nutrient limitation, and free radicals, assists 
the organism to survive. FOXO members play an important role in stress response in 
many species, and AMPK has also been proven to regulate stress responses and to work 
with FOXOs in mammalian systems (Greer, Oskoui, et al. 2007). This suggests the 
interactions between FOXOs and AMPKs are evolutionarily conserved. Under normal 
stress-free conditions, yeast FOXO members, Fkh1 and Fkh2, regulate cell-cycle 
progression by controlling the transcription of cell cycle dependent proteins such as Clb2 
(Hollenhorst et al. 2000; Simpson-Lavy and Brandeis 2010). Under stress conditions, 
FOXOs have been proven in many model systems to enhance the activity of other 
proteins or enzymes necessary for DNA repair (Miyauchi et al. 2004) and normal cellular 
functions (Greer, Oskoui, et al. 2007). In yeast, the combined deletion of FKH1 and 
FKH2 generates a yeast strain with a reduced capacity to survive oxidative stress, similar 
to the growth defect of snf1Δ mutants (Postnikoff et al. 2012).  
1.8.6 Enhanced AMPK activity promotes longevity in many organisms 
 AMPK has a tight connection with cellular longevity in all eukaryotes tested 
including yeast and mammals (Lu et al. 2011; Yao et al. 2015). Multiple studies from 
independent laboratories using yeast, worms, plants, and animals suggest higher AMPK 
activity promotes longer lifespan. In yeast, deletion of SNF1 results in a dramatic decrease 
of both CLS and RLS (Ashrafi et al. 2000; Lin et al. 2003; Harkness et al. 2004; Lu et al. 
2011). Many lifespan studies employ simple model systems such as yeast, worms, or fruit 
flies. Ease of quantitation and faster outcomes make these models powerful tools to study 
aging. Indeed, many key factors that affect aging have been found in these model systems. 
For instance, Aak-2 (AMP-activated protein kinase 2), the C. elegans ortholog of AMPK, 
has been shown to be required for extension of lifespan under states of caloric restriction 
(Lee et al. 2008; Schwarz et al. 2015). In plants, AMPK is necessary to maintain the 
	  	  
	   25	  
function and production of mitochondria, which is highly relevant to aging (Hartl and 
Finkemeier 2012). AMPK-induced mitochondrial biogenesis is suggested to slow down 
the aging process. In lower eukaryotes, but also in higher animals, there is a need for 
activated AMPK to slow down the aging process. Research indicates that activating 
AMPK in human cells can stimulate production and activation of Sirt1 (Sirtuin 1), which 
is found to increase in correlation with longer lifespans (Salminen et al. 2011; Lam et al. 
2013). In addition, Sirt1 can also be activated by caloric restriction, which as noted above 
is associated with stimulation of AMPK activity (Lam et al. 2013).  
1.9 The role of AMPK in human health and disease 
1.9.1 A healthy lifestyle activates AMPK activity 
 AMPK has a role in human health, including correlations with diabetes, cancer, and 
aging. For example, due to its role in maintaining energy homeostasis, dysfunction of 
AMPK is linked with metabolic disorders such as insulin resistance/ Type 2 diabetes 
mellitus (DM2) (Owen et al. 1979; Bergeron et al. 1999; Arkun 2016). It is not known if 
blunted AMPK activity is a result of obesity and insulin resistance, or a cause contributing 
to the metabolic disorders (Baur et al. 2006; Coughlan et al. 2013; Ruderman et al. 2013; 
Arkun 2016). It is known that weight loss, insulin sensitizing medications, and exercise 
all activate AMPK with simultaneous health benefits (Musi et al. 2001; McGee et al. 
2003; Ruderman et al. 2013). Interestingly, genome wide screening has not found AMPK 
mutations to be present in higher proportion in those individuals with metabolic 
syndromes (obesity, insulin resistance), suggesting that the dysregulation of AMPK 
activity may be at the post-translational level. Extended exercise helps to enhance AMPK 
activation and activity, further improving mitochondrial biogenesis (Reznick and 
Shulman 2006), increasing the rate of cellular glucose uptake, and lowering serum 
glucose levels (Bergeron et al. 1999; McGee et al. 2003). Paradoxically, constitutive 
activation of AMPK mediates glycogen accumulation in skeletal and cardiac muscles, 
which is associated with cardiac dysfunctions and is detrimental to health (Hunter et al. 
2011). Activated AMPK also inhibits further cholesterol synthesis and storage, and 
releases glycogen stores from the liver for energy use, ultimately reversing the abundance 
of hepatic fat and diminishing the appearance of fatty liver (Baur et al. 2006; Takekoshi et 
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al. 2006; Ross et al. 2016). 
 Lifestyle changes improve diabetic outcomes and glucose control, and are first line 
therapies for the management of DM2 (Lam et al. 2013).  In addition, recent studies 
indicate a novel role for AMPK in increasing blood supply to exercised muscles by 
stimulating and stabilizing neovascularization (Nagai et al. 2014), and angiogenesis 
(Ouchi et al. 2005; Neurath et al. 2006). All of these health benefits for humans are likely 
the results of increased AMPK activity during exercise or long-term training (Takekoshi 
et al. 2006). Furthermore, research on human skeletal muscle biopsies from healthy males 
found that even during a single round of high intensity acute exercise, AMPK appears to 
contribute to the energy homeostasis (Hoffman et al. 2015). Natural activating genetic 
mutants of AMPK have been found in pigs (interestingly, in the γ subunit) (Andersson 
2003) that are prized for their lean yet heavy muscle mass. By extrapolation, this may 
infer that enhanced AMPK activity could benefit human health through regulation of 
adipose content within metabolically active skeletal muscle. 
1.9.2 AMPK and human lifespan and health span 
 In human life, AMPK activity contributes to health at least at the cellular level. As a 
sensor, AMPK promotes autophagy, which functions to clear the cell of protein 
aggregates and recycle the fundamental components for reuse (Kim et al. 2011; Inoki et 
al. 2012). Once AMPK activity drops sharply, cells lose the ability to repair damaged 
DNA and clear dysfunctional proteins (Kim et al. 2011; Pineda et al. 2015). It has been 
found that the AMPK activity drops with aging, resulting in a loss of AMPK-dependent 
activity associated with maintaining normal cellular functions (Hardman et al. 2014). 
Evidence for the need of functional AMPK in human health comes from studies looking 
at the impact of dysfunctional AMPK in animal models and cell lines. These results 
further extend the knowledge of AMPK dysfunction, leading to other diseases that impact 
human life. For example, genetic and pharmacological manipulation on C. elegans 
AMPK showed that activated AMPK protects neurons from the dysfunction induced by 
human exon-1 huntingtin expression (Vazquez-Manrique et al. 2016). AMPK also works 
as a metabolic tumor suppressor, thereby preventing cancer development (Rutherford et 
al. 2016; Wang et al. 2016; Zou et al. 2016).  
 Our modern lifestyle chronically inhibits AMPK activity due to the overabundance 
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of nutrients and low physical activity, both of which hold AMPK in the repressed, un-
phosphorylated state. This, in combination with aging, is worse for cellular and body 
health, or the AMPK system, than aging alone. Investigations have indicated that in 
mouse models, suppressed AMPK function reduces insulin sensitivity and produces 
inflammation, which may contribute to metabolic syndrome and its associated insulin 
resistant state (Baur et al. 2006; Coughlan et al. 2013; Ruderman et al. 2013). Metabolic 
syndrome, conversely, further inhibits AMPK activity, subsequently affecting human 
health (Ruderman et al. 2013). A globally prescribed medication, metformin, is a 
derivative of the French Lilac plant, and has been used to treat DM2. It is an effective 
insulin sensitizer, lowering blood glucose levels and effectively improving the metabolic 
balance. It was used for years before it was discovered that it indirectly activated AMPK, 
as detected by its phosphorylation, presenting a mechanism that may explain its benefits 
to metabolic dysfunction in humans.   
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CHAPTER 2 Hypothesis and Objectives  
2.1 Rational  
In the literature, encompassing multiple model systems, the regulated and dynamic 
control of the activation and activity of the heterotrimeric kinase enzymes AMPK and the 
AMPK-like family have been shown to be very important to affect normal cell functions. 
This enzyme class is necessary to maintain cellular and organismal health and lifespan 
while enduring changes in environmental stressors and altered energy needs. Furthermore, 
while it is acknowledged that the correct function and regulation of AMPK/AMPK-like 
activities is correlated with human health and metabolic regulation, it is challenging to 
study the underlying regulatory mechanisms to appreciate how to optimize this to 
improve clinical health outcomes, as research in humans is limited. The study of AMPK 
in human health is limited by the complexity of tissue expression (8 subunits 
preferentially expressed in different tissues), higher-level hormonal influences on AMPK 
activity and activation, and reversible post-translational modifications, among others. 
Research models including mouse and in vitro human cell culture have been used to 
investigate and elucidate the fundamental aspect of AMPK control, as have worms (C. 
elegans), plants, and zebrafish (Danio), all of which struggle with tissue-specificity and 
subunit composition. Yeast have proven to be a powerful tool to study the fundamental 
underlying mechanisms regulating the activation and activity of AMPK, referred to as the 
SNF1 kinase in S. cerevisiae. Using this model, there is a simplicity of subunit options (a 
single catalytic α subunit, single regulatory γ subunit, and three defined β regulatory 
subunits), no tissue-specific alterations, and no hormonal influences.  
Using this as a model to study mechanisms of yeast AMPK regulation, we 
investigated the role of the ubiquitin system, including the specific UBA motif within the 
catalytic α subunit, on yeast SNF1 kinase regulation. We asked if we could identify the 
E2 and E3 enzymes that are involved in the previously reported ubiquitination of the Snf1 
α subunit, and the fundamental regulatory role of the highly evolutionarily conserved 
UBA domain.  
UBA domains can influence protein-protein associations (such as within the 
kinase complex itself) or enzyme activities in response to external ubiquitination signals. 
Mutations within the yeast Snf1 UBA domain had been done previously (Momcilovic and 
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Carlson 2011) and suggested that it may have an inhibitory role, yet mutations within the 
human UBA domain showed different results (Jaleel et al. 2006; Cho et al. 2014). We 
directly addressed this through several complementary techniques. Next, we set out to 
screen all yeast E2s and selected E3s for their role in regulating SNF1 kinase activity. We 
felt this was a particularly important goal as targeted protein ubiquitination can alter 
stability, nuclear location, protein associations, and enzyme activity, any of which is 
relevant to controlled SNF1 kinase. 	  
2.2 Hypothesis 
We hypothesize that ubiquitin binding motifs and ubiquitin-conjugating enzymes 
play distinct roles in the regulation of the yeast SNF1 kinase/AMPK. 
2.3 Objectives  
1. Determine the regulatory role of the ubiquitin-associated (UBA) motif within 
the Snf1 catalytic subunit. 
2. Screen the yeast ubiquitin conjugating enzymes for their regulatory role in 
SNF1 kinase activation and activity. 
3. Determine the role of the ubiquitin ligase Rsp5 in SNF1 kinase activation and 
activity. 
4. Determine the protein stability of SNF1 kinase subunits under enzymatically 
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CHAPTER 3 Material and Methods  
3.1 Whole Protein Extraction 
Cells were grown to logarithmic phase (OD600≤1) when harvested in either YPD 
(1% yeast exact, 2% peptone, and dextrose media) or selective medium. To extract whole 
protein, cells were pelleted and mechanically broken using glass beads in the presence of 
radioimmunoprecipitation assay (RIPA) buffer (25 mM Tris, 150 mM sodium chloride, 
0.1% Sodium dodecyl sulfate, 0.5% sodium deoxycholate, 1% Triton X-100), protease 
inhibitor, and phosphatase inhibitor. Cells were pelleted again, supernatant was collected 
and kept frozen in -80°C freezer (Harkness et al. 2002).  
3.2 Western Blot Analysis 
Whole protein concentration from yeast cells was measured using the 
commercially available Bradford assay and a standard curve. Samples with equal 
amounts of total protein were routinely applied to either 7.5% or 10% acrylamide gels for 
separation. After the proteins were sufficiently separated, they were transferred to a 
nitrocellulose membrane. The membrane was cut into pieces if multiple targets were 
being simultaneously probed for, depending on the size of target proteins of interest. 
These membranes were incubated in blocking buffer (3% Bovine serum albumin (BSA) 
or 3% skim milk, 1 hour), selected primary antibodies (4°C overnight), and secondary 
antibody for detection (1 hour). Tris-buffered saline (TBS) with 1% Tween-20 (TBST) 
was used to wash off the primary and secondary antibodies from the membrane (15 
minutes for 4 times) before exposure to Enhanced Chemiluminescence reagents (ECL). 
The chemiluminescence signal was captured on a VersaDoc (BIO-RAD) molecular 
imager and quantitation performed with VersaDoc software (Quantity One 4.6.9). 
3.3 Protein Stability Assay  
To inhibit protein synthesis, 10 µg/mL cycloheximide in 95% ethanol (CHX) was 
added to dividing early-logarithmic phase cells in YPD medium. Equal cell numbers were 
collected every 30 minutes for cell lysate preparation and subsequent Western Blot 
analysis.  
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3.4 Fluorescence Microscopy 
Fluorescence microscopy was used to detect green fluorescent protein (GFP) 
signal in whole living yeast cells. Selective media lacking histidine (His-) or complete 
medium (CM) was used for strains containing plasmid-expressed Snf1-GFP or 
endogenous Snf1-GFP, respectively. To determine the subcellular localization of Snf1-
GFP or Mig1-GFP, logarithmically growing cultures were divided between non-
activating conditions (2% glucose) versus activating conditions (5% glycerol) for 30 
minutes. Live cells were stained with mounting medium containing 4',6-diamidino-2-
phenylindole (DAPI) for immediate DNA visualization. All images were captured using a 
100x objective (oil). To determine the subcellular localization of Hcm1-GFP, cells were 
arrested in G1 (Gap1 phase of cell cycle) using α factor. Images were taken every 30 
minutes from release of G1 arrest. Cells were viewed with an Olympus BX51 
fluorescence microscope 100x objective equipped with an Infinity 3-1 UM camera. 
Images were collected using Infinity Analyse software version 5.0. A minimum of 125 
cells for each strain and condition were consecutively scored for co-localization of the 
GFP-tagged subunits and DAPI nuclear staining. 
3.5 Invertase Assay  
Yeast strains were grown to early-logarithmic phase in 2% YPD. 1 x 106 cells 
were removed to ice from the 2% glucose sample, based on optical density (an OD600 of 1 
is approximately equivalent to 2 x 107 cells). The remaining cells were washed and 
resuspended in 0.05% YPD for 2 hours. 1 x 106 cells were again removed as the low 
glucose, activated samples. Colorimetric measurement of invertase activity (glucose 
production from sucrose) was performed, with the following parameters. 50 µl cell 
suspensions had 0.5 M sucrose (12.5 µl) added for 10 minutes at 37°C, before stopping 
the reaction with 75 µl 0.2M dipotassium monohydrogen phosphate (K2HPO4). 500 µl 
Assay Mix (50 µl of 5000 U/mL glucose oxidase, 62.5 µl 1 mg/mL peroxidase, and 375 
µl 10 mg/mL o-dianiside (in 95% ethanol) into 25 ml 0.1 M potassium phosphate 
buffered to pH 7.0) was added to start the color reaction. After 20 min at 37°C the color 
was developed with 500 µl 6 M hydrogen chloride (HCl). OD540, blanked to a no sucrose 
control, gave values used to calculate invertase activity, reported as mM glucose 
converted/minute/106 cells. Activity was normalized (value of 1) to that of 2% glucose 
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WT in each biological repeat. Statistical analysis was done using PRISM Version 6.0b 
software and 2-way ANOVA (Harkness and Arnason 2014). 
3.6 2-hybrid Analysis 
The yeast 2-hybrid reporter strains (WT and its modified versions ubc1Δ, or rsp5ts) 
were doubly transformed with pairs of empty vectors (negative control: pGAD-C2 and 
pGBD-C2), the same backbones expressing target genes, regarding to the different 
manuscripts. 1x105 cells of logarithmic cultures (in 3 µl volumes) of each transformation 
sets were repeatedly spotted on the glucose gradient of the slant plates, and grown at 
30°C until colonies were established. The images were scanned before and after color 
development. The glucose gradient slant plates involved sequential stacking and cooling 
of 20 ml 2% glucose (bottom) and 0.05% glucose (top) media poured at ~30° slant into 
petri plates. Selective medium lacking leucine and uracil (Leu-Ura-) was used in both 
layers for dual plasmid maintenance. Plates were equilibrated overnight prior to use. 
Freshly prepared warm liquid X-Gal agarose overlay medium was layered to completely 
cover cells, solidified and incubated at 30°C and images scanned again after color 
development.  
3.7 Transformation of Yeast Strains 
Yeast transformation was used to generate genomic mutations either using 
polymerase chain reaction (PCR) products or plasmids that express proteins of interest, 
following the LiAc-DNA-PEG protocol. For details, cells of parental strains were 
pelleted from overnight YPD culture, resuspended with 100mM lithium acetate (LiAc), 
and incubated at 30°C for 10 minutes. Cells were pelleted again, added target DNA, 50% 
polyethylene glycol (PEG) and100mM LiAc, then incubated at 30°C for at least 20 
minutes. After incubation, heat shock cells at 42°C for 5 minutes and quickly put on ice. 
Cells were pelleted and resuspended with selective media, then grew on agar plates in 
30°C incubator. Only cells containing transformed plasmids or mutations can grow on 
selective media plates.  
3.8 mRNA Expression Analysis 
Total RNA was isolated (RNAeasy Kit, Qiagen) from logarithmically (OD600≤0.4) 
growing cell cultures, followed by reverse transcription (RT) (QuantiTect Reverse 
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Transcription Kit, Qiagen). 500 ng cDNA (complementary DNA) of each sample was 
used as template in amplification reactions and equal reaction volumes were retrieved. 
Abundance of PCR products for interested genes was normalized to signal for ribosomal 
RNA (rRNA) at 26 cycles. VersaDoc (BIO-RAD) quantitation was obtained from 
RedSafe nucleic acid stain signal (FroggaBio). Statistical analysis was done using PRISM 
Version 6.0b software and 2-way ANOVA. 
3.9 Analysis of Stress Resistance 
The snf1Δ fkh1Δ fkh2Δ strain was created by genetic crossing (snf1Δ [YTH1510] 
× fkh1Δ fkh2Δ [YTH2578]). Tetrads were picked and markers scored on G418 (Geneticin) 
and YPSuc (1% yeast extract, 2% peptone, 2% sucrose media) plates, with triple 
deletions confirmed by PCR. Oxidative stress was induced by exposure to hydrogen 
peroxide (H202). The indicated strains were grown to late stationary phase in CM, with 
equal cell numbers left untreated, or treated with 100 mM H202 for 60 minutes at 30°C. 
All cells were washed, then plated on YPD for 2 days at 30°C before scoring survival as a 
percentage compared to untreated.  
3.10 Cell Cycle Arrest  
To arrest cells in G1 phase, α-factor was added to asynchronous (Asy) early-
logarithmic phase cell culture in YPD (pH 3.5) for 2 hours (with a final concentration of 
4 µg/ml). G1 arrested cells demonstrated >90% with the expected G1 cell morphology 
(pear shaped) under light microscopy. Cells were released by washing away the α-factor 
in fresh YPD. Equal volume cell samples were collected each 30 minutes for protein 
extraction and/or fluorescence-activated cell sorting (FACS) analysis. Note that only 
strains with a mating type of Mata can be arrested by α-factor.  
3.11 Flow Cytometry (FACS) 
Yeast strains of interest were grown to logarithmic phase (OD600 of 0.4), 8 x105 
cells (1 ml) were pelleted and washed with 50 mM Tris buffer (pH8.0), then resuspended 
in 1 mL 70% ethanol overnight at room temperature to fix. Cells were pelleted and 
resuspended in 500 µl of 50 mM Tris buffer and digested with 10 µl 10 mg/ml RNaseA at 
37°C for 2 hours. Propidium iodide (10 µg/ml) was added to cells for ≥1 hour at room 
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temperature away from light. FACS was performed using the EPICS® XL and data was 
analyzed with Flowjo software (v10.0.7).  
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The results reported within each manuscript chapter support the thesis hypothesis 
and satisfy the objectives presented within Chapter 2. These manuscripts extend the 
knowledge of the ubiquitination system in the regulation of the SNF1 kinase. The 
manuscripts are independent investigations yet the contents are related and supportive. 
Chapter 4 focused on the UBA domain that potentially binds ubiquitin within the Snf1 
subunit; Chapter 5 investigated the stoichiometry of the SNF1 kinase complex subunits 
and the potential ubiquitination-degradation pathway components that affects their 
stability; Chapter 6 and 7 focused on individual ubiquitin cascade enzymes and their roles 
in regulating SNF1 kinase activation and activity. In addition, these manuscripts 
document the development of the yeast 2-hybrid assay methodology using slant plates, 
which extends this classic technique to study protein-protein interaction on the same plate 
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4.1 Introduction 
The ability to shift between feasting and fasting is a central and essential metabolic 
adaptation that impacts biology at every level (Owen et al. 1979). Abundant nutrients can 
trigger reproductive readiness in multi-cellular organisms, and promote cell growth and 
division in single-celled organisms, by switching from catabolic to anabolic metabolic 
pathways through the simple flipping of ON and OFF switches (Hardie 1999). One 
switch that is active under times of energy depletion, such as during fasting, exercise, or 
oxygen depletion is a non-hormonal central energy sensor and regulator known as the 
AMPK, and its yeast ortholog, SNF1 kinase (Carlson et al. 1981; Hardie 1999). All 
AMPK family members share distinct evolutionary homology transcending primary 
sequences, tertiary protein folding and quaternary protein associations of the 
heterotrimeric kinase complex (Rudolph et al. 2005; Elbing et al. 2006; Amodeo et al. 
2007). The yeast SNF1 kinase contains the catalytic Snf1 (α) subunit, the regulatory Snf4 
(γ) subunit, and one of three β-subunits Sip1, Sip2 or Gal83; the β-subunits bridge the α 
and γ subunits in the complex and individually direct the subcellular location of the 
kinase (Jiang and Carlson 1997; Vincent et al. 2001). The SNF1 kinase is important for 
the yeast stress response (Hardie et al. 1998) and facilitates adaptation to glucose 
limitation, regulating the activity of metabolic enzymes and the transcription of metabolic 
genes. In addition to metabolic effects, this family of kinases has also been found to 
protect against oxidative stress, and to impact the lifespan of model systems (Ashrafi et 
al. 2000; Harkness et al. 2004; Greer, Dowlatshahi, et al. 2007; Wu and Wei 2012). As 
an enzyme complex that must efficiently respond to metabolic signals, its activity 
incorporates the rapid and reversible phosphorylation of its catalytic α subunit by well 
defined upstream kinases (Pak1, Elm1 and Tos3) (Sutherland et al. 2003) and 
phosphatases, with a major contributor being protein phosphatase I; Reg1-Glc7 (Celenza 
and Carlson 1986; Ludin et al. 1998; Woods, Vertommen, et al. 2003; Momcilovic and 
Carlson 2011). Further layers of regulatory finesse include the reversible physical 
allosteric association between the α and γ regulatory subunits and the nuclear 
translocation of the active trimeric complex to alter gene expression that aims to preserve 
the energy balance of the cell (Jiang and Carlson 1997; Adams et al. 2004; Momcilovic 
and Carlson 2011). Also conserved is acetylation and ubiquitination, recently reported for 
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both mammalian AMPK and yeast SNF1 kinase complexes (Baskin and Taegtmeyer 
2011; Lu et al. 2011; Wilson et al. 2011; Zungu et al. 2011), which appear to have 
inhibitory roles in regulation of the kinase. Similarly, SUMOylation has been shown to be 
a negative regulator of Snf1 (Simpson-Lavy and Johnston 2013), clearly adding to the 
complexity of regulation of this central energy-sensing switch. 
 The current epidemic of lifestyle related obesity, insulin resistance, and DM2 is 
overwhelming healthcare systems and budgets. The recommended lifestyle changes all 
stimulate AMPK; exercise, caloric restriction/weight loss, and muscle contraction all 
activate human AMPK with clinical metabolic benefits of improved glucose control and 
lowered cholesterol (Chen et al. 2000; Musi et al. 2001; Greene et al. 2012). In addition, 
a first line agent to treat DM2, metformin, indirectly results in AMPK activation (Hardie 
2006; Suwa et al. 2006; Zhang et al. 2012) as well as newer evidence of direct metformin 
influences on AMPK (Zhang et al. 2012). Therefore, it is of great interest to understand 
how AMPK is regulated to gain insight into how this might be used to improve clinical 
health.  
The catalytic α subunits of the AMPK and AMPK-like family share very strong 
domain structure between all eukaryotes, including the yeast Snf1 (Rudolph et al. 2005; 
Amodeo et al. 2010; Rudolph et al. 2010). Relevant to this report is the presence within 
the majority of α subunits of a consensus motif for a UBA domain (Jaleel et al. 2006; 
Momcilovic and Carlson 2011), immediately adjacent to the catalytic domain. The UBA 
domains are loose primary sequence motifs of ~45 amino acid resudies that are found in 
many protein families throughout eukaryotes that fold independently into stable surface 
structures (Mueller et al. 2004). Their role continues to be clarified, but includes the 
ability to bind to ubiquitin in a linkage-specific (Class 1; lysine-48 and Class 2; lysine-63) 
or non-selective (Class 4) manner via non-covalent associations between the hydrophobic 
UBA protein face and the globular head of the ubiquitin moiety. Ubiquitin-binding UBA 
domains contribute to target proteolysis (lysine-48 linkages) or to cell trafficking (lysine-
63), yet 25% of budding yeast proteins with UBA domains, including the yeast Snf1, 
have not been shown to bind ubiquitin of any linkage type, defined as Class 3 (Raasi et al. 
2005). The importance of the UBA domain to SNF1 kinase activity and activation in 
yeast may clarify the importance of the role of ubiquitin in regulating yeast and higher 
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eukaryotic AMPK. To date, complete deletion and point mutations within the yeast UBA 
domain resulted in a modest activating effect under both repressive and activating 
conditions (Momcilovic and Carlson 2011). We report here the influence of mutations 
within conserved residues of the Snf1 UBA domain on the activity, activation, and 
allosteric associations between the Snf1 and the Snf4 subunits of the yeast SNF1 kinase, 
in addition to its influence on lifespan and oxidative stress resistance. 
4.2 Materials and Methods  
4.2.1 Creation of Snf1UBA constructs   
Snf1UBA-GFP: genomic Snf1 α-subunit with UBA mutations and C-terminal GFP 
tag. Two point-mutations (G357A, L367I) were introduced by PCR mutagenesis into the 
Snf1 α-subunit UBA motif. Genomic DNA (gDNA) from the Snf1-GFP::His3 strain 
(YDR477W; Life Technologies) was used as a PCR template. Two PCR products 
homologous to the mutated UBA sequences and extending outside the full length SNF1 
gene to include the GFP epitope and HIS3 sequence were generated; [Snf1-500 5'-
TTGCGTGGCGGCGTGGATC] and [Snf1UBA 5'-GTCTTTTTCGTACGCCATGGTGG-
ATGATAAAA] with [Snf1UBA 5'-TTTTATCATCCACCATGGCGTACGAAAA-AG] and 
Snf1+500 5'- GGAACGTAAACACACCCGC] purified and co-transformed into the snf1Δ 
(YTH1510; snf1::G418) strain for integration and selected on His- plates. Confirmation 
was by DNA sequencing. 
 Snf1-GFP: genomic SNF1 α-subunit with WT sequence and C-terminal GFP tag. 
The SNF1-GFP-HIS3 sequence was amplified from YDR477W (SNF1-GFP) using non-
mutagenic primers that flanked the gene locus by 500 bp (Snf1-500 and Snf1+500) and 
homologously recombined into snf1Δ by transformation to create an isogenic Snf1-GFP. 
Snf1UBA-HA:  2-micron plasmid expressing Snf1 α-subunit with UBA mutations 
and C-terminal HA tag. YTH1510 was doubly transformed with both the linearized HA-
tagged Snf1 plasmid (2-micron, TRP+: a kind gift from M. Schmidt (Schmidt et al. 
1999)) with an internal SNF1 sequence deletion (BglII-NcoI digest) and the amplified 
linear PCR product containing full-length SNF1UBA coding sequence. Yeast plasmid and 
genomic DNA was retrieved (Adams and Kamakaka 1999) from TRP+ colonies, and 
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transformed into XL-1 E. coli to select for re-circularized AMP+ plasmids. SNF1UBA-HA 
presence was confirmed by sequencing.  
2 hybrid Snf1UBA, Snf1WT, and Reg1 plasmids: The SNF1UBA full length sequence 
was amplified using SNF1UBA-HA as template [forward: 5'- ATCGATGCGAATTCA-
GCAGTA and reverse: 5' ATCGCTCGAGTCAATTGCTTT] digested with Pst1 and 
EcoRI and ligated in-frame into the pGBDU-C2 2 hybrid plasmid (a gift from S. Fields 
(Fields and Song 1989)). Reg1 sequences were amplified from genomic DNA and cloned 
by EcoRI-BlgII restriction digest ligation into pGAD-C2 [Reg1 forward: 5' 
ATCGATGCGAATTCTCAAATCTAGCA and Reg1 reverse: 5' AAATTCTTAGATC-
TAACTGCTGTCATTTC]. 
4.2.2 Creation of FKH and SNF1 deletion strains 
All strains were based on S288C. Individual cassettes for snf1::kanMX6, 
fkh1::kanMX6 and fkh2::kanMX6 were amplified with 500 bp up and downstream. 
Integration was into YTH4269 with selection for Kanres and PCR confirmation. 
Combinations were created by crossing and tetrad dissection, scoring for markers, 
phenotypes, and confirmed by primer-specific amplification.  
4.2.3 Total protein extraction and Western Blot analysis 
The yeast strains used in this study are shown in Table 4.1. Protocols have been 
previously described in sections 3.1 and 3.2.  
4.2.4 Invertase assay 
Protocols have been previously described in section 3.5. 
4.2.5 Fluorescence microscopy 
Protocols have been previously described in section 3.4. In this study, 
fluorescence microscopy was used to visualize the subcellular localization of Snf1-GFP 
and Snf1UBA-GFP. A minimum of 150 cells for each strain and condition were 
consecutively scored for co-localization of the GFP-tagged subunits and DAPI nuclear 
staining. 
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4.2.6 2-hybrid analysis 
Protocols have been previously described in section 3.6. In this study, the yeast 2-
hybrid reporter strain was doubly transformed with pairs of empty vectors (-ve control: 
pGAD-C2 and pGBDU-C2), the same backbones expressing unmodified Snf1 and Snf4 
subunits (+ve control), or Snf1UBA and Snf4 or Reg1.  
4.2.7 Analysis of lifespan and stress resistance 
Protocols have been previously described in section 3.9. 
4.2.8 SNF1 and SNF4 expression analysis 
mRNA expression analysis protocol has been previously described in section 3.8. 
In this study, RNA was isolated (RNAeasy, Qiagen) from logarithmically growing Snf1-
GFP or fkh1/2Δ Snf1-GFP yeast strains that were transformed with empty vector (-, 
YEp24), or HA-pFkh1 or HA-pFkh2 (Hollenhorst et al. 2000) followed by RT. cDNA 
was used as template in amplification reactions and equal reaction volumes retrieved after 
the indicated number of cycles. Abundance was normalized to signal for rRNA or TUB1 
(α-Tubulin) at 26 cycles. VersaDoc quantitation was obtained from RedSafe nucleic acid 
stain signal (FroggaBio).  
4.3 RESULTS 
4.3.1 Generation of a Snf1 construct with a mutated UBA domain 
To gather a greater understanding of SNF1 kinase regulation and function in 
yeast, we focused on the role played by the UBA domain, a loose linear sequence present 
in yeast and mammalian AMPK-related kinase α subunits that fold into a conserved tri-
helical structure characterized by an hydrophobic face. Such UBA surfaces can associate 
non-covalently with the globular head of ubiquitin or poly-ubiquitin chains, yet this 
function has not yet been detected for the AMPK-related kinase class of human proteins 
(Jaleel et al. 2006), nor reported for the yeast α subunit, Snf1 (Raasi et al. 2005). It has 
been recently published that mutations and deletions within the yeast Snf1 UBA sequence 
led to modest increases in phosphorylation of the SNF1 kinase itself and of an in vitro 
target, suggesting a natural inhibitory role of the UBA domain under normal conditions 
(Momcilovic and Carlson 2011). The two amino acid residues selected for conservative 
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replacement in our studies (Gly357 and Leu361) were based on their high degree of 
conservation within UBA motifs in general (Raasi et al. 2005), as well as within the 
AMPK family specifically (Jaleel et al. 2006). 
We replaced two highly conserved amino acid residues within the UBA domain 
of Snf1 (Snf1UBA) that spans residues 348-389 (Fig. 1A). The mutated glycine residue 
Gly357 (*, G357A) and Leu367 (u, L367I) (Fig. 4.1A) residues are adjacent on the 
hydrophobic face of the crystallized UBA motif (Jaleel et al. 2006) and are present in the 
majority of AMPK-like kinases (Fig. 4.1A). A striking exception is the absence of a 
convincing UBA domain consensus in human α subunits AMPKα1/α2 that lacks Gly357 
yet retains the Leu367 residue. The Gly357 residue was independently mutated in the 
human AMPK-like study (Jaleel et al. 2006) and different conserved mutations were 
previously introduced within yeast Snf1 (Momcilovic and Carlson 2011).  
4.3.2 Activation of the Snf1UBA mutant is greater than wild type 
Endogenous unmodified Snf1-GFP and the mutant Snf1UBA-GFP were expressed 
at similar levels and grew equivalently on sucrose, a nonfermentable carbon source that 
requires SNF1 kinase function for utilization (Fig. 4.1B and C). This is a phenotype of 
the snf1∆ mutant that led to its yeast nomenclature (sucrose non-fermenting). An HA-
tagged version of the same UBA mutation expressed from a high copy plasmid (Snf1UBA-
HA) is similarly able to complement for growth on sucrose (data not shown). The relative 
activation of Snf1UBA was compared to WT by assessing: i) activating phosphorylation of 
Snf1 Thr210 (Thr(P)-210); ii) nuclear import efficacy under activating conditions; and iii) 
the levels of allosteric subunit associations between the Snf1 and Snf4 subunits. 
Activating conditions (0.05% low glucose, L) revealed a pervasive increase in the Thr(P)-
210 phosphorylation of Snf1UBA over Snf1 under both activating and repressive 
conditions for the endogenous (Fig. 4.2A) and plasmid-expressed (Fig. 4.2B) UBA 
versions. This trend towards activation is consistent with the outcome from unrelated 
mutations within the yeast UBA consensus that included both a full UBA deletion 
(residues 347-398) as well as the combined mutation of methionine Met356 and tyrosine 
Tyr358, or Leu385 alone (Momcilovic and Carlson 2011). 
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Figure 4.1 The Snf1 UBA domain mutation characteristics. (A) 
Amino acid sequence alignment of the α-subunit UBA domain of Snf1 to 
UBA domains within other AMPK family protein kinases. Single letter 
amino acid code. Numbering reflects amino acids within each respective 
UBA motif. Identical residues in black, conserved in grey. The two 
amino acid substitutions present in this study within the UBA domain are 
indicated: *G357A; uL367I. (B) Endogenous protein expression of 
genomic GFP-tagged unmodified Snf1 (Snf1-GFP), UBA mutated 
(Snf1UBA-GFP), or untagged-parental strain (WT). (C) Spot dilutions 
demonstrating the growth characteristics of Snf1-GFP, Snf1UBA-GFP and 
snf1Δ isogenic strains on SNF1 kinase repressive (2% glucose) and 
activating (no glucose, 2% sucrose) YP medium. 
 
Activated SNF1 kinase relocates to the nucleus rapidly after stimulating 
conditions are introduced (Vincent et al. 2001). The impact of UBA motif mutations on 
this mechanism was tested by making use of the Snf1-GFP and Snf1UBA-GFP fusion 
constructs, and fluorescence microscopy. The Snf1-GFP subunit was efficiently shuttled 
to the nucleus within 20 minutes following stimulation (82%), as was the case with 
Snf1UBA-GFP (90%) (Fig. 4.2C and D). The greater degree of phosphorylation observed 
for Snf1UBA-GFP under repressive conditions (2% glucose) does not result in a detectable 
increase in nuclear Snf1UBA localization, demonstrating that the phosphorylated Snf1UBA 
remains appropriately cytosolic under these conditions (Fig. 4.2D). It remains possible 
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that Snf1UBA was shuttled at an increased rate over that of Snf1 that is beyond our 
capability to detect. 
Activation of yeast and AMPK trimeric complexes also involves the allosteric 
juxtapositioning of the Snf1-Snf4 subunits, and the strength of their associations can be 
measured using the yeast 2-hybrid system (Fields and Song 1989); β-galactosidase 
production correlates with the strength of the associations between the two proteins 
tested. Increased 2-hybrid associations were observed between Snf4 and the Snf1UBA at 
all glucose concentrations, and visibly exceeded the maximum associations detected 
between unmodified Snf1 and Snf4 (Fig. 4.2E). Together these data provides evidence 
that the wild type UBA domain functions to inhibit SNF1 kinase activation at least in part 
by hindering α-γ associations. 
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Figure 4.2 The UBA mutation increases SNF1 kinase activation. 
The activating Snf1 subunit Thr210 phosphorylation (Snf1ph) is 
enhanced by the Snf1UBA mutation in both repressive high glucose (H: 
2%) and activating low glucose (L: 0.05%) growth media when (A) 
genomically expressed under the endogenous promoter and (B) when 
expressed from a high copy 2-micron yeast plasmid in a snf1Δ strain 
background. The Mean ± S.D. of 4 biological repeats is shown, 
normalized to 2% glucose WT. 2-way ANOVA (Prism 6.0b) indicated 
significant differences (* P<0.05). (C) Subcellular fluorescent location 
of GFP-tagged Snf1 and Snf1UBA under activating (5% glycerol) and 
repressive (2% glucose) conditions. DAPI: DNA/nucleus location. (D) 
150 cells per condition and strain, consecutively scored for co-
localization of DAPI and GFP signal, expressed as % nuclear. (E) Solid 
support 2-hybrid associations on glucose gradient plates (H: 2%; L: 
0.05% glucose) between the Snf4 subunit and either unmodified Snf1 or 
Snf1UBA before and after β-galactosidase overlay. (-); Negative control 
using empty 2-hybrid vectors.  
 
4.3.3 Snf1UBA mutant activity is greater than wild type 
Next, we analyzed the effect of the UBA mutation on SNF1 kinase enzymatic 
activity by indirectly measuring its ability to target and phosphorylate the transcriptional 
repressor Mig1 (Treitel et al. 1998) as compared to unmodified Snf1. Upon activation, 
phosphorylated and nucleus-shuttled Snf1 targets Mig1 for phosphorylation to release 
glucose-dependent repression of SUC2, which encodes the invertase enzyme. Once 
active, invertase catalyzes the quantifiable biochemical conversion of sucrose to glucose 
and fructose (Treitel et al. 1998). We show that Snf1UBA-GFP cells exhibit increased 
invertase activity most notably under activating conditions compared to unmodified Snf1-
GFP (Fig. 4.3A). This is correlated with a detectable increase in the overall intensity of 
the Mig1ph signal (Fig. 4.3B) whereas the associated Mig1ph "super-shift" is only seen in 
low glucose. 
We then measured the impact of the mutated UBA motif on yeast RLS to 
determine if this homeostatic endpoint is also affected by SNF1 kinase activity. RLS 
measures the mitotic capacity of yeast cells by determining the number of daughter cells 
a single mother can produce (Kennedy et al. 1994). We previously demonstrated that 
Snf1 plays a role in extending yeast RLS via Mig1 inhibition (Harkness et al. 2004), and 
others have shown that RLS is reduced when the SNF1 kinase Sip1 β-subunit is deleted 
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(Ashrafi et al. 2000; Lin et al. 2003). Here we show that under minor nutrient stress 
conditions (growth on 2% glucose dropout media), snf1∆ cells have an obvious decrease 
in RLS when compared to plasmid-borne Snf1-HA (16 versus 19 generations; Fig. 4.3C). 
However, when Snf1UBA-HA was expressed from the same high copy plasmid in snf1∆ 
cells, mean RLS was considerably increased beyond wild type levels to 27 generations.  
We repeated the RLS experiment on CM media, which induces a similar nutrient 
stress, using strains harboring endogenous snf1UBA-GFP and SNF1-GFP alleles to avoid 
copy number bias. Our results demonstrate that the UBA mutation, under the control of 
the endogenous promoter, continues to confer extended mitotic longevity (Fig. 4.4A). 
Thus, increased SNF1 kinase activity due to the UBA mutation increases RLS regardless 
of its source of expression. Our results indicate that the increased α-γ subunit 
associations, and nuclear transcriptional activity (invertase), play an important role in 
extending mitotic longevity as measured by the RLS assay.  
4.3.4 Increased lifespan conferred by the UBA mutation is partially dependent on 
the yeast forkhead transcription proteins Fkh1 and Fkh2 
In mammalian cells it is known that activated AMPK phosphorylates FOXO and 
results in increased FOXO-dependent transcriptional activity without altering the cellular 
location of FOXO (Greer, Oskoui, et al. 2007). The FOXO family of Fkh transcription 
factors promotes resistance to oxidative stress, suppresses tumor development, and 
enhances longevity/lifespan (Greer, Dowlatshahi, et al. 2007; Chiacchiera and Simone 
2010). We have recently shown that the yeast FOXO orthologs, Fkh1 and Fkh2, are 
redundant stress responsive transcription factors that extend both RLS and yeast CLS 
when their activity is increased (Postnikoff et al. 2012). While RLS measures how long a 
cell can remain mitotically active, the CLS assay measures how long a population of cells 
can remain metabolically active once they have exited mitotic growth and entered 
stationary phase (Fabrizio et al. 2001). Furthermore, combined disruption of both FKH1 
and FKH2 was required to decrease CLS, and the double mutants no longer responded to 
caloric restriction, indicating that Fkh1 and Fkh2 are critical responders to caloric 
restriction, a metabolic stress that also results in AMPK/SNF1 kinase activation. To date 
however, Snf1 has only been shown to interact with the Hcm1 (Rodriguez-Colman et al. 
2013), and not Fkh1 or Fkh2. 
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Figure 4.3 UBA mutations effect SNF1 kinase activity. (A) 
Comparison of invertase activity under repressive (2% glucose) and 
activating (0.05% glucose) conditions between isogenic yeast strains 
deleted for Snf1 (snf1Δ) or genomically expressing GFP-tagged WT 
(Snf1-GFP) or UBA mutated Snf1 (Snf1UBA-GFP). Average of 3 
biological repeats normalized to Snf1-GFP 2% glucose (value of 1), 
showing the mean, SD (standard deviation) and significance by 2-way 
ANOVA. (B) Phosphorylation shift of the SNF1 kinase nuclear target, 
Mig1, under activating (L, 0.05% glucose) and repressive (H, 2% 
glucose) conditions. Each strain has Mig1-TAP genomically expressed 
from the endogenous promoter (WT) in combination with the SNF1 
disruption, with the additional plasmid expression of empty vector 
(snf1Δ), Snf1-GFP, or Snf1UBA-GFP. (C) Replicative lifespan assay 
(RLS) measuring the number of daughter cells produced by a single 
mother (generations) is reported for the snf1Δ strain expressing Snf1-
HA or Snf1UBA-HA. snf1Δ expresses empty plasmid only in the same 
strain (YEp24). Cells were grown on drop-out (DO) media at 30°C with 
2% glucose. Values represent the average of 4 biological repeats. A was 
performed by Dr. T.G. Arnason. C was performed by Dr. T.A. 
Harkness. 
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Figure 4.4 Fkh1/2 and SNF1 kinase impact lifespan and stress 
response. (A) Replicative lifespan of isogenic strains expressing 
genomic variations of the Snf1 subunit (Snf1-GFP and Snf1UBA-GFP, or 
disrupted at the SNF1 gene locus (snf1Δ)), or in combination with 
disruption of FKH1 and FKH2 grown on CM at 30°C with mean 
lifespan reported at 50% survival. Mean of 3 biological repeats. (B) 
Chronological lifespan, reporting the total length of cell survival in 
stationary phase cell cultures grown in water, of isogenic yeast strains 
with genomic disruptions of SNF1, FKH1, FKH2, or none, as indicated. 
Snf1UBA-GFP was genomically integrated into the fkh1/2Δ and snf1Δ 
strain. (C) Oxidative stress survival of isogenic strains (as in Fig. 4A, 
B.) cultured to stationary phase, then plated onto complete media after 1 
hour exposure to 100 µM hydrogen peroxide. Mean ± S.D. of 3 
biological repeats. A was performed by Dr. T.A. Harkness, and B was 
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To test whether increased Snf1UBA-dependent RLS requires an evolutionarily 
conserved interaction with yeast Fkh1 and Fkh2, we genomically introduced the snf1UBA-
GFP allele, which confers a long-lived phenotype, into a fkh1∆ fkh2∆ strain. Cells 
lacking both FKH1 and FKH2 cannot be used for RLS experiments because of severe 
flocculence (Postnikoff et al. 2012). The snf1UBA-GFP allele, however, reduced 
flocculence in fkh1∆ fkh2∆ cells enough so that the triple mutants could be used in these 
RLS studies. The results show that introducing the FKH1 and FKH2 deletions into the 
Snf1UBA-GFP strain reduced RLS to below WT levels (Fig. 4.4A). This provides the first 
evidence that Snf1 requires functional Fkh1 and/or Fkh2 proteins to regulate RLS.  
A reciprocal lifespan experiment was performed to test whether Snf1 and the 
Fkh1/2 proteins work together. SNF1 was deleted within the fkh1∆ fkh2∆ strain to 
generate the triple deletion mutant. Since we could not perform RLS due to flocculence, 
we performed CLS experiments. A previous global CLS study (Powers et al. 2006) found 
that snf1∆ strains, as well as strains deleted for any of the individual SNF1 kinase 
subunits (γ subunit: snf4∆; β subunits: sip1∆, sip2∆ and gal83∆), all had reduced CLS. 
We confirm here that snf1∆ cells are short-lived when measured by CLS (Fig. 4.4B). 
snf1∆ CLS was found to be similar to fkh1∆ fkh2∆ CLS. Importantly, the snf1∆ fkh1∆ 
fkh2∆ CLS is similarly short-lived. These results suggest that the SNF1 kinase works in 
the same pathway as Fkh1 and Fkh2 to maintain normal CLS. Taken together, Fig. 4.4A 
and 4.4B suggest the Fkh proteins work downstream of Snf1. 
4.3.5 Enhanced stress resistance conferred by the UBA mutation is dependent on 
the yeast Forkhead transcription proteins Fkh1 and Fkh2 
In addition to lifespan, the forkhead and Snf1 cellular functions also intersect for 
stress survival. An evolutionarily conserved stress response network utilizing AMPK and 
Fkh proteins has been described (Chiacchiera and Simone 2010; Salminen et al. 2011; 
Rodriguez-Colman et al. 2013). In yeast, it was shown that the Fhk protein Hcm1, but not 
Fkh1 or Fkh2, was phosphorylated by Snf1 under stress conditions (Rodríguez-Colman et 
al. 2013). We have recently reported that the Fkh1 and Fkh2 proteins are important for 
survival after oxidative stress exposure (Postnikoff et al. 2012) specifically in stationary 
growth phase. In contrast, while the yeast SNF1 kinase has been shown necessary for 
stress survival to numerous insults, sensitivity to oxidative stress in logarithmically 
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grown cells was not detected (Dubacq et al. 2004; Hong and Carlson 2007). To further 
our understanding of whether an interaction exists between Snf1 and the Fkh proteins, we 
asked if the endogenous expression of Snf1UBA-GFP in the fkh1/2Δ strain alleviates the 
stress defect of the fkh1/2Δ strain alone, or augments the stress resistance over that of 
unmodified Snf1. Figure 4.4C shows the survival rates of the various mutants after 
transient exposure to 100 mMol H202. Survival of logarithmic-phase fkh1/2Δ or snf1Δ 
strains did not exhibit sensitivity to hydrogen peroxide (data not shown). Given that the 
stress sensitive phenotype for the fkh1/2Δ did not become apparent until stationary phase, 
we tested if this impacted the stress sensitivity of the snf1Δ also. Significantly, repeat 
testing of these same strains grown to stationary phase revealed that the snf1Δ and 
fkh1/2Δ strains are individually very sensitive to oxidative stress, with less than 15% and 
5% survival respectively, and unable to survive when combined (snf1Δ fkh1/2Δ, 0% 
survival) (Fig. 4.4C). This suggests a synergistic interaction. The Fkh proteins are likely 
triggered by other factors and may have SNF1 kinase-independent functions. The snf1UBA 
allele conferred enhanced survival to oxidative stress over unmodified Snf1, with 66% vs 
43% survival, respectively. In contrast, the introduction of the snf1UBA allele into the 
fkh1/2Δ strain did not confer any survival advantage to oxidative stress exposure, with 
both strains at <5% survival. This suggests that in order for the Snf1UBA strain to respond 
to oxidative stress, a functional Forkhead protein response system is paramount. 
Consistent with the findings for RLS, our data supports the idea that Snf1 activates the 
Forkhead transcription factors in times of stress.  
4.3.6 Fkh1/2 transcription factors are required for SNF1 expression  
Loss of Fkh1/2 resulted in an inability of the overactive Snf1UBA derivative to 
complement for oxidative stress resistance (Fig. 4.4C). The Drosophila Daf16/FOXO 
was recently reported to directly regulate the expression of an atypical AMPK-like γ-
subunit (Tullet et al. 2014), and Fkh1 and Fkh2 affect the transcription of numerous yeast 
genes (Ostrow et al. 2014), leading us to ask if the loss of Fkh1/2 activity resulted in 
decreased transcription of SNF1 kinase subunits. Figure 4.5A shows that the total protein 
abundance of Snf1UBA-GFP was decreased in the absence of Fkh1/2, and that 
overexpression of either Forkhead protein from a plasmid partially restored Snf1 protein 
levels (Fig. 4.5B). This observation was mirrored at the transcriptional level where SNF1 
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expression was decreased by the combined disruption of Fkh1/2 (Fig. 4.5C, 4.5D), and 
subsequent Fkh1 or Fkh2 overexpression from a high copy plasmid partially restored 
SNF1 expression towards baseline, with Fkh1 showing a greater induction of SNF1 
expression than Fkh2. These results were normalized to the rRNA signal to account for 
the differences within the isogenic strains tested (Fig. 4.5E). SNF4 expression was 
negligibly impacted and was not influenced by FKH1 or FKH2 overexpression from a 
plasmid (Fig. 4.5D, 4.5E). 
4.3.7 Mutations to the UBA domain do not impact Reg1 interactions with Snf1 
Snf1 activation was increased overall and less repressed by high glucose levels 
upon introduction of conserved changes to the yeast UBA sequence (Fig. 4.2A,B), and 
the same sequence modifications enhanced Snf1-Snf4 allosteric associations even under 
repressive glucose levels (Fig. 4.2E).  These defects are strikingly similar to those seen by 
disruption of the PP1 phosphatase activity that reverses the SNF1 kinase activating 
Thr(P)-210 phosphorylation, specifically in reg1Δ strains (Ludin et al. 1998). The PP1 
regulatory subunit, Reg1, binds directly to Snf1 in a glucose-responsive manner and 
reg1Δ strains are constitutively active for SNF1 kinase, independent of glucose 
abundance (Jiang and Carlson 1996; Sanz, Ludin, et al. 2000). To the best of our 
knowledge, the portion of the Snf1 subunit that Reg1 binds to has been delineated to the 
N-terminal catalytic domain of Snf1 and not pinpointed further (Sanz, Alms, et al. 2000). 
The Snf1 UBA motif is C-terminal to this, making a direct disruption to Reg1-Snf1 
associations unlikely. However, indirect effects mediated through UBA sequence 
alterations affecting the binding of an intermediary (such as Sip5 which is reported to 
bind both Snf1 and Reg1 (Sanz, Ludin, et al. 2000)) or by inducing structural changes 
within Snf1 may be detected as defects in Reg1-Snf1 associations. 2-hybrid analysis was 
used to compare Snf1-Reg1 and Snf1UBA-Reg1 interactions throughout a glucose gradient 
and demonstrated an indistinguishable intensity of color development (Fig. 4.6). The 
Snf1-Reg1 and Snf1UBA-Reg1 interactions exhibited the expected increase in association 
as the glucose concentrations dropped to 0.05% and is significantly lower than the 
positive control (Snf1-Snf4) in this assay. Because of the weak Snf1-Reg1 interactions 
observed even at the lowest glucose levels, subtle disruptions may not have been 
detected. 
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Figure 4.5 SNF1 expression requires Fkh1 and Fkh2. (A) Western 
Blot of whole cell lysates from logarithmically-growing isogenic yeast 
strains in 2% glucose probed for GFP and tubulin protein abundance. (B) 
Isogenic strains with genomic Snf1 variants were transformed with high-
copy HA-tagged Fkh1 or HA-Fkh2 plasmids. Cells were grown in 2% 
glucose drop-out media. (C) Reverse transcription PCR analysis of SNF1, 
SNF4, TUB1 and rRNA transcript abundance of isogenic strains with, or 
disrupted for, FKH1 and FKH2 and with or without plasmid 
overexpression of HA-Fkh1 or Fkh2. ~200 bp products for all. (D) 
Representative agarose gel of RT-PCR analysis of SNF1, SNF4, TUB1, 
and rRNA at 26 cycles from the strains indicated. (E) Versadoc 
quantitation of DNA signal at 26 PCR cycles (RedSafe; FroggaBio), 
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Taken together, the results presented here indicate that the natural UBA domain 
functions as a negative influence on SNF1 kinase activation and activity in part by 
influencing steady state phosphorylation and Snf1-Snf4 subunit interactions. The critical 
readout of the impact of the UBA mutation is seen in increased stress resistance and 
replicative lifespan. Our study shows that the independently described role for Snf1 and 
the Fkh proteins in life span and stress response may be due to actions within the same or 
overlapping pathways, where Fkhs act upstream of Snf1 to promote SNF1 gene 
expression, while completing a positive feedback loop by facilitating SNF1 kinase 
biological functions. 
 
Figure 4.6 Reg1-Snf1 associations are not disrupted by UBA 
sequence alterations.  Solid support 2-hybrid assay on glucose gradient 
plates (High: 2%; Low: 0.05% glucose) between the Reg1 protein and 
either unmodified Snf1 or Snf1UBA before and after β-galactosidase 
overlay. (_); Negative control using empty 2-hybrid vectors. (+) positive 
control using unmodified Snf1 and Snf4 as in Fig. 4.2E. 
 
4.4 DISCUSSION 
Given the strong proclivity for regulatory mechanisms of SNF1 kinase/AMPK 
control to be conserved between yeast and higher eukaryotes, and the potential 
importance of the UBA domain in providing an additional layer of regulatory 
sophistication of the enzyme, we set out to further characterize the in vivo role of the 
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UBA domain in the regulation of the SNF1 kinase. Here, evidence is presented 
confirming an endogenous repressive role for the yeast UBA consensus in SNF1 kinase 
activation and activity, as well as a complex genetic and functional interaction with the 
Fkh proteins, Fkh1 and Fkh2. 
The extensive presence of a loosely conserved UBA domain within the AMPK 
family catalytic α subunits opens the possibility of a regulatory role for this motif. 
Although UBA domains have the potential to recruit ubiquitinated proteins to their 
hydrophobic motif and thereby affect their activity and activation, this appears to be 
variable. Specifically, the yeast SNF1 kinase UBA domain, like other Class 3 yeast UBA 
domains, has not been shown to bind to mono- or poly-ubiquitin (Raasi et al. 2005), an 
activity also not detected for the UBA domains in human AMPK-related kinases (Jaleel 
et al. 2006). Nonetheless, mutations to the α subunit UBA domains in yeast Snf1 and 
human AMPK-related proteins did affect activity, albeit reportedly in opposing 
directions. In S. cerevisiae it was found that complete deletions, and selected mutations of 
the yeast Snf1 UBA motif did not impair phosphorylation or activation of the yeast SNF1 
kinase; rather, there was a subtle increase in both (Momcilovic and Carlson 2011). In 
contrast, the UBA domain was necessary for full activity when studied in AMPK-related 
protein kinases (Jaleel et al. 2006). This AMPK study mutated consensus amino acids or 
completely deleted the UBA motif and found that this prevented phosphorylation and 
activation of the immune-purified α subunit fragments when analyzed in vitro, suggesting 
an activating function to this motif under normal conditions. It is possible, however, that 
the manipulation, truncation, and expression levels in this mammalian system were not 
representative of in vivo responses to activating signals. 
4.4.1 The UBA domain dampens SNF1 kinase activation through modified 
allosteric associations  
Replacement of two highly conserved amino acids within the Snf1 UBA sequence 
revealed a positive effect on the activity of the SNF1 kinase. Our investigations confirm 
and extend the observations that UBA sequence mutations positively affect the activation 
of the yeast kinase, shown specifically here to be through an enhancement of Snf1-Snf4 
subunit associations, proportionately under both repressive and activating states (Fig. 
4.2E) with reproducible enhancements of Thr(P)-210 and maintenance of efficient 
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nuclear import (Fig. 4.2A-D). Stimulatory conditions have been well documented to 
promote allosteric associations between these subunits (Celenza et al. 1989; Cheung et al. 
2000; Sproul et al. 2009) and this work indicates that the inherent function of the natural 
UBA domain may be to regulate SNF1 kinase activation by restraining α-γ associations. 
The mechanism underlying this modulation of association remains to be determined, yet a 
glucose-responsive association of a peripheral protein(s) with the hydrophobic face of the 
UBA domain may introduce steric hindrance between the α-γ subunits, thereby 
preventing full activation. A direct test of the physical associations between the PP1 
regulatory subunit, Reg1, and Snf1 did not demonstrate a disruption by the conserved 
mutations within the UBA domain, as could have been predicted by the Snf1UBA 
phenotype (Fig. 4.6). 
4.4.2 The UBA domain dampens SNF1 kinase nuclear activity  
In addition to looking at the activation of SNF1 kinase, we also looked at UBA 
influences on activity. The activated SNF1 kinase targets nuclear transcriptional 
repressors to facilitate adaptation to non-glucose carbohydrate sources, such as the lifting 
of SUC2 gene repression and subsequent production of invertase, an enzyme that cleaves 
sucrose into glucose and fructose (Treitel et al. 1998). Invertase activity was increased 
over wild type by the presence of the snf1UBA allele under activating conditions, and less 
noticeably under repressive, supporting an inhibitory role in controlling SNF1 kinase 
activity. This assay is a quantitative measure of SNF1 kinase enzymatic activity on its 
nuclear target, the transcriptional repressor Mig1. A qualitative increase in Mig1 
phosphorylation signal intensity was observed in snf1UBA cells under activating and 
repressive growth, yet the phosphorylation shift was limited to activating conditions only. 
Whereas there is a loss of glucose repression in the activation of SNF1 kinase, its nuclear 
activity remains well controlled, as seen by the maintenance of regulated nuclear import 
(Fig. 4.2C, 4.2D). The observation that the snf1UBA mutation did not affect normal 
cytosolic-nuclear partitioning is important, as it suggest that this regulatory step remains 
intact. This is emphasized by acknowledging that the strong allosteric association 
between subunits and increased phosphorylation of Snf1UBA, even under repressive 
conditions, do not translate to enhanced nuclear import in high glucose. Subsequently, 
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measures of nuclear activity (invertase and Mig1ph) under glucose repression are 
therefore maintained, as observed (Fig. 4.3A, 4.3B). 
4.4.3 The UBA domain influences lifespan in a Forkhead dependent mechanism  
SNF1 kinase is known to be necessary for normal lifespan, as deletion of any 
subunit resulted in shortening of CLS (Powers et al. 2006). A striking effect of the UBA 
mutation is an enhanced RLS of S. cerevisiae beyond that of WT. This effect was not 
diminished by lowering the copy number, as endogenous Snf1UBA-GFP expression levels 
(Fig. 4.4A) were as capable of promoting lifespan extension as high copy plasmid 
expression of Snf1UBA-HA (Fig. 4.3C). Performing the RLS assay on media with nutrient 
limitations revealed the need for Snf1 for RLS maintenance under stress conditions. This 
is in keeping with prior observations using yeast, worms, and mice systems that nutrient 
and caloric restriction independently promotes lifespan (Ashrafi et al. 2000; Baur et al. 
2006; Greer, Dowlatshahi, et al. 2007; Lam et al. 2013). 
FOXOs and AMPK have known physical associations, including the direct 
phosphorylation of FOXO3A by AMPK resulting in increased transcriptional activity, 
longevity and resistance to oxidative stress (Greer, Dowlatshahi, et al. 2007). It was 
recently reported that Snf1 phosphorylates the yeast Fkh protein, Hcm1, in response to 
stress, facilitating shuttling of Hcm1 from the cytosol to the nucleus (Rodriguez-Colman 
et al. 2013). Hcm1 is tightly linked to Fkh1/2 activity as it transcribes FKH1 and FKH2 
during late S phase (Synthesis phase) (Pramila et al. 2006). We have shown previously 
that the yeast APC is a crucial player in maintaining normal lifespan and stress response, 
and that Snf1 and Fkh1/2 are involved in these activities (Harkness et al. 2004; Postnikoff 
et al. 2012). While Snf1 interacts physically with Hcm1, there is no indication in the 
literature that Snf1 interacts with Fkh1/2. Our work clearly shows that Fkh1/2 are 
required for enhanced Snf1UBA function, as deletion of the two genes abolishes increased 
stress response and lifespan afforded by the UBA mutation (Fig. 4.4A and C). It remains 
possible that phosphorylation of Hcm1 by Snf1 ensures the expression of Fkh1 and Fkh1, 
negating the need for a physical phosphorylation event on Fkh1 or Fkh2. 
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4.4.4 SNF1 transcription is influenced by yeast Forkhead proteins 
A novel insight into one mechanism whereby Snf1 and Fkh1/2 mechanistically 
interact arose out of our observation that the Fkh1/2 combined deletion strain exhibited 
decreased abundance of the Snf1 protein. We have determined that this is due to loss of 
Fkh1/2-dependent SNF1 expression. SNF4 expression was not affected despite the 
analogous Daf16/FOXO transcription factor in C. elegans contributing to the expression 
of the γ-subunit of an atypical AMPK-related enzyme (Tullet et al. 2014). In yeast, Fkh1 
alone binds to the SNF1 promoter, consistent with its greater impact on returning SNF1 
expression towards normal as compared to Fkh2 (Fig. 4.5E). Neither Fkh1 nor Fkh2 
recognize the SNF4 promoter, and no impact on SNF4 expression was found when these 
proteins were overexpressed (Fig. 4.5E) (Ostrow et al. 2014). However, the yeast Fkhs 
have complementary functions as combined deletion of FKH1 and FKH2 are required for 
aging and stress phenotypes (Postnikoff et al. 2012); Fkh2 could therefore partially 
induce SNF1 expression by complementation. We demonstrate that while the introduction 
of the UBA mutations enhances both mitotic lifespan and oxidative stress resistance over 
unmodified Snf1, this cellular role is dependent on the presence of the Fkh1/2 proteins as 
Snf1UBA was not sufficient to overcome the fkh1/2Δ strain phenotypes. Taken together, a 
positive feedback loop can be envisioned. Initial stress recognition by the SNF1 kinase 
leads to the activation of the Fkhs that may be mediated by Hcm1. Once the Fkhs are 
active, they elicit a transcriptional stress response and longevity program including the 
expression of SNF1, thus completing the loop.  
4.4.5 Enhanced AMPK activity provides health benefits 
There are several activating mutations within AMPK/SNF1 kinase reported 
throughout the literature. A naturally occurring genetic mutation in pigs within the γ 
subunit yields lean muscular pigs prized by the food industry and is thought to be due to 
enhanced AMP binding (Andersson 2003). Dominant mutations within human AMPK α 
subunits have also demonstrated lowered % body fat (Yeo et al. 2008) and lowered blood 
sugar and lipid levels (Backhed et al. 2007). Furthermore, activation of AMPK by the 
oral anti-diabetic drug metformin is currently in over 200 clinical trials of cancer therapy, 
indicating the worldwide interest in AMPK-dependent benefits to human health. 
Together, there is a clear clinical benefit to enhanced AMPK activity. Exercise and 
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caloric restriction (with weight loss) alone are capable of transiently activating AMPK 
and yielding health gains, yet these treatment options are difficult to adhere to, as 
evidenced by the current epidemic of obesity and insulin resistance. Future identification 
of AMPK activators and repressors may yield new metabolic targets for many human 
conditions. UBA-domain binding partners may play a key role in these approaches.  
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Table 4.1 Saccharomyces cerevisiae strains used in Chapter 4 
 
Strain (previous name) Genotype Source/ 
Reference 
yTER32 (PJ69-4A) MATa trp1-901 leu2-3 ura3-52 his3-200  
gal4∆ gal80∆ LYS2::GAL1-HIS3  
GAL2-ADE2 met2::GAL7-lac 
E. Craig 
yTER70 (YTH1510) MATα ade2 his3 leu2 ura3 snf1∆::kanMX6 This study 
yTER188 (YTH4269) MATα ade2 his3 leu2 ura3 This study 
yTER223 YTH1510 + SNF1-GFP::HIS3 This study 
yTER222 YTH1510 + SNF1UBA-GFP::HIS3 This study 
yTER246 (YTH3792) MAT(?) ade2 his3 leu2 ura3  
MIG1- TAP::HIS3 
This study 
yTER248 (YTH3760) fkh1∆::kanMX6 fkh2∆::kanMX6 This study 
yTER249 yTER246 + snf1∆::kanMX6 This study 
yTER224 yTER222 + fkh1∆::kanMX6 fkh2∆::kanMX6 This study 
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CHAPTER 5 The SNF1 kinase subunit stoichiometry regulates its enzyme activity  
5.1 Introduction 
The AMPK family has a fundamental role in maintaining cellular energy balance 
during times of stress or deprivation (Inoki et al. 2012; Hardie 2014). Through their 
kinase activity, immediate metabolic shifts towards catabolic pathway use are triggered 
by phosphorylating existing cytosolic protein targets (Inoki et al. 2012), whereas 
sustained effects occur upon the activated kinase translocating into the nucleus to target 
transcription factors and alter gene expression to help survive the energy deficit (Kodiha 
et al. 2007; Gowans and Hardie 2014). These enzymes are heterotrimeric protein 
complexes encoding a catalytic α subunit, and regulatory β and γ subunits that are 
evolutionarily conserved from their primary amino acid sequences to their quaternary 
protein associations (Hedbacker and Carlson 2008; Lee et al. 2008). As a simple and 
genetically malleable eukaryotic model, many important discoveries about the 
mechanisms regulating AMPK activation and activity have been identified in yeast and 
confirmed to also occur in higher eukaryotes including plants, mammals and humans 
(Hardie and Sakamoto 2006; Hedbacker and Carlson 2008; Tullet et al. 2014). The yeast 
AMPK ortholog is the SNF1 kinase, and is readily activated by removing a ready glucose 
supply (nutrient deprivation). The activated enzyme, as for all in this family, is 
phosphorylated by well-described upstream kinases at a single site, which enhances 
allosteric associations between the kinase subunits and triggers nuclear import (Carlson et 
al. 1981; Hardie et al. 1998). Of interest to us are the more subtle controls effecting SNF1 
kinase activity, such as those reported for post-translational modifications to subunits of 
the AMPK family including acetylation (Lu et al. 2011; Zhang et al. 2013) and 
SUMOylation (Simpson-Lavy and Johnston 2013). These modifications appear to 
contribute a mild inhibition on yeast and human AMPK activity.   
In both yeast and human systems, the catalytic α subunit has been reported to be 
ubiquitinated in vivo, albeit under non-physiological conditions (Qi et al. 2008; Wilson et 
al. 2011). In both cases, poly-ubiquitination was only detected upon engineered loss of 
the de-ubiquitinating activities in the cells, enabling non-physiological accumulation of 
ubiquitinated protein substrates. The studies in both yeast and human systems concluded 
that there was an inhibitory effect on kinase function: degradation of α subunit in yeast 
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(Wilson et al. 2011) and diminished phosphorylation in human cell lines (Al-Hakim et al. 
2008; Lee et al. 2015). Global mass spectroscopic analysis of the yeast proteome has 
identified two ubiquitin attachment sites within the yeast α subunit, Snf1, at amino acids 
80 and 461 (Starita et al. 2012), yet their specific contribution towards poly-
ubiquitination anchors or impacts on SNF1 kinase activity has not been formally studied. 
Lastly, the stability of the remaining SNF1 kinase protein subunits (Snf4 and the three β-
subunits Gal83, Sip1 and Sip2) has not been formally studied in yeast. Here, the stability 
of the all SNF1 kinase subunits has been assessed under activating and repressive 
conditions for this enzyme. Furthermore, we have mutated the potential ubiquitin-
attachment site lysines (K) to conserved arginine (R) residues and measured the effect on 
SNF1 kinase activation, activity, and function. 
5.2 Material and Methods 
5.2.1 Yeast crossing and tetrad selection 
All yeast strains were included in Table 5.1. Yeast strains of rpn10Δ-Snf1-GFP 
and sn4Δ-Snf1-GFP were crossed to generate isogenic rpn10Δ-snf4Δ-Snf1-GFP, rpn10Δ-
Snf1-GFP, snf4Δ-Snf1-GFP, and WT-Snf1-GFP. Tetrads were selected and strains were 
confirmed using selective media and PCR analysis. Isogenic strains were cultured and 
used to detect the Snf1-GFP protein level by Western Blot as described before.  
5.2.2 Invertase assay 
Protocols have been previously described in section 3.5. 
5.2.3 Creation of Snf1 lysine to arginine (K/R) mutants 
Genomic Snf1 α subunit with C-terminal GFP tag (SNF1-GFP::HIS3, yTER223) 
was used as the DNA template. Conservative mutation of lysine to arginine (K/R) within 
the Snf1 subunit at amino acid positions 80 and 461 (K80R, K461R) were introduced by 
PCR mutagenesis. For the independent mutations, two PCR products were generated and 
annealed at one end through homologous regions containing the mutated K/R sequences, 
with the remaining sequences extending outside the full length SNF1 gene, including the 
GFP epitope and HIS3 sequence (primer sequences see Table 5.2); PCR products were 
purified and co-transformed into the snf1Δ (yTH1510; snf1∆::G418) strain for genomic 
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integration. Integrants were selected on His- plates and mutations were confirmed by 
DNA sequencing.  
5.2.4 Total protein extract and Western Blot analysis 
Protocols have been previously described in section 3.1 and 3.2. Anti-GFP 
(Covance, MMS-118P-500), -Actin (Sigma, A4700, Lot005134), -HA (Roche, 
11867423001), -TAP (Open Biosystems, CAB-1001), and -Tubulin (Sigma, 051M4771) 
antibodies were used in Western Blot analysis and the chemiluminescent signal captured 
on a VersaDoc (BIO-RAD) molecular imager (Quantity One 4.6.9).  
5.2.5 Cycloheximide protein stability experiment 
The yeast strains used in this study are shown in Table 5.1 Protocols have been 
previously described in section 3.3, followed Western Blot analysis.  
5.2.6 mRNA expression analysis 
Protocols have been previously described in section 3.8. 
5.3 Results and Discussion 
The inherent stability of the α, β and γ subunits of the yeast SNF1 kinase was 
determined in vivo, to clarify the role of ubiquitination in the regulation of the yeast 
SNF1 kinase under physiological conditions. Prior reports of α subunit ubiquitination 
(Pineda et al. 2015), γ subunit instability (Jackson et al. 2000), and β subunit ubiquitin-
targeting in orthologous systems (Qi et al. 2008) raised the possibility of multifactorial 
regulatory controls through ubiquitin-mediated degradation. Endogenously expressed and 
genomically epitope-tagged versions of the individual SNF1 kinase subunits were 
assessed individually in isogenic yeast strains for their stability up to 3 hours (Table 5.1). 
Regardless of whether the SNF1 kinase complex was in its repressive (2% glucose) or 
activated (0.05%) state, each of the Snf1, Snf4 and three β-subunits were stable up to 
three hours (Fig. 5.1 A and B). Furthermore, there was no evidence of additional higher 
molecular weight bands to suggest mono- or poly-ubiquitination.   
An assessment of yeast SNF1 kinase enzyme activity includes the quantitative 
measure of the enzyme invertase, encoded by the SUC2 gene (Carlson et al. 1981; 
Carlson and Botstein 1983). SUC2 is normally held repressed under optimal growth 
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conditions, yet is rapidly induced upon low glucose conditions by the active SNF1 kinase 
targeting the SUC2 repressor, Mig1, for phosphorylation and subsequent translated 
(Treitel et al. 1998). The measure of invertase activity upon individual deletion of each of 
the SNF1 kinase subunits is shown in Figure 5.1C; an absolute (Snf1), and partial (Snf4 
and Gal83) requirement for specific subunits is evident for the nuclear function of SNF1 
kinase. It is well known that the nuclear SNF1 kinase heterotrimer is composed of Snf1-
Snf4-Gal83, implying that even the non-catalytic Snf4 and Gal83 subunits are required 
for nuclear activity. 
We had observed that strains deleted for SNF4 exhibited a decrease in detectable 
Snf1 protein that was unaffected by glucose abundance. This held true whether SNF1 was 
endogenously expressed (Fig. 5.2A) or highly expressed from a plasmid (Fig. 5.2B), 
implying an independence of promoter transcription. We asked if this might be a 
stoichiometric effect functioning to maintain heterotrimer subunit abundance. In support 
of this, expression of SNF4 from a high copy plasmid was able to effectively increase 
Snf1 protein levels back to that of WT in a snf4Δ strain (Fig. 5.2C). We next queried if 
the decreased Snf1 abundance was due to its degradation, and formally assessed the 
protein stability of endogenous Snf1 in the absence of the Snf4 subunit (Fig. 5.2D). Semi-
quantitative measurement of the Snf1-GFP signal revealed that there was a slow 
(T1/2~1.5-2.0 hours) decline in Snf1 protein abundance in the absence of Snf4, which 
was independent of the activation state of the SNF1 kinase (Fig. 5.2D). Interestingly, the 
reciprocal experiment revealed that Snf4 remained stable up to 3 hours in the absence of 
the Snf1 subunit (Fig. 5.2F), indicating that the α and γ subunits are regulated differently. 
Of the three β-subunits, the individual loss of Gal83 was alone in affecting Snf1 
protein abundance (Fig. 5.3A). The decrease in Snf1 protein was not related to a loss of 
its transcription, as SNF1 mRNA levels were unaffected in either the Snf4 or Gal83 
deletion strains (Fig. 5.3B). 
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Figure 5.1 SNF1 kinase activity is dependent on inherent subunit 
abundance. A and B, Protein level of endogenous tagged Snf1 α subunit, 
Snf4 γ subunit, and all 3 β subunits (Sip1, Sip2, Gal83) in WT strains 
grown under activating (0.05% glucose) and repressive (2% glucose) 
conditions. Cycloheximide was added at time “0” and cell lysates were 
collected every half hour up to 3 hours at the times indicated. C, 
Comparison of invertase activity under repressive (2% glucose) and 
activating (0.05% glucose) conditions between isogenic yeast strains with 
the indicated SNF1 kinase subunit deletions. Reported values are 
normalized to WT in 0.05% glucose (value of 100).  C was performed by 
Dr. T.G. Arnason.  
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To investigate the importance of the reported ubiquitin-attachment site lysines in 
SNF1 kinase function, we created K/R versions of Snf1 with K80R, K461R and the 
combination K80/461R, and integrated them genomically under the endogenous 
promoter. Steady state levels of Snf1 and these K/R derivatives were assessed in isogenic 
strains with, or without, Snf4 protein (Fig. 5.4A). In the WT background, Snf1 and its 
derivatives were readily detectable, yet in all cases the deletion of SNF4 resulted in 
similar declines of Snf1 protein without a stabilizing effect with lysine mutations (Fig. 
5.4A). Therefore, the mutation of Lys80, Lys461 or the combination did not stabilize 
Snf1 such as would be expected if these were the site of ubiquitin-mediated degradation 
signals. Formal degradation assays of Snf1K80R and Snf1K461R, in the absence of Snf4 
were performed and confirmed that there was no stabilization of the Snf1 protein upon 
lysine mutation. 
The significance of Snf1K80R and Snf1K461R on SNF1 kinase function was next 
determined through analysis of SUC2 transcription under activating conditions in 
unmodified and K/R derivatives of Snf1. RT-PCR of SUC2 mRNA did not reveal 
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Figure 5.2 The Snf1 catalytic subunit is unstable in the absence of the 
Snf4 γ subunit. A, Comparison of protein abundance of endogenous 
Snf1-GFP in the snf4Δ mutant as compared to its isogenic WT strain. B, 
Comparison of the protein abundance of plasmid-expressed Snf1-HA in 
the snf4Δ mutant as compared to its isogenic WT strain. C, Western Blot 
analysis of the Snf1-GFP protein abundance in the snf4Δ strain, with and 
without, plasmid-expressed Snf4 subunit. D and E, Western analysis and 
its quantitation of Snf1-GFP protein stability in the snf4Δ strain after 
CHX addition. F. Protein stability of endogenous Snf4-TAP protein in 
the snf1Δ strain under activating and repressive growth conditions.  H: 
high glucose (2%), repressive. L: low glucose (0.05%), activating 
conditions. 
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Figure 5.3 Steady state Snf1 protein abundance is dependent on the 
Gal83 subunit. A, Endogenous Snf1-GFP protein abundance in isogenic 
WT strains, or individually deleted for SIP1, SIP2, or GAL83 grown 
under activating (L) and repressive (H) conditions. B, RT-PCR of SNF1 
mRNA expression in WT, snf4Δ, and gal83Δ strains. Samples were taken 
after 26 cycles.  
  
 
To directly assess the involvement of ubiquitin-mediated protein degradation via 
the proteasome, we made use of the rpn10Δ strain, which lacks a critical yeast 
proteasome subunit rendering it nonfunctional. In such mutants, poly-ubiquitinated 
proteins destined for degradation accumulate (Lin et al. 2011; Lipinszki et al. 2012). Snf1 
abundance was noted in strains deleted for SNF4, RPN10, or the combination of the two. 
The rpn10Δ mutation did not result in Snf1 protein accumulation when combined with 
snf4Δ (Fig. 5.5A). From this, we conclude that the proteasome was not involved in the 
Snf1 protein degradation under these conditions.  
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Figure 5.4 Lysine to arginine mutations within Snf1 do not alter Snf1 
protein stability. A, Steady state Western analysis of endogenous Snf1-
GFP protein levels in early logarithmic phase in the absence of Snf4 
subunit with K81R, K461R and combined mutation K80/461R. B, and C, 
Extended Western Blot analysis of Snf1K/R in snf4 mutant strains over a 3 
hours time-course in 2% and 0.05% glucose conditions. D, quantitation 
of Snf2-GFP protein levels from C, with time “0” were normalized as 
100. E, RT-PCR of SUC2 mRNA expression after 26 cycles in WT and 
the individual K/R strain with, and without the presence of SNF4. H: 
high glucose 2%, repressive). L: low glucose 0.05%, activating 
conditions. It is impaired in snf4Δ mutants, regardless of the lysine to 
arginine mutations on Snf1 subunit.  
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A supportive experiment was performed adding MG132 as a potent chemical 
inhibitor of the 20S proteasome (Han et al. 2009) while assessing for Snf1 abundance. As 
shown in Figure 5.5B, the addition of MG132 did not alter the amount of Snf1 protein in 
the absence of Snf4. For neither the rpn10Δ nor the MG132 experiments did we notice 
additional higher molecular weight bands associated with Snf1, to suggest the presence of 
abundant poly-ubiquitin chain attachments. 
Despite the previous detection by others of Snf1 poly-ubiquitination, and its 
correlation with decreased protein levels (Wilson et al. 2011), our investigations 
conclusively demonstrated that the subunits of the yeast SNF1 kinase are stable in both 
the active and inactive enzyme complex. We have determined that the relative abundance 
of the Snf1 catalytic subunit depends on the presence of the Snf4 and/or Gal83 subunits, 
and not on a functional proteasome. We suggest that this is a physiological correction for 
subunit stoichiometry rather than a regulatory ubiquitin-mediated clearance of excess 
protein via the proteasome. Lastly, although Lys80 and Lys461 within the Snf1 subunit 
have been reported to be ubiquitin-attachment sites (Starita et al. 2012), our mutational 
analysis failed to detect a role for these positions in stability or function. Future 
experiments in multicellular organisms or higher eukaryotes, may determine discrete 
roles for the ubiquitin-α-subunit conjugates. 
 
Figure 5.5 Inhibition of 20S proteasome activity does not impact 
SNF1 protein abundance. A, Western analysis of endogenous Snf1-
GFP steady state abundance in isogenic WT, snf4Δ, rpn10Δ, and snf4Δ-
rpn10Δ strains. B, Western analysis of Snf1-GFP abundance comparing 
levels in WT and snf4Δ strains with and without the addition of the 
proteasome inhibitor, MG132. 
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MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52 
 
T. Harkness 
yTER70 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52 snf1Δ::kanMX6 W. Xiao 
yTH1611 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52 snf4Δ::kanMX6 W. Xiao 
yTER5 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52 mig1Δ::kanMX6 W. Xiao 
yTER29 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52 sip1Δ::kanMX6 W. Xiao 
yTER41 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52 sip2Δ::kanMX6 W. Xiao 
yTER30 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52 gal83Δ::kanMX6 W. Xiao 
yTER223 MATa ade2 his3 leu2 ura3 SNF1-GFP::HIS3 R. Jiao et al. (2015) 
yTER1 MATa his3∆0 leu2∆0 met15∆0 ura3∆0 SNF4-TAP::HIS3 Open Biosystems 
yTER118 MATa his3∆0 leu2∆0 met15∆0 ura3∆0 SIP1-TAP::HIS3 Open Biosystems 
yTER119 MATa his3∆0 leu2∆0 met15∆0 ura3∆0 SIP2-TAP::HIS3 Open Biosystems 
yTER117 MATa his3∆0 leu2∆0 met15∆0 ura3∆0 GAL83-TAP::HIS3 Open Biosystems 
yTER250 yTER223 + snf4Δ::kanMX6 This study 
yTER8 yTER1+ snf1Δ::kanMX6 This study 
yTER275 yTER223 + sip1Δ::kanMX6 This study 
yTER276 yTER223 + sip2Δ::kanMX6 This study 
yTER274 yTER223 + gal83Δ::kanMX6 This study 
yTER235 yTER223 + snf1K80R This study 
yTER236 yTER223 + snf1K461R This study 
yTER237 yTER223 + snf1K80R-K461R This study 
yTER244 yTER235 + snf4Δ::kanMX6 This study 
yTER251 yTER236 + snf4Δ::kanMX6 This study 
yTER230 yTER237 + snf4Δ::kanMX6 This study 
yTH3638 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52 rpn10Δ::kanMX6 W. Xiao 
yTH4269 MATα ade2 his3 leu2 ura3 H. Harkness 
yTER342 yTH4269 + rpn10Δ::kanMX6 This study 
yTER325 yTER250 × yTER342 WT This study 
yTER326 yTER250 × yTER342 snf4Δ This study 
yTER327 yTER250 × yTER342 snf4-rpn10Δ This study 
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SNF1 F 5' AAAGGATGGGCGTGATGGGACTC 3' 
SNF1 R 5' GTCGGAGTCACCTTGCTCGGTATTAGTC 3' 
K80R F 5' ATACCACTACCGGCCAAAGAGTTGCTCTAAAAATC 3' 
K80R R 5' GATTTTTAGAGCAACTCTTTGGCCGGTAGTGGTATG 3' 
K461R F 5' GGATCAGTATCGAGAAGAGGACTCTACAG 3' 
K461R R 5' ACTGTAGAGTCCTCTTCTCGATACTGATCCATGAAGGGTGATT 3' 	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6.1 Introduction 
The SNF1 kinase class of serine/threonine kinases, which includes the AMPK in 
other systems, are of widespread interest because of their important roles in glucose 
homeostasis, stress resistance, and aging (Owen et al. 1979; Hardie 1999; Lu et al. 2011). 
These enzymes are inactive under optimal conditions, yet are rapidly activated in 
response to a wide variety of nutritional and stress cues. The active kinases, in turn, exert 
their activity to alter cellular pathways at the protein and transcriptional level to maintain 
homeostasis or to direct adaptive mechanisms for stress resistance. Simply, low glucose 
growth conditions will activate SNF1 kinase in yeast, whereas muscle contraction or 
fasting will do the same in animals (Celenza and Carlson 1986; Bergeron et al. 1999; 
Hardie 1999). The dominant, essential, and finely responsive regulatory step is the 
phosphorylation of Snf1 by upstream kinases, balanced by its controlled 
dephosphorylation (Celenza and Carlson 1986; Sutherland et al. 2003). This governing 
event is conserved between yeast and all higher eukaryotes. In yeast, SNF1 kinase 
directly phosphorylates a variety of downstream targets, including the nuclear target 
Mig1 (Treitel et al. 1998) and cytosolic target Rod1 (Becuwe et al. 2012). Mig1 
functions as a transcriptional inhibitor that prevents SUC2 expression, whereas Rod1 is 
involved in glucose transporter endocytosis (Becuwe et al. 2012). Several other described 
events act to regulate SNF1 kinase including allosteric tightening of the Snf1 (α) and 
Snf4 (γ) subunits within the heterotrimeric complex (Jiang and Carlson 1997), and the 
nuclear accumulation of the Snf1-Gal83 (β subunit)-Snf4 enzyme within the nucleus, 
necessary for transcriptional changes (Vincent et al. 2001). In addition, our recent work 
reported that the yeast orthologs of mammalian FOXO transcription factors, Fkh1 and 
Fkh2, regulate SNF1 gene transcription, impacting the protein abundance of the Snf1 
subunit (Jiao et al. 2015). The Snf1 subunit contains autoinhibitory and UBA domains 
that act as restraining functions on activity (Hedbacker and Carlson 2008; Jiao et al. 
2015). More recently, additional negative influences have been shown to occur through 
Snf1 subunit post-translational modifications, specifically ubiquitination and 
SUMOylation, which effectively decreased Snf1 protein abundance through degradation, 
with resulting reductions in SNF1 kinase activity (Wilson et al. 2011; Zungu et al. 2011; 
Simpson-Lavy and Johnston 2013). Ubiquitin becomes covalently attached to target 
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proteins through the sequential action of ubiquitin activating (E1), conjugating (E2), and 
ligase (E3) activities: In yeast there is a single E1, a finite well-described group of 
thirteen E2s, and an ever-expanding recognition of E3 ligase activities.  
Our goal was to identify discrete E2s that are involved in SNF1 kinase regulation 
in response to glucose levels and anticipated revealing those which are involved in Snf1-
ubiquitin attachment. Here, we report that the cell cycle and stress-related E2, Ubc1, 
indirectly affects SNF1 kinase activity not through stability, but through upstream events 
affecting the yeast FOXO orthologs Fkh1/2 that provide transcriptional control of the 
Snf1 subunit. Ubc1 is known to act, along with Ubc4, with the APC to target and poly-
ubiquitinate substrates for cell-cycle related degradation to enable exit from metaphase 
(M phase), and entry to G1 (Rodrigo-Brenni and Morgan 2007), and the ubc1∆ mitotic 
arrest point is consistent with a disruption of APC-dependent exit from mitosis and 
failure to enter G1 (Seufert et al. 1990). Our data suggests Ubc1 acts on a third Fkh, 
Hcm1, in an APC-independent manner to impact the SNF1 kinase via upstream events. 
Hcm1 appears to require Ubc1 to facilitate its nuclear shuttling, and activation of the 
Fkh/Snf1 stress response pathway. 
6.2 Materials and Methods 
6.2.1 Creation of UBC1 deletion strains 
All strains utilized in this manuscript are listed within Table 6.1. The 
ubc1∆::KanMX6 cassette was amplified using primers 500 bp up and downstream of 
UBC1 and genomic DNA isolated from the UBC1/ubc1∆::KanMX6 diploid strain 
(yTER301) as template. The entire cassette was individually integrated into the Fkh1-
TAP, Fkh2-TAP, Mig1-TAP, Rod1-TAP, Snf4-TAP, Gal83-TAP, Hcm1-GFP, Hcm1-
TAP, and 2-hybrid reporter strains, with primary selection for successful integrants being 
KanRes and final confirmation by PCR. Snf1-GFP ubc1Δ was created by crossing (SNF1-
GFP::HIS3 x ubc1∆::HIS3), tetrad dissection, scoring for markers, phenotypes, and 
confirmation by primer-specific PCR amplification.  
6.2.2 Total protein extract and Western Blot analysis 
Protocols have been previously described in section 3.1 and 3.2. Anti phospho-
AMPK (Cell Signaling, 2535L), GFP (Covance, MMS-118P-500), Actin (Sigma, A4700, 
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Lot005134), Clb2 (Santa Cruz, y-180), TAP (Open Biosystems, CAB-1001), and Tubulin 
(Sigma, 051M4771) antibodies were purchased and the chemiluminescent signal captured 
on a VersaDoc (BIO-RAD) molecular imager (Quantity One 4.6.9). 
6.2.3 Invertase assay 
Protocols have been previously described in section 3.5. 
6.2.4 Fluorescence microscopy 
Protocols have been previously described in section 3.3. In detail, fluorescence 
microscopy was used to determine the subcellular localization of Snf1-GFP and Mig1-
GFP, A minimum of 125 cells for each strain and condition were consecutively scored for 
co-localization of the GFP-tagged subunits and DAPI nuclear staining. 
6.2.5 2-hybrid analysis 
Protocols have been previously described in section 3.6. In this study, the yeast 
WT 2-hybrid reporter strain and the modified 2-hybrid strain ubc1Δ (ubc1∆::KanMX6 
cassette integrated into PJ69-4 α) were doubly transformed with pairs of empty vectors (-
ve control: pGAD-C2 and pGBD-C2), or the same backbones expressing unmodified 
Snf1 and Snf4 subunits (+ve).  
6.2.6 mRNA expression analysis 
Protocols have been previously described in section 3.8. In detail, RNA was 
isolated (RNAeasy Kit, Qiagen) from logarithmically (OD600 ≤0.4) growing WT Snf1-
GFP or ubc1Δ Snf1-GFP yeast strains that were transformed with pFkh1-GFP or pFkh2-
HA plasmids followed by RT (QuantiTect Reverse Transcription Kit, Qiagen).  
6.2.7 Cell cycle arrest  
Protocols have been previously described in section 3.10. WT and Hcm1-GFP 
were used in this experiment. Equal volume cell samples were collected each 30 minutes 
for protein and fluorescent activated cell sorting (FACS) analysis. The same Hcm1-GFP 
strain was used in Fig. 6.6C and D and Fig. 6.7A and B. 
6.2.8 Flow cytometry  
Protocols have been previously described in section 3.11.  
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6.2.9 Cycloheximide experiment 
Protocols have been previously described in section 3.3.3. To stop protein 
synthesis, 10µg/ml CHX was added to live logarithmic phase cells (OD600≤0.8) in YPD 
media. Equal cell numbers were collected every 30 minutes for cell lysate preparation 
and subsequent Western Blot analysis.   
6.3 Results 
6.3.1 Deletion of the E2 enzyme, Ubc1, impairs SNF1 kinase-dependent invertase 
activity   
When glucose is limiting, yeast adapts to using alternative carbon sources. A key 
function of the SNF1 kinase is to adapt metabolic pathways to non-glucose carbohydrate 
sources, and the mechanism is particularly well documented for sucrose. Sucrose 
utilization requires the expression of invertase, an enzyme that cleaves the disaccharide 
sucrose molecule into glucose and fructose, which is encoded by the SUC2 gene (Treitel 
et al. 1998). When glucose is abundant, SUC2 expression is repressed by the binding of 
the transcriptional repressor, Mig1, at the SUC2 promoter. Under limiting glucose 
conditions, activated SNF1 kinase enters the nucleus, phosphorylates Mig1 protein via its 
inherent kinase activity and releases Mig1 from the SUC2 promoter. The subsequent 
translation of SUC2 can be quantitatively determined by colorimetric Invertase assay 
(Harkness and Arnason 2014) or directly through RT-PCR, as an indirect measure of 
SNF1 kinase activity.  
Figure 6.1A demonstrates the expected rise in invertase activity after 2 hours of 
growth in low (0.05%) glucose in a WT yeast strain, and the complete dependence of this 
on the Snf1 α catalytic subunit (snf1Δ). In contrast, disruption of the SUC2 
transcriptional repressor Mig1 (mig1Δ) demonstrates high activity regardless of glucose 
levels, as expected for loss of regulated repression. Deletion of the UBC1 gene (ubc1Δ) 
resulted in a significant decrease in invertase activity as compared to the WT. This defect 
was also observed in WT and ubc1Δ strains carrying the endogenous Snf1-GFP fusion 
into either strain (WT-Snf1-GFP or ubc1Δ-Snf1-GFP). To expand on this, we also tested 
invertase activity at short intervals leading up to the 2-hour time point (Fig. 6.1B) and 
report the presence of early (1 hour) and sustained impairment of invertase activity. The 
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corresponding changes to SUC2 mRNA level in the WT and ubc1Δ strains, under 
activating and repressive conditions, paralleled that of the invertase activity (Fig. 6.1C).  
6.3.2 Loss of Ubc1 function does not impair SNF1 kinase nuclear accumulation, 
allosteric associations or substrate targeting   
Invertase defects (or decreases in maximal SUC2 expression) can arise from 
disruption of any one of multiple steps in SNF1 kinase activation, including protein 
abundance, activating phosphorylation, allosteric associations, nuclear import, or 
phosphorylation of Mig1. These stages can be isolated and independently assessed to 
pinpoint where the Ubc1 protein is affecting SNF1 kinase activity. First, we asked if 
Ubc1 was required for movement of the Snf1-Gal83-Snf4 kinase complex into the 
nucleus under activating conditions, as a failure to efficiently accumulate in the nucleus 
would explain the impairment in transcriptional release of SUC2 expression. We initially 
expressed Snf1-GFP constitutively from a 2µ yeast plasmid transformed into WT and 
ubc1Δ strains and used live fluorescent microscopy of these isogenic strains to localize 
Snf1-GFP to the nucleus (identified by DAPI staining) (Fig. 6.2A) and observed that the 
plasmid-expressed Snf1 subunit rapidly relocates to the nucleus after stimulating 
conditions in a manner indistinguishable from WT (Vincent et al. 2001). Furthermore, 
endogenous expression of a genomic version of GFP-tagged Snf1 subunit did not alter the 
efficiency of nuclear accumulation in WT or ubc1Δ isogenic strains (Fig. 6.2B). Multiple 
biological repeats of these experiments allowed us to score the relative efficiency of 
nuclear import of Snf1-GFP in these WT and ubc1Δ strains, demonstrating that there is 
no impairment of nuclear accumulation in the absence of the functional Ubc1 protein. 
 
	  	  
	   79	  
 
Figure 6.1 Yeast strains deleted for the ubiquitin conjugating 
enzyme, Ubc1, are impaired for SNF1 kinase-dependent invertase 
activity expressed from the SUC2 gene. Comparison of invertase 
activity under repressive (2% glucose) and activating (0.05% glucose) 
conditions between isogenic yeast strains normalized to WT in 0.05% 
glucose (value of 100), showing the mean and SD. WT-Snf1-GFP and 
ubc1Δ-Snf1-GFP have a genomic GFP sequence integrated in-frame 
with the endogenous Snf1 sequence. A, Invertase activity after 2 hours 
of activating growth conditions.  Statistical significance based on 3 
biological repeats using t-test (Prism 6.0).  B, Chronological invertase 
activity of WT and ubc1Δ strains, sampled intermittently over 2 hours 
following shift to low glucose media. Average of four biological repeats 
with SD are indicated for each time point. C, Agarose gel of RT-PCR 
products (26 cycles) using primers against SUC2 and rRNA loci from 
RNA isolated from WT and ubc1Δ strains grown in 2% (H: high) and 
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Next, we assessed if the UBC1 disruption interfered with the allosteric 
associations between the α and γ subunits of the kinase upon activation. 2-hybrid analysis 
was used to compare Snf1-Snf4 interactions throughout a glucose gradient; β-
galactosidase production results in a visible blue color and correlates with the strength of 
the associations between these two proteins (Jiao et al. 2015). In WT yeast, we observed 
increased Snf1-Snf4 associations within the 2-hybrid assay as the glucose concentration 
drops, which is also seen in the isogenic ubc1Δ strain, at even greater levels than WT 
(Fig. 6.2C). Clearly, the invertase defect linked with UBC1 disruption is not related to 
allosteric hindrance. 
We next asked if the UBC1 deletion affected the ability of SNF1 kinase to 
phosphorylate known protein targets. De-repression of SUC2 requires SNF1 kinase-
dependent phosphorylation of the nuclear transcriptional repressor protein, Mig1. Non-
nuclear targets for SNF1 kinase phosphorylation include the Rod1 protein that resides at 
the plasma membrane (Becuwe et al. 2012). Glucose responsive phosphorylation of both 
nuclear Mig1 and cytosolic Rod1 can be directly assessed by Western analysis by their 
visible phospho-shift to higher molecular weights (Treitel et al. 1998; Becuwe et al. 
2012). We find a noticeable upwards phospho-shift of each target in low glucose in both 
WT and ubc1Δ strains (Fig. 6.2D). Although there is an apparent decrease in Mig1 
protein abundance in the ubc1Δ strain, the phospho-shift is not impaired, nor is there a 
defect in the expected Mig1 nuclear export under activating conditions (Fig. 6.9C). 
Therefore, Ubc1 deletion does not impair the enzymatic activity of SNF1 kinase. 
	  	  















cells only with overlay L
ow
   









   




   
  -   + 
WT ubc1Δ 
  -   +   -   + 
WT ubc1Δ 


















WB: Mig1ph-TAP  
H          L         H         L                 glucose 




WB: Rod1ph-TAP  
WB: Rod1tot#-TAP 
H          L         H          L            glucose 
	  	  
	   82	  
Figure 6.2 Loss of Ubc1 function does not impair SNF1 kinase 
nuclear accumulation, allosteric associations or substrate targeting.  
A, Fluorescent microscopy of GFP-tagged yeast Snf1 constitutively 
expressed from a high copy 2µ plasmid or B, expressed from the 
endogenous Snf1 promoter in isogenic WT and ubc1Δ strains grown 
under repressive (2% glucose) or shifted to activating (5% glycerol for 
30 minutes) conditions. The percent of cells with Snf1-GFP nuclear 
accumulation was quantitated from four biological repeats. 125 
consecutive cells were scored for co-localization of GFP and DAPI 
signal in high and low glucose in the isogenic WT and ubc1Δ strains. C, 
2-hybrid associations between empty vectors (-) and Snf1-Snf4 pairs 
(+) in WT and ubc1Δ strains are shown. Equal cell numbers were 
spotted down a glucose gradient (0.05% to 2% glucose) before and after 
β-galactosidase color development from overlay. D, Isogenic WT and 
ubc1Δ strains harboring endogenous TAP-epitope tags to Mig1 and 
Rod1 were divided into high (H: 2%) and low (L: 0.05%) glucose 
media for 30 minutes prior to cell lysis. Duplicate sample were run in 
parallel on 10% acrylamide gels (for total TAP-protein; Mig1tot and 
Rod1tot, upper panels) and 7.5% (to enhance the phospho-shift; Mig1ph 
and Rod1ph, lower panels). WB: Western Blot primary antibody/target. 
Light: non fluorescent 100 x objective. GFP: green fluorescent protein 
epitope tag. DAPI: (4',6-Diamidino-2-Phenylindole, Dihydrochloride) a 
fluorescent DNA interchelator.  
 
6.3.3 Snf1 protein abundance, but neither stability nor phosphorylation, is 
decreased by Ubc1 disruption  
An obvious question to ask was whether the role of Ubc1 in SNF1 kinase 
regulation was to target Snf1 for ubiquitination, and ultimately degradation. It is known 
that the catalytic Snf1 α-subunit can be poly-ubiquitinated and its abundance affected 
(Wilson et al. 2011). We compared the steady-state abundance of endogenous Snf1-GFP 
protein in logarithmically growing WT and ubc1Δ strains (Fig. 6.3A) and observed a 
clear decrease in Snf1 abundance, irrespective of the activation state of the enzyme, 
limited to the ubc1Δ strain. This is not consistent with Ubc1-dependent ubiquitination 
and subsequent degradation of Snf1, as this would instead manifest as an increase in Snf1 
protein in the UBC1 deletion. Activating Snf1 phosphorylation was maintained at near-
WT levels despite the decrease in total Snf1 protein (Fig. 6.3A). In addition to Snf1, 
protein levels of both the endogenous Snf4 γ and Gal83 β subunits were likewise 
decreased in the ubc1Δ strain, compared to WT (Fig. 6.3B). To directly assess if there 
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was enhanced degradation of Snf1 in the absence of Ubc1 function, we performed CHX 
protein degradation assays of Snf1 over a 3-hour period (Fig. 6.3C) in WT and ubc1Δ 
strains. Snf1 was stable over the three-hour period in the WT strain and also appeared 
stable in ubc1Δ. To confirm the stability of Snf1 in the ubc1Δ strain, a biological repeat 
was performed with a greater protein load (80 µg/lane versus 40 µg/lane) (Fig. 6.3D). 
These results suggest that Ubc1 does not play a role in Snf1 protein stability. 
 
 
Figure 6.3 Snf1 protein abundance, but neither stability nor 
phosphorylation, is decreased by Ubc1 disruption. A, Early 
logarithmic phase WT and ubc1Δ strains harboring genomic Snf1-GFP 
were grown in 2% (H) and 0.05% (L) glucose for 1 hour prior to cell 
lysis, and equal total protein loaded in duplicate for Western analysis of 
total Snf1 (Snf1tot-GFP) and phosphorylated Snf1 (Snf1ph-GFP).  B, 
WT and ubc1Δ strains harboring genomic Gal83-TAP or Snf4-TAP 
were treated as in (A) and Western analysis for TAP abundance is 
shown. C, Assessment of Snf1 protein stability over 3 hours in WT and 
ubc1Δ strains in the presence of cycloheximide, added at time (0), in 
2% glucose. Equal cell numbers were removed at the indicated time 
points with 40 µg loaded. D, Biological repeat of Snf1-GFP stability (as 




	   84	  
6.3.4 SNF1 expression and Forkhead protein abundance are decreased upon Ubc1 
deletion   
We addressed the possibility that SNF1 transcription was decreased in the ubc1Δ 
strain, as an explanation for the decreased abundance of the Snf1 protein. RT-PCR of the 
SNF1 gene revealed a clear decrease in mRNA level in the ubc1Δ strain (Fig. 6.4A), 
being approximately 50% that of the isogenic WT (Fig. 6.4B).  We had previously found 
the yeast FOXO orthologs, Fkh 1 and Fkh2, to be involved in SNF1 gene expression (Jiao 
et al. 2015) and asked if the absence of Ubc1 function was affecting Fkh1/2 activity, 
upstream of Snf1. In asynchronous cells, we observed that disruption of UBC1 noticeably 
diminished Fkh1 protein abundance, while Fkh2 protein was essentially absent in the 
same strain even when significantly more protein (lysate) was tested (80 µg/lane for Fkh2 
versus 15 µg/lane for Fkh1) (Fig. 6.4C). Fkh1 and Fkh2 are known to be transcriptionally 
regulated in synchrony with the cell cycle under the influence of a third forkhead 
member, Hcm1 (Pramila et al. 2006). Yeast strains deleted for UBC1 have been found to 
exhibit with cell cycle defects and to accumulate with large buds in late G2/M phase 
(Seufert et al. 1990). Indeed, we found that the protein abundance of endogenous Clb2 
was markedly elevated in the ubc1Δ strain as compared to WT, consistent with an 
accumulation of cells residing in G2/M phase when Clb2 levels are highest (Hollenhorst 
et al. 2000).  To confirm this, FACS of early logarithmic (OD600 of 0.4) asynchronous 
yeast cells from ubc1Δ strains demonstrated a significant inherent accumulation of cells 
with fully replicated DNA (2n) in G2/M (Fig. 6.4D). Light microscopy of cells 
representative of those undergoing FACS show a heterogeneous population in WT with 
various bud sizes, yet a clear accumulation of large budded yeast cells in ubc1Δ, 
consistent with previous reports of G2/M delay (Seufert et al. 1990). The published report 
noting that FKH1 and FKH2 transcript levels are highest in G2/M phase and lowest in G1 
(Pramila et al. 2006) was inconsistent with the decreased Fkh protein levels we observed 
in the ubc1Δ strain partially stalled at G2/M, leading us to investigate this further. 
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Figure 6.4 SNF1 expression and Forkhead protein abundance are 
decreased by Ubc1 deletion. A, SNF1 and rRNA products from RT-
PCR (26 cycles) were run on an agarose gel. RNA was isolated from 
isogenic WT and ubc1Δ strains that were grown to early log phase. B, 
Quantitation of three biological repeats of SNF1 and rRNA abundance 
from (A) is shown with mean, SEM, and t-tailed significance (Prism 
6.0). C, The transcription factors Fkh1 and Fkh2 were endogenously 
TAP-tagged within the WT and ubc1Δ strains, and steady-state protein 
levels in 2% glucose (Fkh1-TAP left panel, 15 µg/lane, and Fkh2-TAP 
right panel 80 µg/lane) assessed by Western analysis. Clb2 is detected 
endogenously. D, Light microscopy (100x objective) of an early 
logarithmic asynchronous culture showed the proportion of large-
budded cells, with corresponding FACS identifying the relative 
population of cells with replicated DNA (2n) in ubc1Δ compared to the 
WT strain. 
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6.3.5 Snf1 protein and glucose-responsive SUC2 expression levels are nearly 
reestablished by Fkh1 or Fkh2 overexpression in the ubc1Δ  strain  
Given that Fkh1 and Fkh2 can drive the expression of SNF1 (Jiao et al. 2015), and 
that Fkh1/2 gene expression fluctuates with the cell cycle, we asked if Snf1 protein levels 
fluctuate in synchrony with the cell cycle. There have been no reports of SNF1 kinase 
being regulated in a cell cycle dependent manner to the best of our knowledge. A G1 
arrest-release experiment was performed in WT yeast to determine the inherent 
abundance of the Snf1 subunit protein level throughout the cell cycle. Fig. 6.5A reveals 
that Snf1 protein levels do not change as synchronized cells exit G1 and pass through the 
cell cycle, with fluctuations of Clb2 used as a surrogate marker for passage through the 
cell cycle (Kuhne and Linder 1993). Further confirmation of successful synchronization 
comes from the FACS analysis of these cells, showing the gradual shift of 1n to 2n 
(replicated) DNA (Fig. 5B). To ascertain if the decreased Snf1 abundance was a simple 
result of limited forkhead proteins, Fkh1 and Fkh2 were constitutively expressed from 
plasmids in the ubc1Δ strain. The resulting Snf1 protein (Fig. 6.5C) and SNF1 transcripts 
(Fig. 6.5D) are increased with Fkh1 expression, which is not as apparent with Fkh2. 
Advancing one step further, we similarly investigated if Fkh1 or Fkh2 expression in the 
ubc1Δ strain restored the low-glucose-activated SUC2 expression to that of WT levels. 
Figure 6.5E shows that low glucose-induced expression of SUC2 is at, or higher than, 
WT levels in the presence of the Fkh1 plasmid.  
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Figure 6.5 Snf1 protein and glucose-responsive SUC2 expression 
levels are reestablished by Fkh1 or Fkh2 overexpression in the 
ubc1Δ strain. A, α-factor arrest release of the WT yeast strain 
harboring an endogenous Snf1-GFP tag, with detection of Snf1-GFP 
and endogenous Clb2. Equal cell numbers were taken after release from 
G1 phase at the time points indicated, and Western analysis of the cell 
lysates as shown. B, Corresponding FACS of samples in (A) at the 
indicated time points, with un-replicated (1n) and replicated (2n) DNA 
abundance indicated.  C, Western analysis of steady-state Snf1-GFP 
protein levels in WT and ubc1Δ strains with, or without, 2µ plasmid 
expression of Fkh1 (pFkh1) and Fkh2 (pFkh2) in 2% glucose. D, RT-
PCR (26 cycles) of SNF1 and rRNA expression in the ubc1Δ strain 
with, and without, independent 2µ plasmid expression of Fkh1 (pFkh1) 
and Fkh2 (pFkh2), with comparison to isogenic WT. E, RT-PCR (26 
cycles) of SUC2 expression under repressive (H: 2%) and activating 
(L:0.05%) glucose levels with strains and plasmids as described in (D). 
F, RT-PCR of genes encoding SNF1 kinase γ subunit (SNF4), β subunit 
(GAL83), SUC2 repressor, MIG1, and the FKHs (FKH1, FKH2), 
comparing the ubc1Δ and WT strains. Asy: asynchronous. G1: α-factor 
arrest in G1. 
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To distinguish between etiologies underlying the decreased protein abundance of 
Fkh1 and Fkh2 (Fig. 6.4C), Snf4 and Gal83 (Fig. 6.3B) and Mig1 (Fig. 6.2D), we asked 
if the ubc1Δ deletion also affected their transcription. With the exception of Snf4, all RT-
PCR products were of lower abundance in the ubc1Δ strain (Fig. 6.5F). Our data suggests 
that Fkh1/2 transcription of SNF1 does not fully control Snf1 protein abundance in the 
ubc1Δ strain; despite compensated SNF1 mRNA levels (Fig. 6.5D), Snf1 protein levels 
did not reach that of WT (Fig. 6.5C). Furthermore, constitutive plasmid expression of 
Snf1-HA within the ubc1Δ strain did not result in WT levels of Snf1 protein (Fig. 6.9A), 
suggesting that Snf1-HA is decreased in the ubc1Δ strain regardless of its endogenous 
transcription. Finally, we tested whether over-expression of the Snf4 γ subunit would 
enhance Snf1 proteins levels, and concluded that it did not (Fig. 6.9B).   
6.3.6 Hcm1 is impaired in its cell cycle-dependent nuclear import, upon deletion of 
Ubc1 
We sought a more detailed explanation for the decrease in Fkh1 and Fhk2 
expression within the ubc1Δ strain, and focused on Hcm1, the Fkh family member 
known to regulate Fkh1 and Fkh2 expression in a cell cycle dependent manner (Pramila 
et al. 2006). We tested both Hcm1 protein abundance, and its ability to shuttle between 
the cytosol and nucleus. We first found that the steady-state protein abundance of Hcm1 
was modestly decreased upon disruption of the UBC1 gene (Fig. 6.6A), although the 
protein appeared stable over an extended three-hour period (Fig. 6.6B). Hcm1 normally 
exhibits regulated nuclear import during G1 of the cell cycle, and we asked if the 
expected nuclear accumulation of Hcm1 in G1 (Rodriguez-Colman et al. 2013) is, in fact, 
disrupted by deletion of the UBC1 gene. Fluorescent microscopy was used to determine 
endogenous Hcm1-GFP location within cells arrested in G1 and then released. We 
observed a clear nuclear accumulation in arrested WT cells, in direct contrast to a lack of 
nuclear-GFP signal in the ubc1Δ strain arrested in G1 (Fig. 6.6C). The morphology of the 
yeast cells, combined with the flow analysis (Fig. 6.6D) confirms that G1 arrest was 
successful in WT and ubc1Δ strains.  
To further analyze Hcm1 protein abundance differences between the WT and 
ubc1Δ strains, we compared the Hcm1 protein level throughout the cell cycle after G1 
arrest and release in WT. Figure 6.7 showed the cell-cycle fluctuations in Hcm1 protein 
	  	  
	   89	  
levels, fully consistent with Hcm1 levels reported by others (Landry et al. 2014). 90 
minutes after release, Hcm1 protein level reached maximum, followed by a decline at 120 
minutes at which time Clb2 levels peaked. Supporting this, FACS analysis and 
microscopy images collected at the 120 minute time-point are consistent with late 
mitosis/telophase; fully replicated (2n) and late mitosis (double budded, nuclei separated) 
(Fig. 6.7B).  The doublet signal observed for the Hcm1-GFP Western Blot analysis is not 




Figure 6.6 Hcm1 is impaired in its cell cycle dependent nuclear 
import upon deletion of Ubc1. A, Equal numbers of early logarithmic 
phase cells from WT and ubc1Δ strains with, or without, an endogenous 
Hcm1-TAP tag were lysed followed by TAP Western analysis. B, 
Assessment of Hcm1 protein stability over 3 hours in WT and ubc1Δ 
strains in the presence of cycloheximide, added at time (0), in 2% 
glucose. Equal cell numbers were removed at the indicated time points 
with 30 µg loaded. C, Fluorescent microscopy of genomically 
integrated GFP-tagged Hcm1 expressed from its endogenous promoter 
in isogenic WT and ubc1Δ strains. Both strains were arrested in G1 
followed by release, with cells collected at the indicated time-points. D, 
FACS analysis of cells collected at the time-points in (A), highlighting 
the relative proportion of replicated DNA (2n) upon release from G1.  
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6.3.7 Ubc1 impacts SNF1 gene expression in an APC-independent manner 
Ubc1 is known to act with the APC to facilitate the metaphase-to-anaphase 
transition, and we were interested in determining whether Ubc1’s impact on transcription 
was APC-dependent, or –independent. We made use of yeast cells harboring the Apc5 
subunit mutation (apc5CA), to test this.  Figure 6.7C indicates that SNF1 gene expression 
was not affected in the apc5CA temperature sensitive strain, and was decreased only in 
ubc1Δ cells. We next compared if the cell cycle arrest position and cell morphology 
between the apc5CA and ubc1Δ strains were similar. Early logarithmic, asynchronous, 
yeast cells from ubc1Δ and apc5CA strains were analyzed using FACS and cells were 
imaged using propidium iodide staining of nucleic acid (Fig. 6.7D). Interestingly, the 
inherent arrest point of the ubc1Δ strain exhibited a distinctly different 1n/2n content, and 
nuclear positioning to that of apc5CA cells (Fig 6.7D). Together, these results clearly 
indicate that the role of Ubc1 on SNF1 expression is independent of the APC. 
6.3.8 Schematic of Ubc1-dependent mechanisms and potential targets impacting 
SNF1 kinase activity   
Figure 6.8 graphically summarizes the observations made regarding the role of 
Ubc1 in SNF1 kinase function. In general, deletion of Ubc1 function resulted in 
decreased protein abundance of all three SNF1 kinase subunits tested, with transcriptional 
declines limited to Snf1 and Gal83 subunits, as Snf4 expression was not affected. The 
maintenance of WT-levels of Snf1 phosphorylation suggests a rebalancing of upstream 
kinase and phosphatase activities. The impaired SNF1 expression is due to a simultaneous 
decrease in FKH1 and FKH2 expression and protein levels, ultimately appearing to arise 
from a failure of Hcm1 to accumulate in the nucleus to facilitate their transcription. The 
Ubc1 protein target involved in Hcm1 shuttling is not known. Enhanced allosterism 
within the SNF1 kinase complex may arise from the relative hyper-phosphorylation of 
Snf1, or from the loss of a Factor X that contributes to steric hindrance of subunit 
associations. 
	  	  
	   91	  
 
Figure 6.7 Hcm1 abundance is cell cycle dependent. Cells arrest at 
late M phase upon Ubc1 deletion. A, α-factor arrest release of the WT 
yeast strain harboring an endogenous Hcm1-GFP tag, with detection of 
Hcm1-GFP and endogenous Clb2. Equal cell numbers were taken after 
release from G1 phase at the time points indicated, and Western 
analysis of the cell lysates as shown. B, Corresponding FACS analysis 
of WT samples in (A) at the indicated time-points, with un-replicated 
(1n) and replicated (2n) DNA content indicated. Light images (100x 
objective) indicate the cell morphology and nuclear position (propidium 
stained nucleic acid). C, RT-PCR (26 cycles) of SNF1 and rRNA 
expression in the ubc1Δ apc5CA strains, with comparison to isogenic 
WT. D, FACS of early logarithmic asynchronous cultures 
demonstrating the relative population of cells with replicated DNA (2n) 
in ubc1Δ and apc5CA strains, compared to isogenic WT, with 
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Figure 6.8 Schematic models of Ubc1-dependent mechanisms and 
their potential targets impacting SNF1 kinase activity. In the ubc1Δ 
strain, the Hcm1 protein fails to shuttle to the nucleus in a cell cycle 
dependent manner. The mechanisms is unknown, yet may include the 
failure of Ubc1 to degrade a cytosolic Hcm1 tether, or to provide an 
ubiquitin-mediated import signal. The lack of nuclear Hcm1 results in 
impaired expression of FKH1/2 genes, which required Hcm1 for 
expression. The decrease in Fkh1/2 protein in turn impedes the 
expression, and subsequent protein abundance, of Snf1. The Snf1 
protein present, however, retained its functional ability to target 
cytosolic (Rod1) and nuclear (Mig1) proteins for phosphorylation, and 
itself be phosphorylated and trans-located in response to activating 
conditions. There are enhanced allosteric associations between Snf1 and 
the regulatory Snf4 subunit in the absence of Ubc1 function, again by 
an unknown mechanism that may involve the removal of a moiety 
causing steric hindrance, Factor X. No obvious candidate protein is 
known that associates with the activated complex that would be 
stabilized by a loss of E2 activity. 
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Figure 6.9 Snf1 protein levels are decreased in the ubc1Δ strain, 
regardless of its transcription level. A, HA tagged Snf1 subunit was 
constitutively expressed from a high copy 2µ plasmid in WT and ubc1Δ 
strains. Transformed strains were divided, grown under activating (L) 
and repressive (H) glucose concentrations, and protein lysates taken for 
anti-HA Western analysis. B, plasmid expression of constitutively 
expressed Snf4-GST in the ubc1Δ strain (UBC1−) does not compensate 
for WT (UBC1+) protein levels of Snf1-HA (also plasmid expressed). 
Total protein was tested using anti-HA or anti-GST Western Blot. Anti-
Tubulin and Actin western analysis was used as loading control. L: 
0.05% low glucose; H: 2% high glucose. C, Fluorescent microscopy of 
GFP-tagged Mig1, a SUC2 transcriptional repressor constitutively 
expressed from a high copy 2µ plasmid in WT and ubc1Δ strains grown 
under repressive (2% glucose) or shifted to activating (5% glycerol for 
30 minutes) conditions. Light: non-fluorescent 100 x objective. GFP: 
green fluorescent protein epitope tag. DAPI: (4',6-Diamidino-2-
Phenylindole, Dihydrochloride) a fluorescent DNA interchelator. 
 
6.4 Discussion   
The SNF1 kinase/AMPK family of enzymes are tightly regulated, non-hormonal, 
sensors of stress and nutrient availability that facilitate adaptation of cellular pathways to 
maintain homeostasis. The yeast SNF1 kinase is a heterotrimeric protein kinase complex 
that is activated, in part, by energy and nutrient limitations via an essential 
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controlling their activation and activity is also of great interest.  Many fields, not the least 
of which is the potential benefit to human health, will advance with greater knowledge of 
regulatory targets to enhance the activity of these enzymes.  
Through its kinase function, activated SNF1 kinase shifts the utilization of 
specific metabolic pathways in order to maintain cellular ATP levels (Hardie et al. 1998). 
The SNF1 kinase is strongly evolutionarily conserved from yeast to humans, and 
fundamental mechanisms regulating SNF1 kinase activity in yeast have been proven to be 
likewise used in higher eukaryotes, including the essential phosphorylation on its α 
subunit, regulated dephosphorylation, allosteric subunit associations, and nuclear 
shuttling (Hedbacker and Carlson 2008). In addition to these discrete steps in SNF1 
kinase activation, it has also been reported that the catalytic α subunit of the yeast SNF1 
kinase, Snf1 is poly-ubiquitinated and degraded (Wilson et al. 2011), similar to an earlier 
report of this mechanism acting on the human ortholog, AMPK (Al-Hakim et al. 2008). 
Of note, we do not find evidence for inherent Snf1 protein instability and degradation in 
these experiments, irrespective of the kinase activation state or glucose availability (Fig 
6.3A).  
The covalent attachment of ubiquitin to a target protein requires the concerted 
action of the ubiquitin-activating (E1), ubiquitin-conjugating (E2), and ubiquitin-ligase 
(E3) activities (Finley et al. 2012), and specific protein targets are recognized and 
selected by specific E2/E3 combinations (Rodrigo-Brenni and Morgan 2007). The 
identity of the E2(s) required for the reported ubiquitin conjugation to Snf1 has not been 
reported in yeast or in other eukaryotes to our knowledge, and as an approach to identify 
these factors, we systematically screened E2 deletion strains for effects on invertase 
activity, a SNF1 kinase-dependent event. Given the well-known consequence of protein 
stability changes upon ubiquitination, we had predicted that deletion of important E2 
enzymes in Snf1-ubiquitin targeting would create a stabilizing effect on Snf1, with the 
possibility of enhanced SNF1 activity due to Snf1 accumulation.  
Here, we do not report the E2 involved in targeting Snf1 for ubiquitination. 
Instead, we report that deletion of the gene encoding the E2 Ubc1 resulted in a ~50% 
reduction of SNF1 kinase activity that did not arise from deficiencies in glucose-
regulated nuclear import or subunit associations, or in its ability to target cytosolic or 
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nuclear targets for phosphorylation. Rather, the explanation resides in the noticeable 
decrease of Snf1 protein in the ubc1Δ strain, regardless of whether the growth conditions 
are activating or repressive for SNF1 kinase activity (Fig. 6.3A). It is interesting to note 
that, despite lower total Snf1 protein, a conspicuous and consistent enhancement of Snf1-
Snf4 interactions exists throughout the 2-hybrid glucose gradient (Fig. 6.2C) and the 
relative degree of Snf1 phosphorylation is maintained at near WT levels (Fig. 6.3A), yet 
was not capable of complementing for SNF1 kinase invertase activity. A simultaneous 
decrease of the β  (Gal83) and γ (Snf4) subunits of the SNF1 kinase heterotrimer in this 
strain very likely contributes to this decrease in nuclear activity. This phenomenon of 
Snf1 hyper-phosphorylation has been noticed previously (Hsu et al. 2015) and has been 
proposed to be a compensatory mechanism to preserve SNF1 kinase function, with our 
results suggesting that it may also extend to allosterism. Decrease in the level of one 
subunit within SNF1 kinase has also been shown to correspond to decreases in the 
remaining (Elbing et al. 2006). Accordingly, we observed decreases in the γ subunit 
(Snf4) and the β subunit (Gal83) in the ubc1Δ strain (Figure 6.3B), perhaps as a means of 
preserving normal stoichiometry within the enzyme complex.  
 One of the major functions of ubiquitin conjugation is to target proteins for 
degradation by the proteasome (Seufert et al. 1990). In contrast to protein degradation 
resulting from poly-ubiquitination through lysine-48 chains, mono-ubiquitination of 
proteins has been shown to contribute to protein stability (Torres et al. 2009). 
Furthermore, ubiquitin conjugation can also have other important functions unrelated to 
protein degradation such as subcellular trafficking and protein associations (Wiebel and 
Kunau 1992). Ubc1 is known to contribute to lysine-48 poly-ubiquitin chain formation 
(Rodrigo-Brenni and Morgan 2007), whereas in vivo reports of intrinsic mono-
ubiquitination activity were not found. Interestingly, we found the Snf1 subunit to be 
stable for hours in both the WT and ubc1Δ strains (Fig. 6.3C), without detection of higher 
molecular weight bands under these physiological conditions to suggest Snf1 is poly-
ubiquitinated. While the stability of Snf1 in the WT strain was initially unexpected, it is 
clear that the previously reported affects of Snf1 instability in response to SUMOylation 
and ubiquitination required the forced accumulation of poly-ubiquitin chains attached to 
Snf1. This was enabled by genetic manipulation of the yeast strains, through disruption of 
	  	  
	   96	  
the gene encoding the ubiquitin-removal function, UBP8, and the resulting poly-
ubiquitinated proteins that are targeted for proteasomal degradation (Wilson et al. 2011; 
Simpson-Lavy and Johnston 2013). Otherwise Snf1 was not noticeably degraded.  
 Unexpectedly, the deletion of UBC1 resulted in a substantial decrease in SNF1 
expression (Fig. 6.4A and 6.4B), and is likely a strong contributing cause for the low 
Snf1 protein levels in this strain. This correlates with a simultaneous decrease in Fkh1 
and Fkh2 protein and transcript levels (Fig. 6.4C and 6.5F). We had previously 
demonstrated that Fkh1, and to a lesser extent Fkh2, are necessary for SNF1 expression 
(Jiao et al. 2015). Constitutive expression of either Fkh1 or Fkh2 in the ubc1Δ strain 
returned SNF1 transcript levels towards WT levels; Fkh1 was able to restore Snf1 protein 
levels and SUC2 induction to a greater extent than Fkh2 alone (Fig. 6.5C and 6.5E).   
 The expression of FKH1 and FKH2 fluctuates with the cell cycle, and we asked if 
the inherent cell cycle defect in ubc1Δ might be affecting the low Fkh1/2 levels. The 
ubc1Δ strain is reported to arrest as large budded cells, which we also observed (Fig. 
6.4D). Our FACS analysis confirmed the high proportion of cells with replicated DNA 
indicating G2/M (Fig. 6.4D), and our propidium iodide staining for nuclei acid shows that 
the nuclei have clearly separated (Fig. 6.2A & B, Fig. 6.7E), altogether consistent with a 
late mitotic arrest. Lastly, the clear accumulation of Clb2 in asynchronous ubc1Δ cells is 
known to be a result of deficient E2 activity for the APC-dependent targeting of Clb2 for 
degradation, which is required for cell cycle progression through M into G1 (Rodrigo-
Brenni and Morgan 2007), explaining the arrest point of the ubc1Δ strain. The discrete 
differences between the apc5CA mutant and ubc1Δ cell cycle arrest points suggests that the 
Ubc1 cell cycle defect may be APCCdh1 mediated. APCCdh1 controls the M/G1 transition, 
whereas APCCdc20 controls the metaphase/anaphase transition. General defects in APC 
function result in large budded cells with the nucleus aligned at the bud neck, as observed 
in Fig. 6.7D. Nonetheless, our observation indicates the cell cycle arrest in ubc1Δ cells is 
consistent with an isolated impairment of APC activity. Furthermore, the expression of 
FKH1/2 is normally high in G2/M in WT cells (Pramila et al. 2006), yet we note an 
unexpected clear decrease of FKH1/2 expression in the ubc1Δ strain that is enriched for 
G2/M phase cells. The answer appears to be due to Ubc1 affecting Hcm1, a third member 
of the Fkh transcription factor family. Hcm1 is known to drive FKH1/2 expression 
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(Pramila et al. 2006). A decline in Hcm1 protein abundance may explain the low Fkh1/2 
protein levels in the absence of Ubc1, as Hcm1 was present at lower levels in the ubc1Δ 
strain, even compared to WT M-phase cells (peak expression of Hcm1) (Fig. 6.6A, Fig. 
6.7A). What also became evident, however, was a specific defect in Hcm1 nuclear entry: 
Hcm1 is known to shuttle between the cytosol and the nucleus in a cell-cycle manner, 
which controls its availability to the promoter regions of target genes, including FKH1/2 
(Rodriguez-Colman et al. 2010). It is interesting to find that deletion of UBC1 severely 
impairs the nuclear accumulation of Hcm1 in G1 arrested cells (Fig. 6.6B). The role of 
ubiquitin in regulated nuclear import of target proteins has been well established 
(Muratani and Tansey 2003; Hoeller and Dikic 2009). Accordingly, Ubc1 may normally 
target Hcm1 directly (or indirectly through an associated chaperone protein) for 
ubiquitination to promote import of Hcm1, or alternatively target a cytosolic tether for 
degradation. The identity of such a putative Ubc1-target controlling Hcm1 nuclear import 
was not revealed in this study, and we were unsuccessful in identifying Hcm1-ubiquitin 
conjugates through co-immunoprecipitation experiments (not shown).  
 It is also intriguing that a search of the literature revealed evidence that activated 
Snf1 is, in fact, a requirement for Hcm1 nuclear import (Rodriguez-Colman et al. 2013). 
It is possible, therefore, that the decreased Snf1 protein abundance in ubc1Δ cells 
contributes to a negative feed-forward loop, impairing Hcm1 import and ultimately 
decreasing Fkh1/2 expression and protein abundance. This possibility deserves further 
investigation, as despite decreased Snf1 abundance, the relative activation state, as 
measured by its Thr210 phosphorylation, remains at WT levels.   
We have discovered that the ubiquitin-conjugating enzyme, Ubc1, is indirectly 
required for SNF1 kinase activity at the level of transcription. Ubc1 function was first 
associated with the cellular stress response (Seufert and Jentsch 1991), and later with 
vesicle biogenesis, endoplasmic reticulum associated degradation (ERAD) (Meusser et 
al. 2005), and APC-dependent mechanisms for regulated cell cycle progression (Rodrigo-
Brenni and Morgan 2007). What we describe here appears to be a novel function for 
Ubc1 that is independent of the APC ubiquitin ligase complex. 
The schematic cartoon in Figure 6.8 highlights our observations and several 
questions that surround the regulation of SNF1 kinase by Ubc1 activity. Despite WT 
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levels of phosphorylation, nuclear import, and kinase activity on cytosolic and nuclear 
targets, there remains a deficiency in this activated complex to provide full SUC2 
expression. A simple explanation is that this may relate to the relatively low abundance of 
each of Snf1-Snf4-Gal83 protein subunits found in this heterotrimeric enzyme complex in 
the Ubc1 deletion strain. This decrease in Snf1 protein levels appears to be indirectly 
affected by Ubc1 through transcription via the Fkhs and Hcm1 and not through ubiquitin-
mediated protein degradation. However, there appears to remain an overriding regulation 
of Snf1 protein levels that ultimately serves to maintain a stoichiometric balance between 
the three SNF1 kinase subunits. Secondly, the mechanism underlying the Ubc1-
dependent failure of Hmc1 nuclear import is not known. Potential Ubc1 protein targets 
involved in Hcm1 shuttling are not reported, but may include a cytosolic tether that 
normally requires Ubc1 for degradation and subsequent release of Hcm1. Alternatively, 
ubiquitin can serve as a nuclear import signal and this would be a novel role for Ubc1. 
Next, the enhanced allosterism noted within the SNF1 kinase complex in the ubc1Δ strain 
may arise from the relative hyper-phosphorylation of Snf1 at Thr210, or from the loss of 
a Factor X that contributes to steric hindrance of subunit associations. Disruption of the 
UBA domain in Snf1 also resulted in enhances allosteric associations (Jiao et al. 2015), 
opening the possibility that this domain or protein face may have protein-binding partners 
that physically regulate SNF1 kinase activity through binding.   
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Table 6.1 Saccharomyces cerevisiae strains used in Chapter 6 
 
Strain	  	   Genotype	   Reference	  
yTER32  MATa trp1-901 leu2-3 ura3-52 his3-200 gal4∆ gal80∆  
LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lac 
E. Craig 
yTER301 UBC1/ubc1Δ::KanMX6 W. Xiao 
yTER305 yTER32 + ubc1::KanMX6 This study 
yTER206 MATa ade2 his3 leu2 ura3 SNF1-GFP::HIS3 Life Technologies 
yTER279 MATα his3-Δ200 leu2-3 112 ura3-52 lys2-801 trp1-1 (Seufert and Jentsch 1991) 
yTER277 MATα his3-Δ200 leu2-3 112 ura3-52 lys2-801 trp1-1  
ubc1Δ::HIS3 
(Seufert and Jentsch 1991) 
yTER299 yTER206 × yTER277 This study 
yTH3926 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52  
FKH1-TAP::HIS3 
T. Harkness 
yTH3929 MATa ade2 his3Δ200 leu2-3 lys2Δ201 ura3-52  
FKH2-TAP::HIS3 
T. Harkness 
yTER303 yTH3926 + ubc1Δ::kanMX6 This study 
yTER304 yTH3929 + ubc1Δ::kanMX6 This study 
yTER246 MATa his3∆0 leu2∆0 met15∆0 ura3∆0  
MIG1-TAP::HIS3 
Open Biosystems 
yTER297 MATa his3∆0 leu2∆0 met15∆0 ura3∆0  
ROD1-TAP::HIS3 
Open Biosystems 
yTER306 yTER246+ ubc1Δ::kanMX6 This study 
yTER307 yTER297 + ubc1Δ::kanMX6 This study 
yTER311 MATa ade2 his3 leu2 ura3 HCM1-GFP::HIS3 Life Technologies 
yTER312 yTER311+ ubc1Δ::kanMX6 This study 
yTER117 MATa his3∆0 leu2∆0 met15∆0 ura3∆0  
GAL83-TAP::HIS3 
Open Biosystems	  
yTER313 yTER117+ ubc1Δ::kanMX6 This study 
yTER1 MATa his3∆0 leu2∆0 met15∆0 ura3∆0 SNF4-TAP::HIS3 Open Biosystems 
yTER314 yTER1+ ubc1Δ::kanMX6 This study 
yTER315 MATα ade2 his3Δ200 leu2-3,112 lys2Δ201 ura3-52 
apc5CA-PA::His5+ 
T. Harkness 
yTER316 MATa ade2 his3Δ200 leu2-3,112 lys2Δ201 ura3-52 
apc10::KanMX6 
T. Harkness 
yTER187 MATa ade2 his3Δ200 leu2-3,112 lys2Δ201 ura3-52 This study 
yTER70 MATa ade2 his3Δ200 leu2-3,112 lys2Δ201 ura3-52 
snf1Δ::KanMX6 
(Jiao et al. 2015)  
yTH1482 MATα ade2 his3Δ200 leu2-3,112 lys2Δ201 ura3-52  
mig1Δ::LEU2 
M. Carlson 
yTER344 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 HCM1-TAP::HIS3 GE Dharmacon 
yTER346 yTER344+ ubc1Δ::KanMX6 This study 
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CHAPTER 7 The E3 ubiquitin ligase Rsp5 is required for SNF1 kinase activity  
7.1 Introduction 
The SNF1 kinase is required for adaptation to non-glucose carbohydrate growth, 
its preferred carbohydrate source. Disruption of SNF1 kinase activity or activation 
renders yeast unable to efficiently grow on alternative carbohydrate sources such as 
sucrose, giving a clear phenotype for which it is named (Carlson et al. 1981). Under 
conditions of abundant glucose, the kinase is inactive, cytosolic, and non-phosphorylated, 
yet is rapidly activated when grown under limiting glucose conditions or on non-glucose 
carbon sources (Carlson et al. 1981; Hardie et al. 1998). Activation of the SNF1 kinase 
trimeric complex is not limited to the essential phosphorylation of the catalytic α subunit, 
Snf1, at Thr210 (McCartney and Schmidt 2001), but also includes the allosteric 
juxtapositioning of the α and γ subunits within the heterotrimeric complex (Jiang and 
Carlson 1996), and relocation to the nucleus (Hedbacker et al. 2004), vacuole (Yu et al. 
2012), or plasma membrane (Schmidt and McCartney 2000), a movement dependent on 
the respective presence of three β subunits Gal83, Sip1, or Sip2 (Vincent et al. 2001). 
Activated SNF1 kinase rapidly targets other proteins for phosphorylation, thereby 
rebalancing metabolic pathways to maintain homeostasis. At the same time, transcription 
factors are nuclear targets of active SNF1 kinase, resulting in alterations of gene 
expression that establish sustained shifts in cellular metabolism. There is striking 
evolutionary conservation of the structure, function, and regulation of this kinase family 
extending to plants, animals, and humans where it is often referred to as AMPK (Crozet 
et al. 2014). Many fundamental mechanisms found to control this AMPK enzyme class 
have arisen from discoveries in S. cerevisiae, an extremely valuable model because of the 
simplified number of SNF1 kinase subunits available, ease of manipulating enzyme 
activity, and genetic malleability of the organism (Hardie 1999; Nath et al. 2003; Woods, 
Johnstone, et al. 2003; Hedbacker and Carlson 2008). 
  Additional layers of SNF1 kinase regulatory control are also known, and include 
additional post-translational modifications to the catalytic and regulatory subunits such as 
SUMOylation (Simpson-Lavy and Johnston 2013), acetylation (Lu et al. 2011), and 
ubiquitination (Wilson et al. 2011), the latter two of which have been shown to also occur 
in higher eukaryotes (Al-Hakim et al. 2008; Zungu et al. 2011; Eden et al. 2012). In 
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general, the consequences of ubiquitination are diverse and encompass proteasomal 
degradation (Hoeller and Dikic 2009), subcellular localization (Eden et al. 2012; Davis et 
al. 2013), protein associations and enzyme activation (Zungu et al. 2011). This rapidly 
reversible modification is enabled through an exquisitely regulated cascade of ubiquitin-
conjugating (E2s) and ligase (E3) enzymes that direct target selection, balanced by the 
de-ubiquitinating enzymes that in concert modify the resulting linkages between ubiquitin 
moieties (Pickart and Raasi 2005). To date, the result of direct ubiquitin attachment to 
Snf1 appears to be inhibitory as measured both by degradation of the α subunit and 
decreased activity upon downstream targets (Wilson et al. 2011). 
The ubiquitin system and its regulatory pathways is one of the most highly 
conserved biological processes, and it is reasonable to anticipate that an elucidation of the 
role of ubiquitin in yeast SNF1 kinase regulation will translate to aspects of regulation of 
AMPK-like kinases in other eukaryotes. To identify the E2 and E3 enzymes important in 
SNF1 kinase activity, we screened for defects in SNF1 kinase adaptation to growth in 
sucrose when their individual activities were disrupted. S. cerevisiae has thirteen E2 
enzymes that exhibit a variety of distinct phenotypes and cellular defects when their 
individual E2 activity is disrupted (Finley et al. 2012). We identified the stress-related 
E2s (Ubc4 and Ubc5) and Rsp5, the cognate E3, as being robustly involved in regulated 
SNF1 kinase activity. Here we present evidence that the ubiquitin system plays a role in 
SNF1 kinase activity at multiple steps including allosteric associations and nuclear 
accumulation.  
7.2 Materials and Methods 
7.2.1 Strains and media 
The yeast strains used in this study are shown in Table 7.1. Yeast were grown at 
30°C in rich media (YPD: 10 g/l yeast extract, 20 g/l bactopeptone, 20 g/l glucose) or in 
synthetic complete drop-out media (DO: 20 g/l glucose, 1.7 g/l yeast nitrogen base, 5 g/l 
ammonium sulfate) lacking the appropriate nutrient for plasmid selection. The 
concentration of glucose was decreased from 2% to 0.05% as indicated. 
7.2.2 Invertase assay 
Protocols have been previously described in section 3.5.  
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7.2.3 Total protein extract, protein stability assays, and Western Blot analysis 
  Protocols have been previously described in section 3.1 and 3.2. Anti phospho-
AMPK (Cell Signaling, detecting Snf1-Thr210), GFP (Covance), TAP (Open 
Biosystems), Actin (Sigma), and α-tubulin (Sigma) antibodies were used in this study. 
Protein stability assays (time course) have been previously described in section 3.3. 
Strains harboring integrated TAP- or GFP-epitope tags were expressed under their 
endogenous promoters. CHX (10 µg/ml) was added to prevent further protein synthesis at 
the time of culture division into 2% and 0.05% glucose media (0 min). Actin or tubulin 
signal is from the same nitrocellulose blot as GFP or TAP in every case.  
7.2.4 Construction of a temperature-sensitive rsp5ts 2-hybrid reporter strain 
A two-step PCR-based mutagenesis protocol was used to introduce the rsp5ts 
(P772S) (Harkness et al. 2002) temperature-sensitive (ts) mutation directly into the PJ69-
4α 2-hybrid strain. PCR fragment 1: 5’ primer to the C-terminal 500 bp of RSP5; 3´ 
primer fused with 60 nucleotides of DNA 100 bps upstream of URA3. Genomic DNA 
isolated from the rsp5ts strain is used as template. PCR fragment 2: 5’ primer 100 bp 
upstream of the URA3 gene start codon; 3´ primer fused with 60 nucleotides immediately 
downstream of the RSP5 gene. Purified PCR fragments 1 and 2 were co-transformed into 
the PJ69-4α strain, which encodes the ura3-52 mutant allele. Homologous recombination 
of the two PCR fragments introduced the recombined PCR fragment into the genome 
precisely at the 3´ end of RSP5 with incorporation of the P772S mutation. Selection of 
recombinants was through growth on plates lacking uracil (URA-), temperature 
sensitivity, and sequence confirmation, based on methods described previously (Storici 
and Resnick 2006). 
7.2.5 2-hybrid analysis 
Protocols have been previously described in section 3.6. The yeast 2-hybrid 
reporter strain (WT) and the temperature-sensitive rsp5ts 2-hybrid reporter strain were 
doubly transformed with pairs of empty vectors: empty vectors pGAD-C2 and pGBDU-
C2 (−), or the same backbones expressing unmodified Snf1 and Snf4 subunits (+) in this 
study. 
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7.2.6 Fluorescence microscopy 
Protocols have been previously described in section 3.4. Fluorescence microscopy 
was used to determine the subcellular localization of Snf1-GFP in live yeast cells. Each 
strain was transformed with a 2µ HIS+ plasmid expressing SNF1-GFP (a kind gift from 
M. Carlson). Logarithmic phase growth cultures were divided between non-activating 
DO media (Vincent et al. 2001) lacking histidine with 2% glucose versus activating (3% 
glycerol, no glucose) conditions for no more than 30 minutes. A minimum of 150 cells 
for each strain was scored for co-localization of the GFP-tagged Snf1 signal and DAPI 
nuclear staining. If the GFP signal did not accumulate in the nucleus (nuclear), nor was it 
excluded from the nucleus (cytoplasmic), the GFP signal was scored as homogeneous. 
7.2.7 Statistical analysis 
Statistical analyses used PRISM Version 6.0b software, showing mean and SD, 
with significance calculated by t-test. 
7.3 Results 
7.3.1 Invertase activity is impaired in strains disrupted for Ubc4 and Ubc5 E2 
activity and Rsp5 E3 activity 
Activated SNF1 kinase targets the nuclear transcriptional repressor, Mig1, for 
phosphorylation, thereby releasing the inhibition of the SUC2 gene that encodes for 
invertase (Treitel et al. 1998; McCartney and Schmidt 2001). This enzyme converts 
sucrose to glucose and fructose, and facilitates the adaptation of yeast metabolism to this 
alternative sugar source (Carlson et al. 1981; Carlson and Botstein 1982). A quantitative 
colorimetric assay for glucose production from sucrose (the invertase assay) was utilized 
to screen yeast strains disrupted for yeast E2s for their involvement in this activity 
(Harkness and Arnason 2014). The screen is particularly useful as it reveals both loss of 
nuclear SNF1 kinase activity (in low glucose) and loss of glucose repression (in high 
glucose). Figure 7.1A demonstrates the expected rise in invertase activity in WT yeast 
after 2 hours of growth in low (0.05%) glucose, at either 30°C or 37°C. UBC4 and UBC5 
were disrupted in combination as they exhibit strong homology and can effectively 
compensate for each other; phenotypes are evident upon their combined disruption in the 
deletion strain used (ubc4/5Δ) (Seufert and Jentsch 1990). Our data shows that the 
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combined deletion of these E2s result in significantly decreased invertase activity (Fig. 
7.1A and 7.1B). There are many E3 enzymes in yeast and an exhaustive screen of all was 
beyond the scope of our investigation, yet several have links to SNF1 kinase that were of 
interest to test. Elc1 (Elongin C 1), an E3 ubiquitin ligase, had previously been reported 
to affect the stability of Snf4 (Hyman et al. 2002), yet we found invertase was not 
impacted by disruption of the ELC1 gene (Fig. 7.1A). The APC is a multi-subunit E3 and 
has been associated with SNF1 kinase function in longevity pathways (Harkness et al. 
2004). Mutation of the Apc5 subunit, which is essential for APC activity, did not 
significantly alter invertase maximums (Fig. 7.1A). The ubiquitin ligase Rsp5 and SNF1 
kinase both target the arrestin-like protein, Rod1, for ubiquitin and phosphorylation, 
respectively (Becuwe et al. 2012). Rsp5 also targets glucose and galactose transporters, 
among others, in response to glucose levels (Roy et al. 2014) (Horak and Wolf 2001). 
Notably, Rsp5 is known to act as the ubiquitin-ligase for Ubc4/5 and Ubc1 (Stoll et al. 
2011), and to share overlap with their stress-resistance phenotypes (Hiraishi et al. 2006). 
Mutations to Rsp5 severely impaired invertase activity in a temperature dependent 
manner (Fig. 7.1A and 7.1B). As shown, invertase activity is significantly decreased to 
less than 15% of WT in the rsp5ts mutant at non-permissive temperatures (37°C), and 
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Figure 7.1 Yeast strains lacking ubiquitin enzymes Ubc4/5 and 
Rsp5 are impaired for SNF1 kinase-dependent invertase activity. 
Comparison of invertase activity under repressive (2% glucose) and 
activating (0.05% glucose) conditions between isogenic yeast strains 
normalized to WT in 0.05% glucose (value of 100), showing the mean 
and SD. A, Invertase activity of WT, ubc4/5Δ, elc1Δ, apc5ts, and rsp5ts 
after 2 hours of activating growth conditions. For ts mutants, permissive 
(30°C) or non-permissive (37°C) temperatures were used to impair 
function of the target proteins. Statistical significance was based on 3 
biological repeats using a t-test (Prism 6.0).  B, A time-course for 
invertase activity of WT, ubc4/5Δ, and rsp5ts strains, sampled 
intermittently over 2 hours following shift to low glucose media. 
Average of four biological repeats with SD are indicated for each time 
point. A and B were performed by Dr. T.G. Arnason. 
 
A time course invertase assay was performed on strains mutated for Ubc4/5 or 
Rsp5 to better appreciate the differences from wild type activity (Fig. 7.1B). The WT 
strain rapidly increased invertase activity. The ubc4/5Δ mutant strain failed to generate 
any meaningful invertase activity, similar to that observed at the non-permissive 
temperature in the rsp5ts strain. Again, growth at 30°C appeared only semi-permissive for 
the rsp5ts activity, as it never reached that of WT (Fig. 7.1A).  
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7.3.2 The Snf1 α subunit is stable under activating and repressive growth 
conditions, independent of Rsp5 activity 
Maximal invertase activity requires that all preceding steps of SNF1 kinase 
activation occur efficiently, including phosphorylation of Snf1-Thr210, allosteric 
associations between Snf1 (α) and Snf4 (γ), and translocation of the trimeric complex to 
the nucleus (β, Gal83). However, it was possible that the role of ubiquitin in SNF1 kinase 
regulation was through alterations in subunit stability due to E2 and E3 targeting activity. 
Time course stability studies of the endogenous Snf1 protein (Fig. 7.2A) revealed that 
Snf1-GFP is stable up to 2 hours in the WT strain. Neither repressive nor activating 
glucose levels affected its stability. Next, the protein stability of endogenously expressed 
Snf1-GFP in the rsp5ts strain was assessed by a protein stability time-course that included 
CHX addition and tested over 3 hours (Fig. 7.2B and 7.2C). This was done at semi- 
(30°C) and non-permissive (37°C) temperatures for the rsp5ts conditional mutant strain. 
Figure 7.2C clearly revealed complete stability of the Snf1 catalytic subunit in the 
absence of full Rsp5 function.   
7.3.3 Phosphorylation of Snf1 does not require Ubc4/5 or Rsp5 
The profound decrease in invertase activity in the ubc4/5Δ and rsp5ts strains may 
be due to a failure of Snf1 activation by phosphorylation at Thr210 (Snf1ph). When tested, 
Snf1ph was induced to WT levels upon a shift to low glucose growth conditions in the 
ubc4/5Δ strain and the rsp5ts strain even at non-permissive growth temperatures (Fig. 
7.3A and 7.3B). A ratio of Snf1ph/Snf1-GFP from pooled data of repeat experiments 
highlighted this trend (Fig. 7.3C), and established that neither Rsp5 nor Ubc4/5 are 
required for efficient glucose-responsive phosphorylation of the Snf1 subunit. 
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Figure 7.2 Snf1 protein abundance is independent of Rsp5 activity. 
Early logarithmic phase WT and rsp5ts strains harboring genomic Snf1-
GFP were grown in 2% and 0.05% glucose prior to harvest. 
Cycloheximide was added at time 0 to prevent new protein synthesis. 
Equal amount of total protein was loaded for Western blot analysis of 
GFP (Snf1-GFP) and Tubulin as an internal loading control. A, 
Assessment of Snf1-GFP protein stability over 2 hours in the WT 
strain. B, Assessment of Snf1-GFP protein stability over 2 hours in the 
rsp5ts mutant strain under semi-permissive temperature. C, Assessment 
of Snf1-GFP protein stability over 2 hours in the rsp5ts mutant strain 






2% glucose 0.05% glucose 
  0    10    15   30   60  90  120 (min)
WT 30° C 
WB: Snf1-GFP!110 kDa - 
55 kDa - 
  0    10    15   30   60   90  120
WB: Tubulin 
2% glucose 0.05% glucose 
rsp5ts 30° C 
110 kDa - 
55 kDa - 
  0    10    15   30    60    90  120
WB: Snf1-GFP!
  0    10    15    30   60   90   120
WB: Tubulin 
(min)
2% glucose 0.05% glucose 
rsp5ts 37° C 
110 kDa - 
55 kDa - 
  0    10    15   30    60    90  120
WB: Snf1-GFP!




	   108	  
 
Figure 7.3 Efficient Thr210 phosphorylation of the Snf1 subunit is 
retained in the ubc4/5Δ and rsp5ts strains. Early logarithmic phase 
WT, ubc4/5Δ and rsp5ts strains expressing genomic Snf1-GFP were 
grown in 2% (H) and 0.05% (L) glucose for 30 minutes prior to cell 
lysis, and equal total protein loaded in duplicate for Western blot 
analysis of total Snf1 (Snf1tot-GFP) and phosphorylated Snf1 (Snf1ph). 
A, Comparison of Snf1ph versus Snf1tot-GFP in WT and ubc4/5Δ strains. 
B, Comparison of Snf1ph versus Snf1tot-GFP in WT and rsp5ts strains 
under either permissive (30°C) or non-permissive (37°C) temperature. 
And C, Statistical quantitation of three biological repeats of A and B, 
with mean and SD.  
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7.3.4 Rsp5 contributes to glucose-responsive allosteric subunit associations within 
the SNF1 kinase complex 
The preceding experiments did not identify the step at which the invertase activity 
was impacted by ubc4/5Δ or rsp5ts, as Snf1 stability and Snf1ph appeared unaffected. We 
next asked if allosteric associations between the α and γ subunits required an intact 
ubiquitin targeting cascade. The relative strength of associations between Snf1 and Snf4 
can be observed using the 2-hybrid colorimetric system. To directly test the role of the 
ubiquitin system in SNF1 kinase allosterism, we introduced the conditional rsp5ts 
mutation into a standard 2-hybrid reporter strain and measured the impact on Snf1-Snf4 
protein associations. Figure 7.4 shows the results of this experiment, comparing the WT 
and rsp5ts versions of the reporter strain, each transformed with pairs of plasmids, either 
empty vectors (-) or the Snf1-Snf4 pair (+). As seen in Figure 7.4, the relative color 
intensity increased down the concentration gradient for the WT strain grown at both 30°C 
and 34°C experiments. Introduction of the rsp5ts conditional mutation diminished Snf1-
Snf4 associations throughout the glucose gradient under semi-permissive temperatures, 
with an augmented effect at non-permissive temperatures. Cells were transferred to 30°C 
or 34°C for 2 hours prior to overlay and likewise incubated for another 16 hours before 
final color images were captured; the rsp5ts strain can grow at 34°C but will not survive 
under extended exposure to 37°C.  
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Figure 7.4 Rsp5 contributes to the allosteric subunit associations 
within the SNF1 kinase. 2-hybrid associations between empty vectors 
(-) and Snf1-Snf4 pairs (+) in WT and rsp5ts strains are shown under 
permissive (30°C) and semi-permissive (34°C) temperatures. Equal cell 
numbers were spotted down a glucose gradient (L: 0.05% to H: 2% 
glucose) before and after β-galactosidase color development from 
overlay. 
 
7.3.5 Compromised Rsp5 function impairs nuclear Mig1 phosphorylation by the 
SNF1 kinase  
A defect in Snf1-Snf4 physical associations under activating conditions may 
partially explain the decreased invertase production in the rsp5ts strain. Knowing that 
invertase activity also requires that the SUC2 transcriptional repressor, Mig1, is 
phosphorylated by nuclear SNF1 kinase in order to lift repression and permit invertase to 
be produced led us to isolate and analyze this step in activity (Goldstein and Lampen 
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1975). First, an extended analysis of Snf1ph was done in the rsp5ts strain at 30°C and 
37°C over a 2 hour time-course in high and low glucose (Fig. 7.5A and 7.5B).  A 
significant and sustained phosphorylation of Snf1 was noted in low glucose at both 30°C 
and 37°C. To test the requirement for Rsp5 in Mig1 phosphorylation, a similar 
experiment was done except that the shift to 37°C was introduced at the same time as the 
shift to low glucose. In Figure 7.5C, a Mig1-TAP signal was observed at time zero in 
0.05% glucose that shifts towards a lower band over time, consistent with a gradual loss 
of the Mig1 phospho-shift (Jiao et al. 2015). Our data indicates that the loss of Mig1 
phosphorylation is neither due to its stability in rsp5ts (Fig. 7.6A), nor the non-permissive 
temperature, as cells cultured at 37°C exhibit proper Mig1 phosphorylation (Fig. 7.6B). It 
suggests that, although SNF1 kinase remains phosphorylated and presumably active, its 
ability to phosphorylate Mig1 is specifically lost; the release of Mig1 inhibition on SUC2 
repression is impaired and may contribute towards the explanation for impaired invertase 
activity in the rsp5ts strain. Similarly, our data indicates that Mig1 phosphorylation is lost 
in the absence of UBC4/5, whereas Rod1, the cytosolic target of SNF1 kinase, continues 
to be phosphorylated in this double deletion strain under low glucose growth conditions 
(Fig. 7.5D, lower panel). These results suggest that SNF1 kinase is selectively impaired 
in its nuclear activity.  
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Figure 7.5 SNF1 kinase nuclear activity is impaired in ubc4/5Δ and 
rsp5ts strains. A and B, Western Blot analysis of Snf1ph in rsp5ts strain 
at 30°C and 37°C over a 2 hour time-course in SNF1 Kinase repressive 
(2% high glucose, H) and activating (0.05% low glucose, L) growth 
conditions. C, Mig1 phosphorylation under low glucose growth 
conditions in the rsp5ts strain upon a shift to non-permissive 
temperature (37°C) for 3 hours, D, SNF1 kinase–dependent 
phosphorylation of Mig1 (nuclear target) and Rod1 (cytosolic target) in 
WT and  ubc4/5Δ strains.  
	  	  
	   113	  
 
Figure 7.6 Rsp5 activity affects Mig1 phosphorylation, independent 
of the temperature. Early logarithmic phase rsp5ts strain harboring 
genomic Mig1-TAP were grown in 2% and 0.05% glucose prior to cell 
lysis. Equal amount of total protein was loaded for Western blot 
analysis of TAP (Mig1-TAP). A, Western analysis of Mig1-TAP 
protein stability over 2 hours in the rsp5ts strain, under permissive 
(30°C) or non-permissive (37°C) growth temperatures. B, Western 
analysis of Mig1 phosphorylation in WT strain under 2% glucose (H) 
repressive conditions versus 0.05% glucose (L) activating conditions. 
Cells were cultured at 30°C and 37°C prior to sample retrieval.   
 
7.3.6 Snf1 is mislocalized under activating conditions when either Rsp5 or Ubc4/5 
functions are impaired 
The maintenance of Snf1ph with a gradual loss of Mig1 phosphorylation, 
concurrent with the introduction of Rsp5 dysfunction (Fig 7.5C), next led us to ask if 
there was a specific defect in the nuclear import of Snf1 in the rsp5ts strain. It was 
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possible that the RSP5 and/or UBC4/5 mutations resulted in SNF1 kinase complexes that 
are either mislocalized or defective in nuclear accumulation, resulting in low invertase 
activity. Fluorescent microscopy was used to visualize the cellular location of the GFP-
tagged Snf1 subunit in WT yeast, and in the presence of mutant alleles of UBC4/5 and 
RSP5. Figure 7.7A-D shows representative images of the subcellular location of Snf1-
GFP in repressive (high glucose) and activating (low glucose) conditions, as compared to 
the DAPI signal identifying the yeast nucleus (and mitochondrial DNA to a lesser extent). 
Yeast frequently harbor relatively large vacuoles, seen as voids on both DAPI and GFP, 
particularly visible here for the rsp5ts and ubc4/5Δ strains. The WT strain (Fig. 7.7A) 
demonstrated clear Snf1-GFP nuclear exclusion in high glucose (as previously reported), 
and strong nuclear accumulation in low glucose. In contrast, there was a noticeable lack 
of nuclear accumulation in low glucose in the ubc4/5Δ strain, while retaining appropriate 
cytosolic location (with obvious nuclear exclusion) of Snf1-GFP in high glucose (Fig. 
7.7B). In some cells, the GFP signal appears excluded from the nucleus under activating 
conditions, as indicated by DAPI staining. In the rsp5ts strain at 30°, Snf1-GFP is able to 
accumulate in the nucleus when activated (Fig. 7.7C), yet this is clearly lost upon shifting 
to the non-permissive 37°C conditions (Fig. 7.7D). In this strain, we observe that under 
activating conditions, the Snf1-GFP signal is widely dispersed and was excluded from the 
nucleus in some cases. In both ubc4/5Δ and rsp5ts strains as compared to WT, we 
unexpectedly observed that the Snf1-GFP signal was occasionally enhanced within the 
vacuole to varying intensities, and in other cases was fully dispersed. To quantitate these 
differences in subcellular location under activating conditions, at least 150 cells per strain 
were scored for nuclear accumulation (% Nuclear), nuclear exclusion (% cytosolic), 
vacuolar accumulation (% vacuolar), and undifferentiated (% Homogeneous) (Fig. 7.7E). 
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Figure 7.7 Snf1-GFP is mislocalized under activating conditions 
when either Rsp5 or Ubc4/5 functions are impaired. A-D, 
Fluorescent microscopy of GFP-tagged Snf1 constitutively expressed 
from a high copy 2µ plasmid (His+) in WT, ubc4/5Δ, and rsp5ts strains 
grown under repressive (2% glucose) or shifted to activating (3% 
glycerol for 30 minutes) conditions. 2-hour pre-exposure of the rsp5ts 
strain to non-permissive temperature (37°C) was used to disable the 
Rsp5 function prior to microscopy. E, Quantitation of the subcellular 
location of Snf1-GFP under activating conditions correlated to the 
strains/temperature in A-D. 150 consecutive cells per condition were 
scored for nuclear (majority accumulated in the nucleus), cytosolic 
(majority in the cytoplasm with nuclear exclusion), vacuolar 
(accumulated in the vacuole), and homogeneous (undifferentiated 
between nucleus and cytoplasm). 
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7.4 Discussion 
The SNF1 kinase is a non-hormonal regulator of metabolism that is activated 
under times of nutrient limitation or stress to enable changes to biological pathways that 
permit survival and adaptation to changing growth conditions. The yeast S. cerevisiae is a 
powerful model system to study this kinase class, which has highly conserved orthologs 
throughout eukaryotes, collectively referred to as the AMPK family. Conservation from 
yeast to humans is not only at the structural and functional level, but also found in many 
upstream regulatory events and downstream results (Hong and Carlson 2007).  
Ubiquitination has been reported to modify the catalytic subunits in both yeast 
and human AMPK-related enzymes, and their poly-ubiquitin results in degradation and 
decreased kinase activity (Al-Hakim et al. 2008; Wilson et al. 2011). A negative 
regulatory role was therefore attributed to the direct attachment of ubiquitin to SNF1 
kinase complex and its human orthologs. While the existence of ubiquitin attachment 
directly onto Snf1 (and AMPK α subunits) is known, the specific enzymes within the 
ubiquitin targeting cascade affecting SNF1 kinase have not been identified. We screened 
yeast strains mutated for ubiquitin-conjugation (E2) and ubiquitin-ligase (E3) activities to 
identify those components involved in regulating SNF1 kinase through ubiquitin action. 
Unexpectedly, we find that specific ubiquitin cascade enzymes at both the ubiquitin-
conjugating (Ubc4, Ubc5) and ubiquitin-ligase (Rsp5) steps were required for positive, 
not negative, regulation of SNF1 kinase activity, without affecting Snf1 stability.  
The yeast strain harboring combined deletions of UBC4 and UBC5 exhibited 
significant defects in invertase activity. We have previously reported that Ubc1, also a 
stress-related E2, is required for SNF1 kinase activity, yet this requirement was at the 
level of transcriptional regulation of the SNF1 gene itself (Jiao et al. 2016). The Ubc1, 
Ubc4 and Ubc5 proteins have overlapping cellular functions in a general sense, all having 
been linked to the turn-over of short-lived and abnormal proteins and being necessary for 
survival under cellular stress (Seufert and Jentsch 1990, 1991).  
Selected E3s were also analyzed and most did not show a direct effect on SNF1 
kinase activity. Elc1 had previously been reported to affect the stability of Snf4 (Hyman 
et al. 2002) and due the potential impact of this on SNF1 kinase protein stoichiometry we 
felt it was possible that the overall enzyme activity may have been altered, yet changes in 
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SNF1 kinase activity were not detected. We also tested the APC, a multi-subunit E3 that 
has been associated with SNF1 kinase function in longevity pathways (Harkness et al. 
2004). Mutation of the Apc5 subunit, essential for APC activity, did not significantly 
alter invertase maximums. We did, however, observe significant defects when the E3, 
Rsp5, was mutated. 
The ubiquitin cascade is an orderly cascade of ubiquitin-attachment to selected 
targets and assembly of poly-ubiquitin chains, involving both E2s and E3s in the 
construction of the final chain formation. The E2s Ubc1, Ubc4 and Ubc5 have been 
reported to have functional associations with the cognate E3, Rsp5 (Arnason et al. 2005; 
Hiraishi et al. 2006). Functionally, Rsp5 can act as the ubiquitin-ligase for Ubc4/5 and 
Ubc1 (Nuber and Scheffner 1999), and shares overlap with their stress-resistance 
phenotypes (Hiraishi et al. 2006). Also, Rsp5 and SNF1 kinase both target the arrestin-
like protein, Rod1, for ubiquitination and phosphorylation, respectively (Becuwe et al. 
2012) and Rsp5 targets glucose and galactose transporters, among others, in response to 
fluctuating glucose levels (Horak and Wolf 2001; Roy et al. 2014). When directly tested, 
Rsp5 activity was found to be critical in facilitating maximum invertase activity (Fig. 
7.1). Given that SNF1 kinase functions in part through stress resistance pathways, 
identification of this cluster of E2 and E3 enzymes was particularly relevant.  
Given the well-known consequence of protein stability changes following 
ubiquitin attachment, we first tested if the stability of the Snf1 catalytic subunit was 
affected, which would provide an explanation for the loss of invertase activity. In fact, it 
was stable for hours in WT yeast. While initially unexpected, it became clear that the 
previously reported effects of Snf1 instability in response to SUMOylation (Simpson-
Lavy and Johnston 2013) and ubiquitination (Wilson et al. 2011) required the forced 
accumulation of poly-ubiquitin chains attached to Snf1. In addition, it has been reported 
that the AMPK-like β subunits specific to mouse brown adipose tissue were unstable with 
half-lives of less than one hour (Qi et al. 2008). It appears that this mechanism is not 
universally applicable as all yeast β subunits are stable regardless of activating or 
repressing conditions (Fig. 5.1B). 
In contrast to protein degradation resulting from poly-ubiquitination through 
lysine-48 chains, mono-ubiquitination of proteins has been shown to contribute to protein 
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stability (Torres et al. 2009). We asked if the result of removing key ubiquitin cascade 
component activity resulted in a change in Snf1 protein stability through absent mono-
ubiquitin placement. Rsp5 is known to be involved in the mono-ubiquitin of multiple 
targets (Stamenova et al. 2004; Torres et al. 2009) and we directly assessed Snf1 stability 
over time in the absence of Rsp5 function.  We observed that Snf1 remains fully stable 
for at least three hours in this strain, similar to WT yeast, essentially ruling out a 
stabilizing mono-ubiquitin event under Rsp5 control. Therefore, using our approach and 
strains, we do not find that Rsp5 affects the protein stability of Snf1. 
The activating phosphorylation of Snf1 at Thr210 residue is essential for its 
cellular functions and nuclear import (Hedbacker et al. 2004), and therefore is a key 
regulatory step to assess to explain changes in invertase activity. Each strain tested was 
capable of augmenting the Snf1ph signal in response to activating conditions at levels 
similar, or better, than in WT yeast. In contrast to the previously explored decrease in 
Snf1 subunit abundance unique to the ubc1Δ strain (Jiao et al. 2016), the amount of Snf1 
protein remained unaffected in the ubc4/5Δ and rsp5ts strains as compared to WT (Fig. 
7.3A and 7.3B). Quantitation of the relative Snf1ph signal to total Snf1 confirmed full 
Snf1ph is retained in ubc4/5Δ and rsp5ts strains and an explanation for loss of invertase 
function is not, therefore, through defects in the activating phosphorylation step. 
The increase in physical binding between the Snf1 and Snf4 subunits are well 
documented to occur in a glucose-responsive manner, and can be measured using the 
yeast 2-hybrid assay. In our study, the yeast 2-hybrid reporter strain was altered to 
include the temperature sensitive rsp5ts mutation (Harkness et al. 2002). Comparing the 
Snf1-Snf4 2-hybrid associations within the WT and rsp5ts strains reveals evidence that 
Rsp5 function is required for a normal degree of Snf1-Snf4 interactions. At 30°C, a 
partial interaction remains between Snf1 and Snf4, as well as a weak response to glucose 
levels, which may reflect the semi-permissive temperature used. The sub-lethal 
temperature of 34°C had to be used to permit survival of the rsp5ts strain throughout the 
duration of the experiment, and a more significant defect in Snf1-Snf4 associations are 
evident at 34°C compared to 30°C, presumably as Rsp5 function is lost. A complete 
disruption of detectable binding of Snf1 and Snf4 may occur at non-permissive 
temperatures (37°) but the temperature sensitive strain would fail to grow or form 
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colonies making it an unviable approach for this analysis. Because of the constant cross-
tethering of Snf1 and Snf4 to the β-subunit regardless of the activation state (Jiang and 
Carlson 1997), direct tests by co-immunoprecipitation studies, for example, is also not 
possible. It may be that Rsp5 normally targets a repressive SNF1 kinase-binding protein 
for ubiquitination and degradation.  
The disruption of Snf1-Snf4 allosteric associations in the rsp5ts strain could have 
provided sufficient explanation for the loss of invertase activity at non-permissive 
temperatures, as Snf4 is necessary for normal invertase activity and it drops essentially to 
zero in a snf4Δ strain (Hubbard et al. 1992). However, our observation that the 
phosphorylation of the SNF1 kinase nuclear target, Mig1, is lost over time and while 
Rsp5 function is gradually blocked, suggested that it may be the nuclear function of Snf1 
kinase that is specifically affected. In addition, Mig1 fails to be phosphorylated in the 
ubc4/5Δ strain, despite the cytosolic target, Rod1, remaining phosphorylated under the 
same conditions (Fig. 7.5D). This efficient phosphorylation of Rod1 in a glucose-
responsive manner in the ubc4/5Δ strain clearly indicates that the ubc4/5Δ mutation has 
retained the inherent enzymatic activities of SNF1 kinase, and is not the underlying cause 
for loss of invertase activity.  
Ubiquitination can affect target protein subcellular relocation (Eden et al. 2012; 
Davis et al. 2013) and ubiquitin-mediated control of nuclear import is well established for 
other proteins (Nie et al. 2007; Trotman et al. 2007). This led us to directly test if the 
nuclear import of Snf1 is impaired in the Rsp5 or Ubc4/5 mutant strains, using 
fluorescent microscopy. While the mechanisms regulating nuclear-cytosolic partitioning 
of SNF1 kinase in response to activating signals are unknown, we do know that the β 
subunit, Gal83, directs Snf1 to the nucleus. Snf1-Gal83-Snf4 protein complexes shuttle 
across the nuclear membrane depending on the Snf1 activation state; the inactive 
complex is nuclear-excluded in ideal growth conditions, but rapidly accumulates in 
response to low glucose. Interestingly, Gal83 will shuttle in a glucose-responsive manner 
in the absence of the Snf1 subunit, whereas Snf1 is nuclear-excluded in the absence of 
Gal83 (Vincent et al. 2001; Hedbacker and Carlson 2008). This suggests that Snf1 
‘piggy-backs’ into the nucleus with Gal83, relying on the nuclear localization/export 
signals within the latter. Unexpectedly, a non-phosphorylatable Snf1 mutant protein 
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restrains Gal83 in the cytosol and excludes it from the nucleus, suggesting that a cytosolic 
Snf1 tether exists.  
Our analysis of Snf1-GFP nuclear import within ubc4/5Δ and rsp5ts strains show 
obvious defects in the nuclear accumulation of Snf1-GFP under activating conditions 
(Fig. 7.7). Our work shows that a fully phosphorylated, active and stable kinase fails to 
efficiently accumulate in the nucleus, clearly implicating Ubc4/5 and Rsp5 activity in 
regulated Snf1 nuclear import. Furthermore, the defects appear to be subtly distinct 
between the two strains. To clarify what we were consistently observing through 
fluorescent microscopy under activating conditions, we quantitated several deviations 
from the import pattern in WT yeast. First, we noted that the clear accumulation of Snf1-
GFP in the nucleus decreased from ~90% in WT to less than 20% in ubc4/5Δ upon 
activation, and the rsp5ts strain showed a temperature-dependent decline, being 
profoundly effected at 37°C (Fig. 7.7E). What was clarified upon quantitation in the 
ubc4/5Δ and rsp5ts strains was the final location of Snf1-GFP upon activation. In the 
ubc4/5Δ strain, more than half of the Snf1-GFP exhibited an enhancement of vacuolar 
location, in contrast to the WT and rsp5ts strains that have negligible vacuolar signal. We 
also note that, as increasing temperature compromises Rsp5 function, the abundance of 
Snf1-GFP in the cytosol increases. Lastly, both the ubc4/5Δ and rsp5ts strains differ 
significantly from WT in that a significant proportion of Snf1-GFP signal becomes 
homogeneous, being diffusely localized throughout the nucleus and cytosol. We do not 
know the underlying mechanisms affected by the ubc4/5Δ and rsp5ts mutations that 
impair nuclear accumulation. Several explanations come to mind and will be tested in 
future studies. It is possible that this mislocalization might be expected if Gal83 function 
was lost, and only Sip1 (Hedbacker et al. 2004) or Sip2 (Vincent et al. 2001) β-subunit 
localization activity remained, respectively. Sip1 is the SNF1 kinase β subunit that directs 
Snf1 to the vacuole and Sip2 signals cytosolic localization under activating conditions 
(Vincent et al. 2001). 
Alternatively, it may be that Rsp5 is required for facilitated nuclear import, 
perhaps by ubiquitin-mediated degradation of a cytosolic tether under its control. We 
correlate the loss of Rsp5 activity with a failure of Snf1 to enter the nucleus as evidence 
supporting the concept of a cytosolic tether. It is also clear that removal of Ubc4 and 
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Ubc5 activities effects Snf1 subcellular location in a subtly different manner, due to the 
widespread lack of a discernably preferred location. The homogenous distribution of 
Snf1-GFP in this strain, in combination with the apparent mislocalization to the vacuole, 
implies that all three known sites (nucleus, cytosol and vacuole) are equally possible and 
unregulated in this strain.  
Given the great evolutionary conservation of both the AMPK family and the 
ubiquitin system, it is highly possible that these novel roles for ubiquitination in Snf1 
kinase regulation will hold true in high eukaryotes. Given the important role that AMPK 
plays in human metabolism, particularly when considering the current epidemic of 
obesity and DM2, we wonder if these insulin resistant states result in defects in nuclear 
localization of AMPK. An intriguing report in the non-metabolic human disease of 
Huntington’s Chorea noted the subcellular mislocalization of AMPK (Ju et al. 2011). 
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CHAPTER 8 General Discussion  
8.1 Conclusions 
As a key sensor of cellular energy levels, the AMPK family of kinase is 
ubiquitous and highly conserved in all eukaryotes, from yeast to humans. Its activation 
enables cells to respond rapidly to changes in environmental stress or nutrient limitations, 
through facilitating metabolic adaptations, namely a switch to catabolic pathways to 
preserve and release energy and nutrients and promote cell/organismal survival. In 
addition to survival, a functional AMPK is necessary to maintain homeostasis of the cells 
or body organs, thus it is highly relevant to organismal health. This is particularly 
relevant in human health, as AMPK activity is responsive to health issues including 
obesity, insulin resistance (DM2), cancers, and aging (Musi et al. 2001; Minokoshi et al. 
2002; McGee et al. 2003). Exercise and weight loss activate AMPK, resulting in a net 
negative energy balance. Model systems have supported the notion that pharmacological 
activation of AMPK can provide similar benefits to health as regular exercise and normal 
body weight. With an inability to effectively 'prescribe' weight loss and exercise as a 
therapy to promote health, there has been great interest in obtaining a better 
understanding of how AMPK and its family members are regulated and activated to 
ultimately use this information to improve health outcomes. In this thesis, the regulation 
of the yeast AMPK ortholog, SNF1 kinase, has been elucidated to reveal that fine-tuning 
of its activity and activation occurs at both the transcriptional and post-translational 
levels.  
 We first demonstrated that the conserved UBA motif found in the catalytic 
subunit of the SNF1 kinase has an inherent inhibitory role, and functions to restrain SNF1 
kinase activity. UBA motifs in general have the potential to non-covalently bind the 
globular head of ubiquitin attached to an unrelated protein and thereby affect enzyme 
activity and/or protein associations (Mueller and Feigon 2002; Varadan et al. 2005). 
However, this is not the role for the UBA domain in yeast, as previous work had 
elegantly determined that the UBA domain of the Snf1 does not bind mono- or poly- 
ubiquitin, as is true for all Class 3 UBA domains (Raasi et al. 2005). Therefore, the 
precise role of the UBA domain within the SNF1 kinase was undetermined. Our work 
demonstrated that conserved UBA mutations significantly alter SNF1 kinase activation 
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and biological activity including enhanced allosteric subunit associations within the 
heterotrimeric complex itself, and increased oxidative stress resistance and lifespan 
(Chapter 4). Significantly, the enhanced UBA-dependent longevity and oxidative stress 
response is at least partially dependent on the FOXO orthologs, Fkh1 and Fkh2, which 
are stress response transcription factors. Significantly, Fkh1/2 activity was demonstrated 
to influence SNF1 gene expression.  
In addition, we developed a novel 2-hybrid method to semi-quantitatively 
measure the allosteric associations between the SNF1 kinase subunits throughout a range 
of glucose concentrations representative of fully repressive (high glucose) to fully 
activating (low glucose) conditions. This method is based on the traditional β-	  
galactosidase colorimetric assay and the use of slant plate growth medium, which allow 
us to distinguish the intensity of protein-protein associations by color development. This 
technique supplies a direct way to compare the trend of protein associations under 
variable activating intensities. We observed that the UBA domain plays an inherent role 
in inhibiting the SNF1 kinase allosterism between the Snf1-Snf4 subunits, as there were 
enhanced associations in our Snf1UBA mutant. The precise mechanism to explain the UBA 
effects on subunit associations remains unclear, yet a glucose-responsive association of a 
peripheral protein with the hydrophobic face of the UBA domain may introduce steric 
hindrance (factor X) between Snf1-Snf4 proteins, thereby preventing full activation. This 
would enable a very subtle level of regulatory control, with much finer tuning than the 
simple 'ON/OFF’ switch of SNF1 kinase activity attributed to its phosphorylation at 
Thr210. We consider the possibility that the expression level of the SNF1 kinase subunits 
within the 2-hybrid vector system may be altered within ubc1Δ and rsp5ts mutant, 
compared to the WT, and therefore alter the 2-hybrid association strength. This will 
require a formal test of the Snf1 and Snf4 protein levels, which can be accomplished 
using commercially available antibodies.  
We next determined that the SNF1 kinase is regulated by its subunit 
stoichiometry, and that under physiological conditions the Snf1, Snf4, and three β 
subunits are stable proteins regardless of the activation state of the enzyme complex 
(Chapter 5). This is in direct conflict with that reported in yeast (Wilson et al. 2011) and 
human (Al-Hakim et al. 2008), where it was observed that the catalytic α subunit was 
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poly-ubiquitinated, which, in yeast alone, resulted in its degradation. In contrast to these 
prior studies, our experiments were performed under physiological conditions, without 
manipulation of the ubiquitin-proteasome system, and at endogenous protein levels. 
As part of our investigations, we aimed to identify the ubiquitin cascade enzymes 
involved in the formation of the poly-ubiquitin chains formed on the α subunits, and the 
influence on SNF1 kinase activity when we prevented their formation by mutating the 
ubiquitin-attachment site lysines. Yeast proteomics had previously identified lysines K80 
and K461 (Starita et al. 2012) within the catalytic subunit, Snf1, as ubiquitin attachment 
sites. In yeast, Snf1 poly-ubiquitination had been associated with its degradation, whereas 
in human cell line studies the stability of AMPK-related kinases was not affected by 
poly-ubiquitination. We have clarified this point by demonstrating that under 
physiological conditions, all endogenous subunits of the yeast SNF1 kinase complex are 
stable regardless of the enzyme activation state and poly-ubiquitination of Snf1 is not 
readily detectable in WT yeast. Deletion of either the β (Gal83) or γ (Snf4) subunits 
reduced Snf1 protein abundance independent of proteasome activity or K80 or K461 
availability, suggesting a stoichiometric correction amongst subunits, rather than 
ubiquitin-dependent degradation. Lastly, neither mutation at K80, K461, nor their 
combination, significantly impaired SNF1 kinase phosphorylation, its activity on 
transcriptional targets, or its stability, leaving the physiological importance of Snf1 
ubiquitination in question, as well as raising the possibility of additional as-yet unknown 
ubiquitin-attachment sites. 
We have searched for the E2 activity in yeast responsible for the previously 
reported poly-ubiquitination of the Snf1 subunit (Wilson et al. 2011). We screened yeast 
strains deleted for individual E2 activities and measured SUC2 expression as an indirect 
marker of SNF1 kinase activation and activity (Treitel et al. 1998; Sutherland et al. 
2003). Efficient SUC2 expression of invertase is dependent on the combined steps of 
phosphorylation, allosteric associations, nuclear import, and kinase activity, such that a 
defect in invertase enzyme activity may reflect a disruption at any of these steps.  If a 
specific E2 was responsible for poly-ubiquitination of the SNF1 kinase and its subsequent 
degradation, we predicted that its disruption would enhance SUC2 expression through 
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enhanced protein stability. However, this was not observed for any E2, and instead 
several were coupled with significant decreases in SNF1 kinase activity/activation. 
Chapter 6 describes our analysis of the role of the E2, Ubc1, in SNF1 kinase 
regulation after noting an intermediate defect in SUC2 expression in its absence. We 
identified Ubc1 as an important regulator of SNF1 kinase activity specifically at the level 
of transcription. The protein abundance of the Snf1 and Snf4 subunits is decreased in the 
ubc1Δ strain, yet their physical association is surprisingly enhanced when assayed using 
2-hybrid analysis. Furthermore, the Thr210 phosphorylation of Snf1 is relatively 
intensified in the ubc1Δ strain. Such hyper-phosphorylation has been noted previously in 
the literature and has been proposed to act as a compensatory mechanism to preserve 
SNF1 kinase activity despite decreased abundance (Hsu et al. 2015). Our results extend 
this compensatory mechanism to intensified allosterism. Our data suggests that the SUC2 
expression defect observed in the ubc1Δ strain comes in part from the reduced enzyme 
subunit stoichiometry, but not kinase activation, allosteric association, and nuclear 
localization as these necessary steps are fully preserved or enhanced. It is unclear how the 
Ubc1 E2 enzyme is involved in allosteric hindrance between Snf1 and Snf4 (factor X) 
and how it diminishes their 2-hybrid association.  
Our data also suggests that the SUC2 expression defect observed in the ubc1Δ 
strain comes from an impairment of SNF1 expression.  The protein abundance of Fkh1, 
Fkh2 and the third Fkh member, Hcm1, is significantly lower in ubc1Δ cells as compared 
to that of WT cells. Hcm1 is required for Fkh1/2 expression, likely explaining the latters’ 
decreased abundance. Significantly, Hcm1 fails to shuttle into the nucleus in the expected 
cell cycle-dependent manner when Ubc1 is not present, and is therefore unable to induce 
the expression of Fkh1/2. The details of how Ubc1 is involved in Hcm1 protein 
regulation and nuclear import are still unknown. It remains to be determined if Ubc1-
dependent ubiquitination of Hcm1 directly (or a tethering protein, indirectly) could 
regulate the Hcm1 protein nuclear import.  
 Chapter 7 describes our analysis of the role of the E2s, Ubc4 and Ubc5, in SNF1 
kinase regulation after noting a profound defect in SUC2 expression in their absence. We 
also reported on the impact that their cognate ubiquitin ligase, Rsp5, has on SNF1 kinase 
activation and activity. We determined that yeast strains disrupted for Ubc4/5 or Rsp5 
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function were markedly impaired for nuclear accumulation of the SNF1 kinase despite its 
full phosphorylation and activity, all without affecting Snf1 protein stability. These 
results supplement the knowledge that ubiquitination and the ubiquitin cascade are 
involved in protein trafficking and nuclear import/export. The result supports a positive 
role for ubiquitin in SNF1 kinase activation at multiple steps and is not limited to 
ubiquitin-dependent proteolysis.  
8.2 Future Directions 
Future investigations of the UBA domain of AMPK within other species 
including plants, fish, or mammalian cell lines would be beneficial. It will be of great 
interest to determine if equivalent UBA mutations in plants, fish, or mammals similarly 
increase the activity of the AMPK or AMPK-like enzymes, and if this translates into an 
enhanced survival response to environmental stresses (temperature, oxidative stress, poor 
quality nutrients) or an increase in lifespan. The point mutations within the UBA motif 
from our study (Jiao et al. 2015) and unrelated mutations in a previous publication 
(Momcilovic and Carlson 2011) confirmed the inhibitory role of the UBA domain in 
yeast. However, little is known in higher eukaryotes. Applications can be readily 
considered to that of increased crop yields or even aquaculture biomass. Fish are 
emerging as a vertebrate model to study aging, evolution, and stress response. 
Interestingly, the fish genome also encodes a conserved UBA motif within the AMPK α 
subunit, as in other species. The genetic manipulations on the UBA sequence within the 
fish genome has the potential to increase its survival from aquaculture stressors with 
enhanced population survival and, ultimately, protein yield. Another example would be 
plants where there is constantly a search to attain higher crop yields. This could 
potentially be done through UBA mutations, should this translate into greater crop 
survival under adverse temperatures, moisture, soil quality, or time to maturation. The 
plant genomes can be effectively manipulated to allow UBA mutations using available 
technology such as CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic 
Repeats). Sucrose non-fermenting related kinase 1 (SnRK1), the plant AMPK, was 
proven to act as a metabolic sensor, and respond to environmental stress (Crozet et al. 
2014). It would be supportive to show the increased stress responses when the UBA 
domain is mutated in plants.  
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We discovered that the E2 enzyme, Ubc1, regulates SNF1 kinase subunit 
abundance. We also determined that the subunits stoichiometry of the SNF1 kinase 
affects its enzymatic activity. Significantly, the decrease in Snf1 subunit abundance is 
due to the diminished transcriptional factors Fkh1/2, regardless of its own protein 
stability. The detailed mechanisms of the Hcm1 nuclear import dysfunction remains 
unsolved. One possible factor is ubiquitination of Hcm1 under the influence of Ubc1 
activity. The role of ubiquitin in protein subcellular localization has been widely 
investigated (Davis et al. 2013) and our observed dysfunction of Hcm1 nuclear 
localization in the Ubc1 mutant (Jiao et al. 2016) makes this a testable mechanism. It may 
be that ubiquitination of Hcm1 controls its nuclear-cytosolic shuttling. In addition, 
research indicated that Hcm1 can be degraded in an E3 SCF-dependent manner (Landry 
et al. 2014), further supporting the likelihood that Hcm1 is ubiquitinated. However, we 
did not detect an Hcm1-ubiquitin conjugate using co-immunoprecipitation. The 
identification of ubiquitination sites on Hcm1 has not yet been reported, yet mass 
spectrometry would be a sensitive means to determine the ubiquitination sites on Hcm1. 
Subsequent single mutations or combined mutations of ubiquitin attachment sites (i.e. 
lysine to arginine) would help us to understand if translocation of Hcm1 is directly 
regulated through ubiquitination.  
We were also very interested to observe that Snf1 subcellular localization is 
regulated by the ubiquitin enzyme cascade (Chapter 7) with subtle variations among the 
E2s and E3s identified. Surprisingly, even though Ubc4/5 and Rsp5 cooperate and 
associate under certain circumstances (Hiraishi et al. 2009; Stoll et al. 2011), the 
outcomes of Snf1 mislocalization upon mutation/deletion of these ubiquitin enzymes are 
quite different. Besides, a confocal microscopy could be used to visualize the Snf1-GFP 
distribution in yeast cells on a monolayer. This technique will further confirm the 
subcellular localization of Snf1 subunit.  
We observed that the disruption of Ubc4/5 activity resulted in an extremely large 
cell size, with slow growth, and possibly a stressed cell phenotype. Within these strains, 
we observed a significant mislocalization of the Snf1-GFP from the nucleus to the 
vacuole, under activating conditions. This could due to the stress of the cell, and it 
remains unclear if Snf1-GFP is localized within, versus on the membrane, of the vacuole.  
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This can be confirmed through confocal microscopy. It may also be possible that the 
vacuolar-targeting β subunit Sip1 may be preferentially associated with the SNF1 kinase 
hetero-complex in this strain. This idea can be examined using co-immunoprecipitation, 
2-hybrid assay or proximity ligation assays. We also observed that the Snf1 subunit was 
unable to accumulate in the nucleus without Rsp5 activity and instead dispersed 
homogenously throughout the cell. It remains unknown if Rsp5 directly binds to Snf1, if 
it ubiquitinates Snf1 directly, or if this is required for nuclear re-localization. The co-
immunoprecipitation of Rsp5 and the SNF1 kinase would help to show the potential 
physical interaction between the two. It is possible that Rsp5 targets Snf1 nuclear import 
indirectly, by targeting a potential cytosolic tether (Factor X) for degradation. Such a 
tether associated with Snf1 may also affect the Snf1-Snf4 associations that were altered 
upon loss of Rsp5 activity (Chapter 7). Specifically, Snf1-Snf4 associations remained 
weak under activating conditions, in the absence of Rsp5 activity. It is a testable 
possibility that this 2-hybrid inhibition is due to the steric hindrance of a non-degraded 
cytosolic tether. The identification of such a tether protein is unknown, but a possibility 
includes Bmh1 and Bmh2 (brain modulosignalin homolog), orthologs of 14-3-3 in 
mammalian systems. 14-3-3 has been proven to bind the UBA domain in fruit flies 
(Benton et al. 2002) and to associate with mitogen-activated protein kinase (MAPK), an 
AMPK-like kinase in mammalian systems (Goransson et al. 2006). Bmh2 has been found 
to physically associate with both Snf1 (Elbing et al. 2006) and Rsp5 (O'Connor et al. 
2015). Since the UBA motif within SNF1 kinase is inhibitory (Chapter 4) (Jiao et al. 
2015), the mutant UBA domain possibly associates with one or both of Bmh1 and Bmh2. 
In addition, Rsp5 has been proven to cooperate with 14-3-3 in yeast, supporting the 
possibility that Bmh1/2 may be a potential tether (Becuwe et al. 2012). It would be 
interesting to look at the phenotype of bmh1/2Δ mutant strains, as we would predict that 
nuclear import might be unregulated, or perhaps constitutive, in the 14-3-3 deletion 
strain. This may be observed in the bmh1/2Δ strain by testing Snf1 phosphorylation, 
SUC2 expression, lifespan and survival under stress conditions. Co-immnoprecipitation 
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